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ALLOSTERY AND APPLICATIONS OF THE LAC REPRESSOR
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The lac repressor has been extensively studied for nearly half a century; this long
and complicated experimental history leaves many subtle connections unexplored. This
thesis sought to forge those connections from isolated and purified components up to
functioning lac genetic switches in cells and even organisms. We first connected the
genetics and structure of the lac repressor to in vivo gene regulation in Escherichia coli.
We found that point mutations of amino acids that structurally make specific contacts
with DNA can alter repressor-operator DNA affinity and even the conformational
equilibrium of the repressor. We then found that point mutations of amino acids that
structurally make specific contacts with effector molecules can alter repressor-effector
affinity and the conformational equilibrium. All results are well explained by a Monod,
Wyman, and Changeux model of allostery. We next connected purified in vitro
components with in vivo gene regulation in E. coli. We used an in vitro transcription
assay to measure repressor-operator DNA binding affinity, repressor-effector binding
affinity, and conformational equilibrium. Only the repressor-operator DNA binding affinity
disagreed with literature values from other in vitro experiments, however it did agree with
a published value which should hold under in vivo conditions. We were able to use our
in vitro thermodynamic parameters to accurately predict the in vivo gene regulation when
cell crowding was considered. Finally we developed an autogenously regulated lac
repressor for AAV-mediated gene therapy. We were able to improve the gene regulation
of the autogenous switch by using multiple operator DNA sites, a tetrameric lac
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to function in various cell types and was capable of reversible regulation of luciferase in
living mice.
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Chapter 1:
The Lac Repressor and Gene Regulation
1.1

Introduction
All life exists in a universe of limited resources. Cells contain a multitude of

potential genes that they can express to achieve various aims and there is a significant
advantage to the cell to be able to choose which genes it is currently expressing in order
to best tailor itself to its environment. A red blood cell expresses hemoglobin in order to
maximize oxygen carrying capacity while a neuron does not. Similarly, sodium channels
are prevalent in the neuron to transmit electric pulses while they are utterly absent in the
red blood cell. Both carry the same genetic material, however they use a large
complement of gene regulation techniques to adapt to their respective environments.
The gene regulation of Escherichia coli (E. coli) is no different. Bacteria must
respond to changing environments: temperature changes, the availability of various
carbon sources, pH, the presence of other bacteria, etc. Bacteria that most efficiently
adapt to their environment will thrive. Those that express useless genes will waste
precious resources and ultimately fail to compete. It is no surprise then that a large
family of proteins has been identified in E. coli and other bacteria that specifically
regulate a huge complement of genes related to sugar metabolism. The LacI/GalR
family of proteins (Weickert & Adhya, 1992) includes more than 1000 members based
upon a 2008 Swiss-Prot BLAST search (Swint-Kruse & Matthews, 2009) and regulates
genes responsible for catabolism, toxicity, and nucleotide synthesis. In general, these
proteins all have a helix-turn-helix motif that binds one or more specific DNA operator
sequences and the affinity of this binding is allosterically modified by the binding of small
1

effector species (Swint-Kruse & Matthews, 2009). Typically, the effector is related to the
genes in question. For example, the lac repressor controls the synthesis of three genes
(lacZ, lacY and lacA encoding for β-galactosidase, β-galactoside permease and
thiogalactoside transacetylase, respectively) that encode for proteins related to lactose
metabolism (Lewis, 2005). The natural effector of the lac repressor is allolactose, a
byproduct of lactose catabolism by β-galactosidase (the product of the lacZ gene).
Allolactose binds the lac repressor and results in an allosteric conformational shift and a
loss of affinity for operator DNA. RNA polymerase is then free to transcribe the lacZ/Y/A
poly-cistronic message and lactose metabolism begins in earnest. This theme of the
effector (allolactose), an intermediate of the process to be regulated (lactose
metabolism), being sensed by a protein (lac repressor) that is used to change the
expression of genes that are metabolically functional (lacZ/Y/A) is repeated throughout
the LacI/GalR family (Swint-Kruse & Matthews, 2009).
This protein family is particularly fascinating because it combines in one
package several essential features of protein biology: DNA binding, small molecule
binding, and allostery. Furthermore, the net effect, regulation of a gene or set of genes,
is completely general: the lac repressor (and many other repressors and activators in the
LacI/GalR family) can be used to regulate any gene that is under control of a promoter
with a lac specific DNA operator sequence. This realization has led to a multitude of
generalized plasmids that constitutively express a repressor and have a second
regulated promoter followed by a multiple cloning site that can be used to insert the
researcher's gene of interest (e.g. the pET series for the lac repressor, the pBAD series
for the arabinose repressor). The system is so simple that it is not only applicable to the
bacteria where it initially was identified. The lac repressor has been used to control
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genes in embryonic stem cells (Caron et al., 2005) and even to control gene expression
in living mice (Cronin, Gluba, & Scrable, 2001).
So if the lac repressor is such a triumph of translational science, why continue to
study it? What is left that is unknown? First and foremost, the lac repressor has
essentially been applied as-is. The most commonly used protein is exactly that which
was initially found in E. coli despite the long held knowledge that the repressor
specifically evolved to optimally regulate lactose metabolism and not the multitude of
scenarios it is actually utilized in, such as toxic gene repression/over-expression or
eukaryotic gene regulation. It is well established that the gene regulation phenotype is
highly modifiable through point mutation (Kleina & Miller, 1990) leading to repressors
that have less leakiness (useful for toxic gene control), that turn the genes more “on”,
and that respond to different effectors and different concentrations. An understanding of
the physical basis for these phenotypic changes could lead to easier translation of
specific lac repressor mutants for specific applications.
The goal of this thesis was to take the current knowledge regarding the lac
repressor and to achieve two goals:
(1) to understand everything within a single theoretical framework or model, and
(2) to apply this knowledge to create genetic switches more ideal for their particular
applications.
1.2

Structure and Function in the Lac Operon
The history of the study of the lac operon mirrors the history of modern

biochemistry and biophysics. The earliest studies were related to the observation that
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cells could alter their ability to metabolize various compounds; one such compound was
the metabolism of lactose by E. coli. The “adaption” of cells from glucose to lactose
metabolism resulted in a diauxic growth curve; cells follow the typical exponential growth
as they metabolize glucose followed by a lag phase as glucose becomes depleted, then
a secondary exponential growth is observed as the cells switch to lactose metabolism
(Monod, 1942). The metabolism of lactose was quickly linked to the enzyme βgalactosidase which was observed to become more prevalent when bacteria were
growing on lactose versus glucose (Cohn, 1957). Studies measuring the accumulation
of radio-labeled galactosides led to the discovery that lactose is actively pumped into the
cell via β-galactoside permease which is also more prevalent during lactose growth
(Buttin, Cohen, Monod, & Rickenberg, 1956). The final regulated gene of the lac operon
was identified through the discovery of thiogalactoside transacetylase (Zabin, Kepes, &
Monod, 1962). What remained however was how the expression of these three genes
were tied to lactose metabolism. Before any actual repressor proteins were identified, a
groundbreaking analysis was performed to understand gene regulation. A negative
control scheme was described where the product of a gene, acting through the
cytoplasm, was able to regulate the synthesis of another set of genes modulated by the
presence of (usually metabolic) small molecules (Jacob & Monod, 1961). The
cytoplasmic agent however, was unknown. The modulation by small molecules was of
particular interest. It was known that other proteins exhibit a property wherein the binding
of a small molecule causes a change in functionality at a structurally (-steric) separated
(allo-) region (allostery). A “plausible” model of allostery was proposed which would, in
time, be shown to be applicable to the lac repressor (Monod, Wyman, & Changeux,
1965). The lac repressor was finally isolated one year later and determined to be the
“cytoplasmic agent“ responsible for regulation of gene expression predicted by Jacob
4

and Monod (Gilbert & Müller-Hill, 1966). Shortly thereafter it was determined that the lac
repressor reversibly binds to a specific DNA region (deemed the operator) to regulate
gene synthesis (Gilbert & Müller-Hill, 1967). Allolactose, a byproduct of lactose
metabolism by β-galactosidase, was found to be the effector in the lac operon (Jobe &
Bourgeois, 1972, 1973). It was not known however that allolactose worked through an
allosteric mechanism (the common prefix allo- means “other” or “different” and is simply
coincidental). DNA sequencing techniques were developed which led to the sequencing
of both the lac repressor (Farabaugh, 1978) and its operator DNA (O1) sequence
(Gilbert & Maxam, 1973). The second and third DNA operators (O2 and O3,
respectively) of the lac operon were discovered and found to also play a role in lactose
metabolism (Pfahl, Gulde, & Bourgeois, 1979). It was then shown that lac repressor
does not prevent binding of RNA polymerase to the promoter, but it does prevent the
initiation of transcription (Schmitz & Galas, 1979). At this point it was established that
the lac operon consisted of the lac repressor (constitutively expressed by the lacI gene)
binding to the DNA operators preventing transcription of the downstream poly-cistronic
message (lacZ/Y/A genes) in a reversible manner dependent upon the natural inducer
molecule allolactose or gratuitous inducers such as isopropyl β-D-thiogalactoside
(IPTG).
The focus at this point changed from identifying the players to identifying their
roles. Central to this focus was the slow problem of determining the three-dimensional
structure of the lac repressor alone and bound to its ligands (DNA and effectors). The
journey from the identification of the lac repressor to the first crystal structure 30 years
later includes a vast array of techniques to probe individual parts of the protein to
determine their individual roles in the overall functioning of the repressor.

5

The first issue was simply understanding what part of the amino acid sequence
of the lac repressor was responsible for what property or properties: folding,
dimerization, tetramerization, DNA binding, effector binding, and allosteric signaling.
Trypsin digestion provided the first clue as to the domain structure of the lac repressor.
Tryptic digestion cleaved the 59 amino-terminal (N-terminal) residues and 20 carboxylterminal (C-terminal) residues preserving a highly trypsin-resistant core (Files & Weber,
1976). These three regions of the protein proved highly relevant to the structure and
function of the lac repressor.
The N-terminal region of the lac repressor was isolated and was determined to
be necessary for DNA binding (Geisler & Weber, 1977) and found to specifically bind the
known O1 lac operator (Ogata & Gilbert, 1978). Modification of tyrosines with
tetranitromethane showed that Y7 and Y17 modifications significantly impaired both
specific and non-specific DNA binding, further indicating the role of the N-terminal region
of the repressor in DNA binding (Hsieh & Matthews, 1981). Genetic mapping was
undertaken on tight DNA binding mutants of the lac repressor and they were found to
correlate to two regions: the N-terminus and near amino acids 255 and 295 (Pfahl,
1981). A small angle X-ray scattering (SAXS) study indicated that the DNA binding sites
of the tetrameric lac repressor consists of the N-terminal 59 residues and that they lie at
opposite ends of an elongated tetramer (Mckay, Pickover, & Steitz, 1982). A genetic
study showed that of 131 amino acid substitutions in 38 of the first 62 N-terminal
positions, almost all abolished DNA binding and only two, P3Y and S61L, showed tighter
DNA binding (Miller, 1984). A nuclear magnetic resonance (NMR) structure of the Nterminal 51 residues showed the now classic helix-turn-helix motif and its structural
homology with two other DNA binding proteins cI and λ (Kaptein, Zuiderweg, Scheek,
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Boelens, & van Gunsteren, 1985) The helix-turn-helix motif has a recognition helix that
fits into the major groove of DNA and makes specific contacts with nucleotides and is a
major determinant of specificity in DNA binding. The specificity determining residues of
the recognition helix were determined to be tyrosine 17 (Y17), glutamine 18 (Q18), and
arginine 21 (R21) and they were thought to make specific contacts with positions 4, 5
and 6 of the DNA operator. Mutagenesis of Y17 and Q18 combined with changes at
positions 4, 5 and 6 showed that not only could DNA affinity be destroyed, but specificity
could be changed entirely (Sartorius, Lehming, Kisters, von Wilcken-Bergmann, &
Müller-Hill, 1989). This work would later be extended to more fully screen these positions
in both the operator and repressor in order to determine functional rules for specific DNA
binding (Milk, Daber, & Lewis, 2010). While two-dimensional NMR demonstrated
specific contacts between headpiece residues and DNA (Kaptein, Lamerichs, Boelens, &
Rullmann, 1990; Slijper, Bonvin, Boelens, & Kaptein, 1996), eventually an X-ray
crystallographic structure of the lac repressor-operator DNA complex was solved that
demonstrated exactly how the lac repressor binds DNA (Lewis et al., 1996; Pace, Lu, &
Lewis, 1990).
The next piece of the lac repressor was the trypsin-resistant core. Early on it
was found that a Y269S mutation and missense mutations at positions 210 and 216
failed to form tetramers (Schmitz, Schmeissner, Miller, & Lu, 1976). A genetic study then
linked approximately 2000 missense mutations to varying phenotypes and found most of
the trypsin-resistant core to be relatively tolerant to mutation although many interesting
phenotypes were still found within this region (Miller & Schmeissner, 1979). Chemical
modification of cysteine 281 decreased repressor affinity for inducer, indicating its
potential role in sugar binding (Daly, Olson, & Matthews, 1986) and this role was later
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confirmed through mutagenesis of C281 (Chakerian & Matthews, 1991). Arginine 197
was also found to be important for inducer binding (Spotts, Chakerian, & Matthews,
1991). Finally, a genetic study, wherein more than 4000 mutations were made along 328
positions of the lac repressor, identified the amino acids spread throughout the linear
sequence to be responsible for inducer binding (Markiewicz, Kleina, Cruz, Ehret, &
Miller, 1994). The crystal structure revealed an effector binding pocket that correlated
well with the genetic data (Daber, Stayrook, Rosenberg, & Lewis, 2007; Lewis et al.,
1996). Interestingly, there was a parallel evolution between the core region of the
LacI/GalR family and periplasmic sugar-binding proteins of E. coli (Fukami-Kobayashi,
2003). The core region was also responsible for dimerization. This dimerization could
be disrupted through mutation (Dong et al., 1999; Spott, Dong, Kisters-Woike, & MüllerHill, 2000) and exhibited plasticity, such that 22 point mutations in the dimer interface
could still form homo-dimers (Swint-Kruse, Elam, Lin, Wycuff, & Matthews, 2001). This
plasticity was elegantly demonstrated in a study that made a known mutant that
disrupted dimerization and looked for compensating mutations in the other monomer,
resulting in a hetero-dimeric lac repressor (Daber & Lewis, 2009). There was also a
structural realignment upon sugar binding within the core region (Barry & Matthews,
1997). The C-terminal lobe of the core region remains relatively unchanged with and
without sugar bound. The more N-terminal lobe, which connects to the N-terminal DNA
binding domain, exhibits a significant structural shift when sugar is bound. The dimer
interface of the N-terminal lobe is of particular interest. Lysine 84 was found to lie along
the dimer interface (Chang, Olson, & Matthews, 1993) and mutating this residue to
leucine (K84L) was found to stabilize the dimer (Barry & Matthews, 1999; Bell, Barry,
Matthews, & Lewis, 2001; Nichols & Matthews, 1997). Curiously, this stabilizing mutant
decreases both DNA and inducer affinity despite not directly being responsible for either
8

DNA or inducer binding, which points at an allosteric role. Indeed other residues in this
region were implicated to have allosteric importance, including alanine 110. The
mutation A110T lowered operator affinity and increased IPTG affinity, whereas A110K
increased operator affinity while decreasing IPTG affinity (Müller-Hartmann & Müller-Hill,
1996). It was later found that positions 94-98, which are known to make rearrangements upon sugar binding, also play a significant role in allosteric signaling
(Zhan, Camargo, & Matthews, 2010). The transmission of the allosteric signal was
beautifully mapped out through a targeted molecular dynamics simulation (Flynn et al.,
2003) and confirmed through mutations (Swint-kruse, Zhan, Fairbanks, Maheshwari, &
Matthews, 2003). They found L148F increased IPTG affinity and decreased operator
affinity (analogous to A110T), whereas S151P had the opposite effect (analogous to
A110K). Clearly there is plasticity not only in dimerization but also allostery. It was well
elucidated then that the N-terminal domain binds DNA and that that binding is
allosterically modified by inducer binding in the cleft of the core region. The allostery
could be altered not only in residues within the core but also in the hinge region of the Nterminal DNA binding domain (Falcon & Matthews, 1999, 2001; Falcon, Swint-Kruse, &
Matthews, 1997).
The C-terminal segment is also extremely important to the overall function of the
lac repressor. Homology studies indicated that the the C-terminal region may have a
leucine zipper motif. Leucine to alanine mutations at positions 342, 349 and 356
resulted in dimeric repressors which could bind inducer and operator DNA with reduced
affinity (Chakerian et al., 1991). It was then shown that removing 5, 11, 18 and 32 amino
acids from the C-terminus also created a dimeric repressor capable of inducer binding
and with reduced DNA affinity (Chen & Matthews, 1992). Next, it was postulated that the
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necessary heptad repeat of three leucines formed an abbreviated coiled-coil domain
resulting in tetramerization. A point mutation was known that resulted in a monomeric
lac repressor species (Y282D). The coiled-coil was tested by extending the C-terminus
with one and two additional heptads, combined with the Y282D mutation, resulting in a
dimeric lac repressor, likely through an extended coiled-coil at the C-terminus (Chen,
Surendran, Lee, & Matthews, 1994). The C-terminus was definitively identified as a
coiled-coil responsible for tetramerization and many properties of the coiled-coil were
soon determined (Fairman et al., 1995; Lewis et al., 1996). Tetramerization of the
repressor was of course central to the ability of the lac repressor to bind two DNA
operators. As noted previously, impairment of tetramerization typically decreased
operator DNA affinity. Obviously, this decrease is not a direct effect, as the N- and Cterminii of the lac repressor are spatially separated; this points to an allosteric
mechanism wherein binding of one DNA operator to a repressor dimer within the
tetramer increases the affinity of the operator DNA for the second dimer. It was known
that the lac repressor bends DNA upon binding (Culard & Maurizot, 1981; Kim, Zweib,
Wu, & Adhya, 1989) and it was soon discovered that when the lac repressor binds two
DNA operators it creates a looped DNA structure (Kramer et al., 1987). Cooperativity of
binding was observed in vivo between the O1 and O3 operators (Sasse-dwight & Gralla,
1988), the O1 and O2 operators (Flashner & Gralla, 1988), and between all three
operators (Oehler, Eismann, Kramer, & Müller-Hill, 1990). A beautiful study was
performed to understand how the spacing of the operators affected the cooperative
binding and found a phase dependence to the spacing where repression, and hence
operator binding, is maximal (Oehler, Amouyal, Kolkhof, von Wilcken-Bergmann, &
Müller-Hill, 1994) and the optimal spacing was determined (Müller, Oehler, & Müller-Hill,
1996).
10

Overall a picture emerged that showed how a dimer of dimers looped DNA in
order to shut off transcription and how the binding of small sugar molecules in a
completely different region could result in the release of DNA to turn transcription back
on. The lac repressor exhibits allostery in its cooperative binding of DNA and allostery in
its connection between DNA and effector binding. While many individual residues were
demonstrated to change or disrupt allostery, they fail to explain how its mechanism
functions. Amazingly, a conformation based model of allostery was already postulated in
1965 by Monod, Wyman, and Changeux, the so-called MWC model, that wonderfully
describes the half-century worth of research into the lac operon that followed. In order to
appreciate and understand the MWC model, we must first understand the physics of
proteins and their conformations.
1.3

Protein Structure and the Boltzmann
Proteins are chains of amino acids and they are known to fold into specific

conformations or structures. A vast amount of work has gone into both experimentally
determining and theoretically predicting protein structures from known amino acid
sequence (Englander, Mayne, & Krishna, 2012). The picture that has emerged of the
so-called “folding problem” is that an energy landscape exists wherein each point on the
landscape is a possible conformation of the protein and each point has a given energy.
A given protein will sample this landscape as it folds and tend towards lower and lower
energies, akin to water running downhill until it reaches a pool at the bottom. Much like
the surface of the earth, there can be many valleys, slight and deep depressions, hills
and mountains in the energy landscape and just as water will pool in the low spots,
proteins will fold into structures which have local energetic minima. Proteins do not fold
into a single conformation but instead they can fold into many conformations, some of
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which are more energetically favorable than others. Just how energetically favorable
depends on a host of factors: solvent, binding partners, temperature, protein sequence,
etc. Therefore the energy landscape isn't static for a given amino acid sequence, it is a
culmination of both the protein and its environment. Furthermore, proteins have energy
all their own in the form of thermal energy. They may be comfortably sitting in a
conformation which is a local minimum and then through the thermal jostling of their
environment be pushed out of that well to find a new conformation in a new energy well.
The thermal energy essentially defines the scale of features that are considered
relevant. At low temperatures, minute energetic differences become relevant and new
minima are present. At high temperatures, only the deepest energy minima are relevant;
the protein has too much thermal energy to be stable in any of the lesser wells.
This abstraction not only leads to a clear intuitive picture of how proteins find
their structural conformations and transition between conformations, it also provides a
mathematical framework to quantify the relative occupation of each conformation for a
given population of protein. The Boltzmann distribution defines the fraction of proteins
that will occupy each conformation based upon the energy and degeneracy of that
conformation with respect to every other conformation,

Ni
=
N

−Ei
)
kB T
Z(T)

gi exp(

(1)

Here Ni/N is the fraction of the protein in the ith conformation. The degeneracy of
each state, gi, defines the redundancy of the conformation. This usually is a result of an
internal symmetry of the protein; for example, a dimeric protein where each monomer
can individually bind a small molecule. The structure of the dimer bound to a single
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molecule is degenerate, it could be bound to either monomer and it would look identical,
thus gi = 2 in this case. Typically, the degeneracy equals one (non-degenerate) as most
conformations are unique. The energy of the ith conformation is Ei and the thermal
energy of the system is given by the product of the Boltzmann constant, kB, and the
temperature of the system, T. The energy and the temperature are always positive
values, so the exponential is maximized (and hence the fraction maximized) at lower
energies. At higher energies the numerator exponentially approaches zero and that
conformation is effectively never populated. The denominator is called the partition
function and is defined as,

Z (T)=∑ gi exp(
i

−Ei
)
kB T

(2)

The partition function essentially is a sum of the energetics of every
conformation. For simple energy landscapes that are fully defined by a mathematical
function, the partition function becomes an integral over that function. However, for
extremely complex (and largely unknown) energy landscapes like that of a protein
folding, the partition function will generally include just those states that significantly
contribute: the local minima.
An example is helpful to understand the Boltzmann distribution. We can consider
a theoretical protein that folds into two primary conformations which we will call T and R
and see how the Boltzmann partitions the protein between the two states. First we
consider the case where the two conformations have the same energy (ET = 2, ER = 2,
kBT = 1). We see that,
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N T NR
e−2
1
= = −2 −2 =
N N e +e
2

(3)

Each state is equally likely because they have the same energy. Now if the T
state has an energy twice that of the R state (ET = 4, ER = 2, kBT = 1), we would expect
most but not all of the protein to reside in the R state. Indeed we find,

NT
e−4
= −4 −2 =0.119
N e +e

(4)

NR
e−2
= −4 −2 =0.881
N e +e

(5)

So roughly 88% of the protein is found in the lower energy, R, conformation.
Clearly, this is an approximation as every protein will sample much more than two
conformations, however it is generally observed that many proteins will primarily reside
in a small subset of conformations which are significantly lower in energy than the other
conformations. Indeed, even a four fold difference in energy results in roughly 99.8% of
the protein residing in the lower energy conformation. Therefore we typically try to
identify the most prominent low energy conformations of a protein and seek to explain its
experimental behavior through these conformations.
The Boltzmann is incredibly useful because it reduces a complex abstraction to a
simple mathematical formula that tells us how often each structural conformation is
occupied. In particular, this foundation will be of use when we seek to understand and to
model protein allostery.
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1.4

Monod, Wyman and Changeux (MWC) Model of Allostery
Proteins range from exquisitely simple to remarkably complex. The simplest

proteins have a single primary conformation and perform a single role: binding a ligand,
catalyzing a reaction, binding another protein, etc. More complex proteins have multiple
stable conformations and modulate their role. But how do they achieve this modulation?
We first consider a simple, theoretical protein that catalyzes a reaction in a
structurally defined pocket on its surface. The rate of catalysis is a culmination of many
factors: buffer, amino acid sequence, the conformation of the protein, etc. However,
most often these things are relatively fixed for the cell. The protein has a conformation
that is defined by its energy landscape. The amino acid sequence is defined by the DNA
sequence. The buffer might change (depending on environmental conditions in and
around the cell) but most often it will be within a well defined range. So what happens
when it would be advantageous for the cell to have the catalysis sometimes fast and
sometimes slow?
The most obvious route is to competitively bind the catalytic pocket of the
enzyme. If the catabolic precursor cannot bind, because something else is there
gumming up the works, the enzymatic rate is slowed. This however requires evolution to
come up with a close mimic to the catabolic precursor which is extremely specific and
may not even be possible. Despite this difficulty, many examples of competitively
binding occur in nature, such as carbon monoxide and oxygen competitively binding to
hemoglobin (which is why carbon monoxide is a poison).
A second route is to alter the amino acid sequence. This can be achieved by
chemically altering key side chains of the protein. These post-translational modifications
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(PTMs) include, but are not limited to, phosphorylation, acetylation, glycosylation and
even cleavage of the protein. One drawback to this approach is that a physical
alteration of the protein is occurring. Reversing PTMs is another business in and of itself
in the cell (e.g. kinases and phosphatases constantly phosphorylating and removing
phosphorylation). Many, many examples of PTMs exist in nature (Beltrao, Bork, Krogan,
& van Noort, 2013).
The third route is to alter the conformation of the protein. An altered
conformation could have an altered catalytic pocket with a slower or faster rate of
catalysis. This can be achieved through a variety of mechanisms including the
aforementioned PTMs and the binding of small molecules or other proteins. The nature
of this approach is that a specific part of the protein does not need to be targeted,
instead any process that stabilizes an alternate conformation with different properties is
potentially useful. Allostery is the phenomenon wherein a function which occurs in one
structurally defined region of a protein is altered from a secondary, spatially separated
region of the protein. Allostery is made possible by altering the energy landscape of a
protein and changing the population of alternate conformations. Again, many examples
of allostery occur in nature (Edelstein & Le Novère, 2013; Lewis, 2013; Nussinov & Tsai,
2013).
Allostery was first successfully modeled by Monod, Wyman and Changeux
(Monod et al., 1965) typically shortened to MWC. The MWC model considers a protein
with two or more potential conformations which are in equilibrium. Each conformation
has its own set of properties related to the function of the protein (binding constants,
catalytic constants, etc.). The bulk behavior of the system at equilibrium will be the sum
of behaviors of the protein in its Boltzmann defined combination of states. Addition of an
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allosteric binding partner changes the relative population of states and changes the bulk
property of the system under study. The MWC model boils down allosteric regulation of
a protein to this: to alter a protein's function, do something to move more of the protein
into a different conformation where the function of interest is different.
To understand this idea, we need to more fully delve into the individual properties
of the MWC model. First, the conformational equilibrium is an intrinsic property of the
protein given its environment (buffer, temperature, etc.). Considering a hypothetical
protein with two conformations, T and R, the conformational equilibrium, L, is defined as,

L=

[T]
[R]

(6)

Here hard brackets denote concentrations of that species. The total
concentration of the hypothetical protein, P, is then defined as,

[P]tot =[T]+[R]=[R](1+L)

(7)

The conformational equilibrium is of course fully defined by the energetic
landscape of the protein, and hence the Boltzmann distribution. Assuming that these
conformations are non-degenerate, we can see,

−ET
)
kB T
[T]
[ P]tot
−(ET−ER )
Z( T)
L=
=
=exp(
)
[R]
−ER
kB T
exp(
)
[ P]tot
kB T
Z( T)
exp(

(8)
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So the conformational equilibrium is simply a function of the energy difference
between the two conformations and is an intrinsic property of the protein.
Lets consider now a hypothetical molecule, X, that binds the protein. It binds the
T and R conformations with different affinities,

KT =

[TX ]
[T][X ]

(9)

KR =

[RX ]
[R][X ]

(10)

Here [TX] and [RX] are the X bound states of conformations T and R,
respectively. Again, the binding affinity constants are intrinsic properties of the protein
given the environmental conditions.
How does all of this add up to allosterically regulate the protein? An example is
most illustrative. We define the hypothetical energy of the system as the following: ET =
4, ER = 2, kBT = 1. Equations (4) and (5) show that roughly 88% of the protein is in the R
conformation and 12% in the T conformation. If the R conformation catalyzes a reaction
at a rate of 10 per second and the T conformation at a rate of 1 per second and given
100 proteins in a cell, there is an effective rate of,

k eff=0.88∗10

rxn
rxn
rxn
+0.12∗1
=8.92
sec
sec
sec

(11)

The effective rate, which is what is measured experimentally, is a bulk property of
the system. MWC would model this through the conformational equilibrium parameter,
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L=exp (

−(ET −ER )
−(4−2)
)=exp(
)=0.135
kB T
1

(12)

Using the MWC solution we typically use concentrations and rates with respect to
concentrations. Here we will assume that the total protein concentration is 1 mM, kR =
10 rxn/sec/mM and kT = 1 rxn/sec/mM. We can then calculate the concentration of the
protein in the R and T conformations,

[R ]=

[P] tot
1mM
=
=0.881mM
(1+L) 1+0.135

[L ]=[P]tot −[R]=0.119 mM

(13)

(14)

And the effective rate is then,

k eff =[R]k R +[L ]k L
rxn
rxn
rxn
= 0.88 mM∗10
+ 0.12mM∗1
=8.92
sec∗mM
sec∗mM
sec

(15)

So the MWC route of course arrives at the same conclusion as the Boltzmann
route.
This effective rate can be allosterically modified by binding ligand X. This more
complicated MWC model is solved by considering the total sums of each species, P and
X, and the thermodynamic constants that link them,

[P]tot=[R]+[RX ]+[ T ]+[TX ]

(16)
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[X]tot=[ X ]+[RX ]+[TX ]

L=

[T]
[R]

(17)

(18)

KT =

[TX ]
[T][X ]

(19)

KR =

[RX ]
[R][X ]

(20)

The general strategy is as before: calculate how much of each species is around
and use that to determine the effective catalytic rate.
If the ligand prefers binding to the lower catalytic state, T, we can effectively turn
off the protein by adding ligand X. For example, if KT = 10 mM-1, KR = 1 mM-1, and [X]tot =
1 mM, then we can calculate the concentration of each species of the protein P by
solving the equations (16) - (20). We do this by solving all of the equations for the free
concentration of the R conformation, [R], in terms of just known thermodynamic
constants and then using [R] to measure the effective catalytic rate. We start by reorganizing the above equations,

[T]=L[R ]

(21)

[TX ]=K T [T ][X ]=K T L[ R][ X]

(22)

[RX ]=KR [R][X ]

(23)
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Plugging these values into equation (17) we get,

[X] tot=[X ]+KR [R ][X ]+KT L[R][ X]=[ X](1+[R ](KR + KT L))

(24)

Re-organizing we get the free concentration of the ligand, [X], in terms of
thermodynamic constants and [R],

[X]=

[X ]tot
1+[ R](K R +KT L)

(25)

We can then insert equations (22), (23), and (25) into (16) to get,

[P] tot=[R]+

KR [R][X] tot
K T L[R][ X] tot
+L[R]+
1+[R](KR +K T L)
1+[R](K R +K T L)

(26)

We then simply need to solve for [R]. Start by multiplying the denominator of
equation (25) on both sides of the equation,

[P]tot +[P]tot [R](KR +K T L) =
[R ](1+L)+[R] ( 1+L)(K R +K T L)+KR [R][X ]tot +K T L[R][X ]tot
2

(27)

Re-organizing to solve for terms of [R],

[R ]2 (1+L)(KR +KT L)+[R](1+L+([X] tot−[P] tot)(K R +K T L))−[P] tot=0

(28)

We define the following constants and solve the second order polynomial,

A=(1+L)(KR +K T L)=(1+0.135)(1 mM−1 +10mM−1∗0.135)=2.67 mM−1

(29)
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[R ]=

B=(1+L+([X] tot−[P] tot)(K R +K T L))=
1+ 0.135+( 1mM−1mM)(1mM−1 +10 mM−1∗0.135)
B=1.135

(30)

C=−[P]tot=−1 mM

(31)

[R ]2 A+[R] B+C=0

(32)

−B± √ (B2 −4AC) −1.135± √ (1.1352 −4∗2.67 mM−1∗(−1mM))
=
2A
2∗(2.67 mM−1 )
[R]=0.44 mM or −0.86 mM

(33)

Since this is a biological system where [R] is a concentration of a protein we are
constrained by reality. Therefore,

0 mM≤[R]≤[P]tot

(34)

Therefore [R] = 0.44 mM. We can then use the value of [R] to calculate the
remaining species,

[T]=L[R ]=0.135∗0.44 mM=0.06 mM

[X]=

[X ]tot
1mM
=
1+[R](K R +KT L) 1+0.44 mM(1mM−1 +10 mM−1∗0.135)
[ X]=0.49 mM

−1

[RX ]=KR [R][X ]=1 mM ∗0.44 mM∗0.49 mM=0.22 mM

(35)

(36)

(37)
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[TX ]=K T [T ][X ]=10 mM−1∗0.06 mM∗0.49 mM=0.29 mM

(38)

And we can check the accuracy of our solution by making sure everything adds
up,

[X] tot=[X ]+[RX ]+[TX ]=0.49mM+0.22 mM+ 0.29mM=1 mM

(39)

[P] tot=[R ]+[RX ]+[T ]+[TX ]
= 0.44 mM+0.22 mM+0.06 mM+0.29 mM=1 mM

(40)

And of course, the entire point of this exercise is to see the effect of adding 1 mM
of ligand X on the catalytic rate of protein P,

k eff =([R ]+[RX ])∗k R +([T ]+[TX])∗k T =
rxn
rxn
0.66 mM∗10
+ 0.34mM∗1
sec∗mM
sec∗mM
rxn
keff =6.94
sec

(41)

The allosteric effect of adding 1 mM ligand X is to change the catalytic rate from
8.92 rxn/sec to 6.94 rxn/sec. This is achieved by altering the effective conformational
equilibrium of the R and T states. Adding ligand X, which prefers binding to the T state,
pushes more of the protein to that state thereby lowering the bulk (effective) catalytic
rate.
The MWC model provides a mathematical framework for understanding the link
between the fundamental thermodynamic parameters (conformational equilibrium, rate
constants, binding constants) and the experimentally measurable values (decreased
catalytic rate). One primary drawback of doing these calculations that should
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immediately be obvious is that even for simple systems, analytical solutions are
complex. For complex systems, such as the lac repressor, the MWC solution either is
not used or simplifications are used to model the experimental behavior.
1.5

The MWC Model of Lac Repressor Genetic Regulation
The allosteric response of the lac repressor is classically modeled by MWC. The

lac repressor is a tetramer that is better understood as a dimer of dimers. A single dimer
of the lac repressor binds a single DNA operator through a pair of its N-terminal helixturn-helix motifs along with a larger DNA binding interface. The N-terminal domain is
linked to a larger clam-shell domain that contains at its center an effector binding
domain. Therefore, one dimer of lac repressor binds two effector molecules and a single
DNA operator. The dimers are then linked through a C-terminal coiled-coil domain that
tetramerizes the protein. A tetramer is therefore capable of binding two distinct DNA
operators and four effector molecules.
Two different allosteric effects are found within a lac repressor tetramer. First,
the binding of one dimer to one DNA operator increases the affinity of the second dimer
to a second DNA operator. However, this is only true when the two DNA operators are
linked into a larger DNA strand and furthermore the cooperativity of binding is highly
dependent upon the spacing between the two operators. As DNA is not a small
molecule, the conformations of the DNA come into play, but its the same old MWC idea:
different conformations are populated when binding occurs and higher affinity is a net
result.
The second allosteric property found in the lac repressor is the link between
effector binding and operator DNA binding. Essentially this allostery occurs within the
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individual dimers of the tetramer, and in fact a dimeric lac repressor is a fully functional
gene regulator. The dimer can be thought of as having two primary conformations, R
and R*. There of course exists a large number of conformations of the lac repressor
dimer, but R and R* can be thought of as the two primary minima in the energy
landscape. The Boltzmann distribution defines the relative occupancies of the R and R*
states at equilibrium and is fully dependent upon the energetic differences between the
two states. The conformational equilibrium of the lac repressor, KRR*, has been
experimentally determined to slightly favor the R* state (Daber, Sharp, & Lewis, 2009;
Daber, Sochor, & Lewis, 2011).
The two conformations each can bind one operator DNA with an affinity (KRO for
the R state; KR*O for the R* state) and two effector molecules each with same affinity (KRE
for the R state; KR*E for the R* state). For the wild type lac repressor, we define the R
state as the conformation with higher operator DNA affinity (KRO > KR*O). The relative
affinities of R and R* for effectors determines whether they are classified as inducers or
co-repressors. If KRE > KR*E then the effector prefers binding to the high DNA affinity
state and will push more of the repressor into a DNA bound state; these effectors are
termed co-repressors (such as orthonitrophenyl-β-D-galactoside (ONPG)). If KRE < KR*E
then the effector binds more strongly to the low DNA affinity state and will decrease
operator DNA binding; these effectors are termed inducers and include allolactose and
IPTG.
The lac operon of E. coli uses three DNA operators (O1, O2 and O3) and a
tetrameric lac repressor and the effector is the inducer allolactose which is a short lived
metabolic intermediate. This is a highly non-trivial system to model and thus a simplest
functional system has been developed which consists of a single operator DNA located
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within the DNA promoter sequence (where O1 is located), a dimeric lac repressor, and
the effector is the non-hydrolyzable inducer IPTG. This system isolates the allosteric
interaction between effector and operator DNA binding.
1.6

Mutations to the Lac Repressor Alters Gene Regulation
Mutational studies of the lac repressor began as a means to discern structurally

and functionally relevant regions of the protein. The lac repressor was discovered
before most standard biochemical techniques existed to answer these questions such as
protein over-expression for purification, protein crystallography, protein NMR and
modern PCR based cloning techniques.
The earliest lac repressor mutants were discovered using mutating agents and
selection pressure to try to isolate mutants. For example, bacteria could be exposed to
N-methyl-N'-nitro-N-nitrosoguanadine and given repeated rounds of forward and
backwards selection pressures to identify tighter binding lac operon phenotypes (Gilbert
& Müller-Hill, 1966). A more refined approach was later developed using amber codon
(UAG) suppression (Belin, 2003) where tRNAs could be used to suppress the amber
stop codon and insert desired amino acids in its place. For example, amber codon
suppression was used to show that mutation of tyrosine 269 to serine (Y269S) inhibits
tetramerization (Schmitz et al., 1976).
The lac repressor was discovered before much of the standard biochemical
approaches existed, therefore the literature of the lac repressor often follows the
changing state-of-the-art of the time. One of the fascinating results of this history is that
studies of the lac repressor exist that would never be repeated for a newly identified
protein today. Chief amongst these studies is the series of 15 papers which sought to
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link genetic alteration of the lac repressor to phenotype. The end result was point
mutations of every amino acid from positions 2 through 329 to 12 or 13 different amino
acids (>4000 mutations in total) which were then phenotypically categorized (Suckow et
al., 1996). The phenotype I- indicates mutations where repression is impaired in the
absence of inducer and are therefore defective. I- mutations alter DNA binding, folding
or aggregation of the lac repressor. The phenotype IS indicates mutations that repress
but do not respond to inducer (super-repressing). IS mutations could alter inducer
binding, allosteric signaling, or be the result of extremely tight DNA binding. The
phenotype Ir indicates mutations that co-repress with what is normally an inducing
effector. Ir mutations could be a result of changing DNA affinity, reversing the allostery,
or altering inducer binding. Essentially these studies created a map wherein different
aspects of the lac repressor allostery was linked to different regions of the amino acid
sequence.
When the x-ray crystallographic and NMR structures of the lac repressor were
solved (Lewis et al., 1996; Loth, Gnida, Romanuka, Kaptein, & Boelens, 2013), this body
of mutational data was mapped onto the three-dimensional structure. In general there is
excellent agreement between these two techniques. Mutations to the effector binding
pocket typically result in the IS phenotype because inducer binding is destroyed; the lac
repressor can bind operator DNA but not effector. Similarly, Ir mutations typically are
found in the effector binding pocket as they involve changing effector affinity. Mutations
to the N-terminal DNA binding domain typically result in the I- phenotypes because
operator DNA binding is destroyed; the lac repressor can bind effector but not operator
DNA. A large fraction of the amino acid substitutions made were tolerated by the
protein. Disruptive amino acids (I-) were found to lie along the dimer interface and at key
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locations of the lac repressor fold. This large scale mutagenesis combined with
structure provides a unique confirmation that the experimentally derived structures are
extremely relevant to the phenotypes observed in living bacteria. The central limitation
of the genetic studies is that they could only identify bulk qualitative phenotypic effects of
the mutations. It took a confirmation with the structure to link mutations with
thermodynamic binding parameters, however only qualitatively.
Later studies began to identify other point mutations of the lac repressor and
quantitatively assess the effects. For example the mutation K84L was identified which
creates a more thermostable repressor but impairs both DNA and effector affinities
(Barry & Matthews, 1999). This mutation was crystallographically characterized and
found to lock dimer interface of the lac repressor in a novel conformation (Bell et al.,
2001).
1.7

Aims
It has been well established how the lac repressor functions within E. coli to

regulate the lacZ/Y/A polycistronic message and induce lactose metabolism when it is
needed. Furthermore it is well known that the gene regulatory phenotype can be
changed by point mutation of the lac repressor or by changing or moving operator DNA
sequences.
Several important gaps in knowledge however remain. How do point mutations
to the lac repressor affect the thermodynamic parameters of the MWC model? Can we
link specific regions of the lac repressor to specific thermodynamic constants?
Furthermore, while we know the lac repressor is functional in purified in vitro conditions,
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do the in vitro measured binding values match the in vivo measured values? Finally, can
we use these known lac repressor genetic switches to treat human diseases?
The specific aims of this thesis seek to address these questions:
1. Linking Mutation to Thermodynamics (Chapter 3). We have taken mutations
to two structurally specific regions and linked them to changes to specific
thermodynamic parameters of the MWC model. Mutations in the specificity
region of the DNA binding domain are seen to alter the repressor-DNA affinity
and potentially the conformational equilibrium. Mutations in the specificity region
of the effector binding pocket are seen to alter the repressor-effector affinities
and the conformational equilibrium. The interplay between the changes in the
thermodynamic parameters results in a wide range of phenotypically interesting
genetic switches ranging from more ideal on-off switches to inverted switches.
2. Linking In Vivo to In Vitro (Chapter 4). We have created a quantitative in vivo
assay that allows for accurate measurement of both regulated transgene (YFP)
and fluorescently tagged lac repressor (lac-mCherry). We measured the
thermodynamic binding parameters of the lac genetic switch from an in vitro
transcription assay and use these values to predict the in vivo phenotypic profile.
We found that in general our measured in vitro thermodynamic values matched
those of previous studies, except for repressor-DNA affinity. Our affinity was
several orders of magnitude weaker than previous studies. Despite this, our
values do recreate the in vivo gene regulatory profile when 40% cell crowding is
modeled. Furthermore, only our values could create functional genetic regulators
at the modeled concentrations of the natural lac operon. This study showed the
seminal importance of confirming in vitro results with in vivo data.
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3. An Autogenously Regulated Lac Repressor for AAV-Mediated Eukaryotic
Gene Therapy (Chapter 5). We have redesigned the lac repressor genetic
switch to be autogenously regulated (regulates its own expression) with the goal
of creating an AAV-mediated gene therapy regulatory tool. This autogenous
switch was shown to work in various cell types in cell culture. We have improved
regulatory behavior of the switch through the use of multiple operator DNA sites
and the restoration of the tetramerization domain in the lac repressor. We found
further improvement by making point mutations to the lac repressor that are
known to improve the phenotype in E. coli. Finally, we packaged our
autogenously regulated lac genetic switch in AAV vectors. These vectors were
used to reversibly regulate luciferase expression in the livers of living mice as a
function of IPTG.
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Chapter 2:
Materials and Methods
2.1

Bacterial Strains and Media
Several bacterial strains were used for prokaryotic experiments and all are

derived from Escherichia coli (E. coli).
The strain DH5α (E. coli fhuA2 Δ(argF-lac)U169 phoA glnV44 φ80’ Δ(lacZ)M15
gyrA96 recA1 relA1 endA1 thi-1 hsdR17) was used for cloning, plasmid preparations,
and for prokaryotic green fluorescent protein (GFP) regulation assays. This strain does
contain some of the lactose operon and therefore is not a clean background within which
to perform the prokaryotic GFP regulation assay. It was later replaced with the EPB225
cell line (described below).
The strain BL21(DE3) (E. coli B dcm ompT hsdS(rB-mB-) gal) was used for
recombinant protein expression to make purified lac repressor and lac repressor
mutants.
The strain EPB229 (E. coli F- λ- ilvG- rfb-50 rph-1 Δ(lacI-lacA)::frt) was used for
prokaryotic GFP regulation assays. This strain was made by the laboratory of Dr. Mark
Goulian and derived from MG1655 (E. coli F- λ- ilvG- rfb-50 rph-1). This strain is the
“wild-type” K-12 strain and has a total deletion of the lac operon allowing for a clean
background within which to study our lac genetic regulatory systems.
Liquid media for standard bacterial growth (plasmid preparation, cloning, initial
prokaryotic GFP regulation assays) was Luria-Bertain (LB) broth. Similarly, LB-agar was
used for growth on solid plates. Later prokaryotic GFP regulation assays with EPB229
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cells used MOPS minimal media supplanted with 0.4% glucose. This media provided
minimal auto-fluorescent background.
Antibiotics were used for selection of bacterial cells transformed with desired
plasmids at the following concentrations:
Ampicillin = 100 μg/mL
Chloramphenicol = 50 μg/mL
Kanamycin = 50 μg/mL
For most prokaryotic GFP regulation assays, a two plasmid selection method
was used by using media with both ampicillin and chloramphenicol.
2.2

Eukaryotic Cell Lines and Media
The cell line HEK293T, derived from human embryonic kidney cells and stably

expressing the Simian Vacuolating Virus (SV40) which codes for the large T-antigen,
was used for Eukaryotic GFP and luciferase regulation assays and also in microscopy.
These cells are highly adapted to cell culture conditions and are not thought to be
particularly characteristic of healthy kidney cells. This cell line is adherent and was
grown on plastic cell culture plates. The culture medium was Dulbecco’s modified
Eagle’s medium (DMEM) containing 20% fetal bovine serum (FBS), L-glutamine and
sodium bicarbonate.
The cell line Cos-7, derived from the African green monkey Cercopithecus
aethiops fibroblast-like kidney cells, was used in Eukaryotic GFP and luciferase
regulation assays. This cell line was developed from the CV-1 line by transformation
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with SV40 to express the T-antigen. This cell line is adherent and grown on plastic cell
culture plates. The culture medium was Dulbecco’s modified Eagle’s medium (DMEM)
containing 20% fetal bovine serum (FBS), L-glutamine and sodium bicarbonate.
The cell line ARPE-19, derived from human retinal pigment epithelial cells, was
also used in Eukaryotic GFP and luciferase regulation assays. This is an adherent cell
line and was grown on plastic cell culture plates. The culture medium was Dulbecco’s
modified Eagle’s medium (DMEM) supplemented with the F-12 nutrient mixture
containing 20% fetal bovine serum (FBS), L-glutamine and sodium bicarbonate.
2.3

Plasmid Preparation
Plasmids were isolated using the NucleoSpin plasmid purification kit (Clontech).

For both the repressor and reporter bacterial plasmids a slightly modified protocol was
followed as they both are low-copy number plasmids. A larger initial volume of LB is
inoculated (8mL) and larger volumes of individual DNA purification buffers are used: 500
μL A1, 500 μL A2, and 700 μL A3 of the Macherey-Nagel quick purification kit. The
remainder of the protocol was unchanged.
Large volumes of plasmid were obtained using the Plasmid Plus Maxi Kit
(Qiagen). This allowed for endotoxin free plasmid preparation for transient transfections
and also for virus preparation from AAV encoding plasmids.
2.4

Cloning

Inverse PCR Mutagenesis
The following protocol was used for point mutations, deletions and small
insertions (typically less than 10 base pairs).
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The primer design completely defines what the result of the cloning will be. Each
primer is broken down into two parts: an annealing region that overlaps with the starting
plasmid and an optional un-matched 5’ tail. The annealing region is designed to follow
two basic rules. First, the melting temperature should be as close to 60C as possible.
Second, both the 3’ and 5’ ends should be either cytosine (C) or guanine (G). The
reverse primer is designed to anneal to the left of the region to change/insert/delete and
the forward primer is designed to anneal to the right of the region to
change/insert/delete.
For a deletion, primers are chosen that skip the region to delete. For a point
mutation, a 5’ tail is added to one of the primers that matches the desired sequence.
Similarly, for an insertion a 5’ tail is added to one of the primers that matches the desired
insertion. Finally, one of the primers is given a 5’ phosphorylation.
Full circle PCR is used with Phusion Hot Start High Fidelity DNA Polymerase
(NEB) and the extension time is set to 20 seconds for every kilobase and follows the
recommended thermal cycle. PCR follows 15 rounds of amplification and is then held at
4C until ready to proceed. The mixture now contains plasmid (initially isolated from
DH5α) and linearized PCR product which has the desired change/insert/deletion. A 10
minute ligation with 2000 Units T4 DNA Ligase (NEB), 10 μL quick ligation buffer (NEB)
and 10 μL PCR product is used to ligate the linearized PCR product into closed plasmid.
This is followed by a 1 hour digestion to remove the initial plasmid by adding 5 μL NEB
#4 Buffer, 25 μL MilliQ, and 20 Units DpnI (NEB). The DpnI enzyme specifically cleaves
DNA with the methylation pattern given by DH5α cells, therefore specifically cleaving
only the starting plasmid while sparing the ligated PCR product. 2.5 μL of this mixture is
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transformed into 50 μL DH5α cells and plated onto LB agar with appropriate selection
antibiotic.
Typically >90% of colonies that survive on the plate have the intended
change/deletion/insertion. Common difficulties are 5’ adenosine (A) or thymine (T)
bases will not make it into the final plasmid which is why they are to be avoided if
possible in the initial primer design step. It is also commonly seen that the starting
plasmid will survive the DpnI digestion so it is recommended to include a DpnI negative
control where primers are omitted so only starting plasmid exists.
In-Fusion
This method is used to insert large DNA segments into plasmids. The primer
design exactly follows the recommendations of the In-Fusion HD Liquid Kit (Clontech).
Long DNA regions (approximately greater than 1 kilobase) were amplified with Phusion
Hot Start High Fidelity DNA Polymerase (NEB) following the standard thermal cycle and
extension time of 20 seconds per kilobase. Small DNA regions (approximately less than
1 kilobase) were amplified with Vent DNA Polymerase (NEB) following the standard
thermal cycle and extension time of 60 seconds per kilobase. Linearized PCR
fragments were isolated through 5% agarose gel filtration and the NucleoSpin Extract II
(Clonetech) purification kit. Alternatively, restriction enzyme digestion was used when
appropriate to linearized DNA fragments as described in the In-Fusion protocol.
Essentially, two linearized fragments are desired: the vector which typically
contains the desired new plasmid and the insert to be placed into that plasmid. The
vector and insert are designed such that 15 base pairs on each end perfectly match.
The In-Fusion enzyme then anneals the insert and vector to create a final plasmid.
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The In-Fusion reaction follows the recommended protocol and 2.5 μL is
transfected into 50 μL DH5α cells and plated onto LB-agar with appropriate antibiotic.
Again >90% of the colonies typically contain the designed insert.
2.5

Lac Repressor Purification
Lac Repressor constructs were cloned into a pBAD expression vector which

controls expression of a gene using the arabinose repressor system. All repressor
constructs were inserted into the multiple cloning site (MCS) of the pBAD vector and
given a 6x-Histidine tag on the C-terminus. Cloning was achieved using in-fusion.
Purification begins by first transforming the desired plasmid into BL21(DE3) cells
and plating onto LB supplemented with ampicillin and incubating overnight at 37C. The
plate is used to innoculate 100 mL 2xYT medium (Sigma) supplemented with ampicillin
in the morning. I picked many colonies (>100) in the innoculation to prevent any
potential bias from selecting a single colony. This starter culture is incubated at 37C with
shaking (~200 RPM) for 3-4 hours until the flask grows past the mid-log phase and
approaches the stationary phase (optical density at 600 nm (OD600) > 1.0). 10mL of the
starter culture is then used to innoculate 1L 2xYT medium supplemented with ampicillin.
The large culture is incubated at 37C with shaking (~200RPM) until early mid-log growth
phase (OD600=0.3-0.4). At this point, the incubator temperature is reduced to 15C to
slow bacterial growth. Expression is also induced at this point by adding 10mL of 20%
v/v arabinose that has been sterile filtered. The liquid culture is allowed to grow
overnight (~16 hours).
In the morning, the culture is removed from the incubator and placed into 1L
centrifuge flasks. The cells are centrifuged at 5000g for 10 minutes at 4C to pellet the
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cells. The supernatant is removed and cells are resuspended 20 mL in Nickel Lysis
Buffer (300 mM NaCl, 50 mM NaH2PO4, pH 8.0). Cells are lysed using three passes
through a cell homogenizer (Avestin) at ~18,000 PSI and whole cell lysate is
immediately stored on ice. Lysate is then centrifuged at 15,000g for 15 minutes at 4C to
separate soluble protein from insolubate cell lysates. Supernatant is filtered through
filter paper (Whatman #3) at 4C to remove further insoluble materials. A sample of the
supernatant is collected for analysis on an SDS-PAGE gel.
A his-tag purification column is prepared by loaded 2 mL His60 Ni Superflow
Resin (Clontech) into a Flex-Column (Kontes) fitted with a stopcock to regulate flow rate
through the column. All work with the his-tag column is undertaken in refrigeration at 4C.
Resin is first equilibrated with 20 mL cold Nickel Lysis Buffer and the stopcock is set to
very slowly drip out the buffer such that the nickel beads will form an equilibrated bed of
beads. Filtered supernatant is then carefully added to the column and flow again is set
to very slowly drip. A sample of the flow through is collected for SDS-PAGE gel analysis.
The beads are then washed three times with Nickel Wash Buffer (50 mM NaH2PO4, 300
mM NaCl, 20 mM Imidazole, 2.5% v/v glycerol, pH 8) and samples of each wash are
collected for SDS-PAGE gel analysis. His-tagged lac repressor is then eluted from the
column using Nickel Elution Buffer (50 mM NaH2PO4, 300 mM NaCl, 250 mM Imidazole,
2.5% v/v glycerol, pH 8) and elutant was collected. A sample of elutant was saved for
SDS-PAGE gel analysis.
Nickel elutant is then buffer exchanged using an Amicon Ultra centrifuge filter
with a 30,000 molecular weight cutoff (Millipore). Elutant is centrifuged at 5,000g for 15
minutes at 4C and the filter flow through is discarded. Typically, depending on yield,
200-300 μL concentrated protein remains above the filter. Protein is carefully
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resuspended in ~3-4 mL ice-cold Gel Filtration (GF) Buffer (200 mM Tris pH 7.4, 200 mM
Kcl, 10 mM EDTA, 3 mM DTT). Buffer replaced in this fashion reduces the initial buffer
to about 7% of its starting concentration. Buffer is replaced three times resulting in <
0.1% of the elutant buffer remaining. Protein is then concentrated a final time to achieve
a protein concentration in the 1-10 mg/mL range as measured using absorbence at
280nM (A280) on a spectrophotometer (NanoDrop).
Purified protein can be saved at this step by flash freezing the protein in liquid
nitrogen and storing at -80C.
All samples from the nickel purification are boiled in LDS sample buffer
(Expedeon) for 10 minutes and run on a 4-12% SDS-PAGE gel (Expedeon) at 110V for 1
hour.
Protein for in vitro transcription assay underwent a size exclusion
chromatography step. His-tag purified lac repressor in GF buffer was concentrated and
loaded onto a Hi Load 16/60 Superdex 75 column and sample was driven by Akta Prime
FPLC. Fractions were collected and samples were SDS boiled and run on SDS-PAGE
gels to determine purity. Protein was concentrated again using centrifugal 30,000 MW
filter and stored in GF buffer. Protein was flash frozen and store at -80C.
2.6

Prokaryotic GFP and YFP Regulation Assays

GFP regulation assay
EPB229 cells were co-transformed with a lac repressor plasmid providing
chloramphenicol resistance and a reporter plasmid providing ampicillin resistance and
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plated onto LB agarose plates with ampicillin and chloramphenicol. Plates were
incubated overnight at 37C and stored at 4C.
The repressor plasmids are all derived from pABD34 plasmid and constitutively
express the LacI gene using its native promoter from E. coli. The LacI sequence has 10
C-terminal residues truncated to prevent tetramerization. Point mutations to the LacI
sequence made using inverse PCR mutagenesis. For repressor quantification
experiments a C-terminal mCherry tag was inserted using in-fusion cloning.
Reporter plasmid were derived from the pBR plasmid and have a reporter gene,
Green or Yellow Fluorescent Protein (GFP or YFP), under control of the native LacZ/Y/A
promoter. The operator sequences of the promoter used were:
O1: 5' AA TT GTG AGC G GAT AAC AA TT 3'
Lsym: 5' AA TT GTG AGC GCT CAC AA TT 3'
In the original assay, only GFP was monitored. Single colonies were picked into
1 mL LB supplemented with ampicillin and chloramphenicol and grown ~ 16 hours at
37C with shaking (~200 RPM). 100 μL of the sample aliquoted into a 96-well clear
bottom plate (Corning) and OD600 and fluorescence (excite: 488 nm, emit: 525 nm) were
measured on Infinite M1000 plate reader (Tecan).
Samples to be assayed are typically picked in triplicate. Fluorescence is
normalized by OD600 and averaged across replicates.
YFP regulation assay
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Reporter plasmid was made as previously reported with the O1 operator
sequence (5’-AA TT GTG AGC G GAT AAC AA TT-3’) followed by YFP and providing
ampicillin (AMP) resistance. Lac repressor was expressed on a second plasmid as
previously described providing chloramphenicol (CAM) resistance. A C-terminal mCherry
tag was added to the Lac repressor gene after an 11bp linker to create the Lac-mCherry
construct.
We double transformed reporter and repressor plasmids into EPB229 cells (FΔ(lacI-lacA)::frt). These cells were derived from the MG1655 “wild type” line. Colonies
were picked in triplicate into MOPS minimal media with 0.4% glucose, AMP and CAM
and grown overnight at 37C with shaking. 50µL of the overnight culture was used to
inoculate 1mL fresh MOPS minimal media supplanted with varying amounts of IPTG. We
measured optical density at 600nm (OD600), YFP fluorescence (excite: 510 nm emit: 535
nm), and mCherry fluorescence (excite: 585 nm emit: 610 nm) for all wells over a 12
hour period using a TECAN M1000 plate reader in 384 well optical bottom plates
(Corning).
In vivo data was normalized for growth by measuring cells in triplicate as they
were growing. All data points collected were then fit to a 2nd order polynomial to obtain a
curve which is fluorescence as a function of OD600. Positive control was established by
co-transforming EPB229 cells with O1 YFP reporter and a CAM plasmid without LacmCherry (pABD34). YFP signal was normalized to the polynomial fit from the positive
control. Final values for fitting were calculated for cells at approximately mid-log growth
phase (0.4 OD600).
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2.7

Prokaryotic Lac Repressor Quantification Assay
EPB229 cells were co-transformed with Lac-mCherry and O1 YFP reporter. An

individual colony was picked into MOPS minimal media with 0.4% glucose, AMP and
CAM and grown overnight at 37C with shaking. 50 µL was innoculated into fresh media
and grown to mid-log phase.
Serial dilutions were made over 10 orders of magnitude and each dilution had
OD600 measured (TECAN M1000 and Ultrospec 2100 pro) and 100 µL plated onto LB
agar with AMP and CAM.
Purified Lac-mCherry was quantitated with both a BCA assay and optical A280
measurements using a Nano-drop. Dilutions were made over 8 orders of magnitude and
50 µL was loaded into clear bottom 384 well plates in triplicate. mCherry fluorescent
measurements (excite: 585 nm emit: 610 nm) were made using various gains to
establish linear regimes for the instrument (TECAN M1000).
We established a raw cell count by plating dilutions of a culture of EPB229 cells.
We found 1.92e6 cells/µL at mid-log growth phase which is similar to standard estimates
of 1e6 cells/µL for E. coli. Aliquots of known cell counts were then used to establish a
linear relationship with OD600 on our plate reader. Similarly, purified Lac-mCherry of
known concentration was used to establish a linear relationship with mCherry
fluorescence on our plate reader at a fixed gain.
EPB229 cells were co-transformed with plasmid constitutively expressing LacmCherry and a reporter plasmid which has YFP under the control of the natural operator
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O1. We measured mCherry fluorescence at a fixed gain and OD600 from which we
calculated the concentration of Lac-mCherry in the well and the number of cells in the
well. The approximate volume of E. coli was estimated to be 1x10-15 L. Multiplying
volume of E. coli by number of cells allows us to estimate what fraction of the well
volume is intracellular.
Calibration of raw mCherry fluorescent signal and OD600 was converted to
intracellular repressor concentration.
2.8

In Vitro Transcription
A reporter plasmid was made with the O1 operator after a T7 promoter. Reporter

was linearized to 450bp and purified by spin column purification (Clontech).
MaxiScript T7 kit (Ambion) was used to perform in vitro transcription. CTP[α-32P]
was incorporated into mRNA transcripts and the water fraction of the standard reaction
was supplanted with varying concentrations of Lac-mCherry and IPTG. Transcription
was allowed to proceed for 30 minutes at 37C until halted by boiling. Samples were
loaded onto polyacrylamide gels and electrophoresis was used to separate free CTP[α32P]

from that incorporated into mRNA. Gels were dried and exposed to radiological

plates. Plates were imaged on a Typhoon scanner and bands were quantitated using
ImageJ (NIH).
2.9

Transient Transfections
Cells were allowed to grow to approximately 50 to 70% confluence and split to

prepare for transient transfection. Cells were allowed to grow in 37C incubator with 5%
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CO2 overnight to attach. Media was changed in the morning and cells were now ready
for transient transfection.
Plasmid DNA was prepared by first mixing with Opti-Mem (Invitrogen), vortexing,
and letting sit at room temperature for 5 minutes. Lipofectamine LTX (Invitrogen) was
then added to the mixture, very briefly vortexed, and then allowed to sit at room
temperature for 30 minutes. The prepared solution is good for several hours at room
temperature. The final mixture is then added to cells which are then returned to the
incubator. Media should be changed after 24 hours. The exact amounts of plasmid
DNA, Opti-Mem, and Lipofectamine LTX (and potential additives such as Plus reagent)
were determined by the cell type and can be found within the product literature.
2.10 Native Gel Electrophoresis
We used the NativePage (Invitrogen) kit for native gel electrophoresis. The
primary advantage of this kit is that it is based upon Blue Native Polyacrylamide Gel
Electrophoresis (BN Page) which uses Coomassie G-250 as the molecule to provide
charge shift for proteins. Coomassie G-250 binds to proteins providing a net negative
charge without denaturing the protein.
Purified protein was thawed and mixed in non-denaturing sample loading buffer.
10 μL of samples and NativeMark (Invitrogen) protein standard were added to wells of
NativePage 4-16% Bis-Tris Gels. Gels were loaded within Novex Mini-cell (Invitrogen)
gel running boxes.
The interior (between the gels) was filled with NativePage cathode running buffer
which contains Coomassie G-250. The exterior was filled with NativePage anode
running buffer. Gels were run at 150V for 2 hours, then removed. Gels were placed in
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Fix (40% methanol, 10% acetic acid), microwaved on high for 45 seconds, and then
shaken on an orbital shaker for 15 minutes to fix the gel. The gels were then switched to
Destain (8% acetic acid), microwaved on high for 45 seconds, and placed on an orbital
shaker overnight to remove any unbound Coomassie G-250. Gels were then imaged.
2.11 Eukaryotic Gene Regulation Assays
All gene regulation assays start by transiently transfecting the cell line of choice
with the appropriate plasmid. Media is supplemented with effector of varying
concentration in wells (IPTG for lac repressor experiments and doxycycline for tet
repressor experiments) and specific experimental conditions are typically grown side by
side in triplicate. Experimental measurement times varied depending upon cell
confluence but typically occurs between 24 and 72 hours after transient transfection.
Fluorescence Microscopy
Fluorescence microscopy was performed in several different ways. For live cell
microscopy, cells were grown as previously described. Media was switched to
phosphate buffered saline (PBS) to reduce auto-fluorescence and cells were imaged on
a Nikon Eclipse TE2000-U inverted microscope equipped with green and blue filters and
a Nikon Intensilight C-HGFI power source.
High resolution fluorescence microscopy was also performed by growing cells in
the Lab-Tek II 8 well Chamber Slides system (Nunc). Cells followed the standard cell
culture, transient transfection, and experimental conditions only scaled down for the
smaller surface area of the individual wells. To prepare for microscopy, cells were
washed three times in DPBS with calcium and magnesium (Corning) and then all media
was removed. Cells were fixed for 1 hour at room temperature with 2%
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paraformaldehyde (PFA) and then washed three times with DPBS with calcium and
magnesium. All liquid was removed and chamber supports were separated from the
slide. Cells were immersed in a small droplet of FluoroMount-G (Southern Biotech)
supplemented with 4',6-diamidino-2-phenylindole (DAPI) to reduce fluorophore
quenching and nuclear staining, respectively. Slide covers were then placed on top of
cells and affixed with nail polish. Slides were stored at 4C. Fixed slides were viewed on
the a Zeiss AX100 microscope with an X-cite series 120Q light source.
Bulk Fluorescence Assays
Quantitative fluorescence data was achieved by measuring the bulk properties of
eukaryotic cells. Two assays were developed which were shown to give approximately
the same result.
First, cells were washed three times with DPBS, were lysed with Reporter Lysis
Buffer (Promega) and the cells were scraped off of the bottom of the growth plates. 50
μL whole cell lysate was then loaded into wells of a 384 well optical bottom plate
(Corning) into the Tecan M1000 and fluorescent emission was read with the following
excitation/emission wavelengths: GFP excite: 485nm emit: 510nm, YFP excite: 510 nm
emit: 535 nm, and mCherry excite: 585 nm emit: 610 nm.
Second, cell culture plates were washed three times with DPBS and the entire
cell culture plate was scanned on the Typhoon scanner. The scanner was set with a 3.5
mm vertical offset to better visualize the cells growing within the wells of the plate. The
473 nm blue excitation laser was used to excite GFP and the >520 nm filter was used to
read emission. Images were analyzed using ImageJ (NIH).
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Luciferase Assay
As before, cells were washed three times with DPBS, were lysed with Reporter
Lysis Buffer (Promega) and the cells were scraped off of the bottom of the growth plates.
5 μL of whole cell lysate was added to 45 μL of luciferase assay buffer (Promega)
containing luciferin within a well of a 384 well optical bottom plate (Corning). Plates
were immediately loaded into the Tecan M1000 and luciferase signal was measured for
each well over time. Peak luciferase signal values were used for quantification.
2.12 Western
Whole cell lysate is first collected from cells of interest as previously described.
Whole cell lysate is then mixed with 4x LDS sample buffer (Expedeon) and boiled at 70C
for 10 minutes to denature the proteins. Samples were loaded into wells of 10-20%
SDS-PAGE gels (Expedeon) and electrophoresed at 110V for 1 hour using the RunBlue
SDS Running Buffer (Expedeon).
Gels were removed and washed with MilliQ water and then prepared for semi-dry
transfer to Immobilon-P transfer membrane (Millipore). Gels were soaked for 10 minutes
in western transfer buffer (25 mM Tris, 200mM glycine, 10% methanol). Transfer
membrane is placed in 100% methanol for 15 seconds, moved to MilliQ for 2 minutes,
and then to western transfer buffer for 5 minutes. Six pieces of 3mm filter paper
(Whatman) are also soaked in western transfer buffer. The transfer stack is prepared as
follows: 3 pieces filter paper – equilibrated PVDF transfer membrane – equilibrated gel –
3 pieces filter paper. The sandwich is then loaded onto the semi-dry transfer plates and
run at at 15V for 15 minutes.
PVDF membrane is then removed from the sandwich and blocked in Blotto (1g
non-fat powdered milk in 20 mL PBS-T(PBS with 0.1% Tween-20)) for 1 hour.
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Membrane was then washed three times for 10 minutes each with PBS-T. Membrane
was then placed in the primary antibody at 4C overnight on an orbital shaker. The buffer
and concentration of primary antibody were determined by the manufacturers
recommendation for each antibody. In the morning, the gel was washed three times
with PBS-T and placed in the appropriate secondary antibody conjugated to horseradish
peroxidase (HRP). The gels were then exposed to chemiluminescent substrate specific
to HRP and imaged.
2.13 Mouse Experiments
AAV8 viral vector was prepared using the University of Pennsylvania Vector Core
from plasmid DNA.
Individual mice were given tail vein injections of AAV8 at a viral dose of (1e11
multiplicity of injection (MOI)) regardless of weight. Weight in grams for each mouse
was recorded throughout the experiment. Mice were fed a normal diet and given two
weeks to incorporate the virus in their liver tissue.
Gavage protocol was 25 μL of 1M IPTG per 10 gm body weight, two times a day
for 3 days. IPTG was gavaged through an oral syringe into the stomach of the mice.
Mice were either given normal water or gavaged IPTG throughout the experiment to
either induce or repress expression of the transgene.
Luciferase imaging was performed by giving mice interperitoneal injections of
luciferin and imaging them on a live mouse scanner. Raw luciferase signal was
quantified with ImageJ (NIH).
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2.14 Modeling
All functions from text were coded into Matlab (Mathworks) scripts to calculate
the MWC model outputs. Standard linear regression minimization functions were used
to minimize the difference between experimental and theoretical curves in order to fit for
the thermodynamic parameters of interest. Various minimization schemes were used
and all were built in Matlab functions such as a genetic algorithm and direct-pattern
search.
The error estimates in fit parameters were done by a monte carlo approach.
Each individual data point had some random fraction of its error added to it and the data
was refit. This process was repeated > 100 times and then the standard deviation of the
individual parameters was taken to be the error in that fit parameter. The best fit to the
data without error added was taken to be the reported value for the individual
parameters.
2.15 Plasmid Maps
The following is a list of all plasmids used throughout this thesis.
Prokaryotic plasmids
pBR series reporter plasmids were derived from giving ampicillin resistance and strict
plasmid copy number of approximately 10-20 per cell (Figure 2.1). The reporter cassette
contains the natural lacZ/Y/A promoter from the lac operon of E. coli. Only one operator
is present in the plasmid and is located downstream of the promoter in the transcriptional
initiation region (Figure 2.2). Regulated genes downstream of the promoter included
eGFP, YFP and the polycistronic message of dimeric lac repressor-mCherry fusion
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followed by YFP. An 18 base pair spacer which was the 18 base pairs that preceded the
LacI-mCherry gene and were:
5' CAA TTC AGG GTG GTG AAT 3'

Figure 2.1. Plasmid map of the pBR-YFP plasmid.

Figure 2.2. Close-up of the operator placement within the lacZ/Y/A promoter of the pBR
reporter plasmids.
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The pLacI series of plasmids provide chloramphenicol resistance and constitutive lac
repressor from the natural lacI promoter of E. coli (Figure 2.3). The lacI gene has the 11
C-terminal codons truncated. The lac repressor-mCherry fusion includes an 18 base
pair linker with the sequence:
5' GGC TCA GGT CTC GAG TTG 3'

Figure 2.3. Plasmid map of the pLacI series plasmid with the lac repressor-mCherry
fusion protein.
The arabinose expression plasmid is pBAD-DEST-49 (Invitrogen) and expression genes
were placed within the first multiple cloning site.
Eukaryotic Plasmids
The pIRES plasmid (Clontech) has a minimal CMVI promoter with two multiple cloning
sites linked by the IRES sequence. The original IRES plasmid put YFP in the first
multiple cloning site and EuLacmCherry in the second multiple cloning site.
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The EuLac sequence was taken from the codon optimized sequence for Eukaryotic cells
with the splice site fixed (Cronin et al., 2001). We first used a dimeric EuLac sequence
with the 11 C-terminal codons removed. Later we used the EuLacTet sequence with the
11 C-terminal codons of wild type lacI restored for tetrameric lac repressor. The
following is the EuLacTet sequence with the 11 C-terminal amino acids that result in
tetramerization highlighted in bold:
5'- ATG AAA CCA GTA ACG TTA TAC GAC GTC GCA GAG TAT GCC GGT GTC TCT
TAT CAG ACT GTT TCC AGA GTG GTG AAC CAG GCC AGC CAT GTT TCT GCC AAA
ACC AGG GAA AAA GTG GAA GCA GCC ATG GCA GAG CTG AAT TAC ATT CCC AAC
AGA GTG GCA CAA CAA CTG GCA GGC AAA CAG AGC TTG CTG ATT GGA GTT
GCC ACC TCC AGT CTG GCC CTG CAT GCA CCA TCT CAA ATT GTG GCA GCC ATT
AAA TCT AGA GCT GAT CAA CTG GGA GCC TCT GTG GTG GTG TCA ATG GTA
GAA AGA AGT GGA GTT GAA GCC TGT AAA GCT GCA GTG CAC AAT CTT CTG
GCA CAA AGA GTC AGT GGG CTG ATC ATT AAC TAT CCA CTG GAT GAC CAG
GAT GCC ATT GCT GTG GAA GCT GCC TGC ACT AAT GTT CCA GCA CTC TTT
CTT GAT GTC TCT GAC CAG ACA CCC ATC AAC AGT ATT ATT TTC TCC CAT GAA
GAT GGT ACA AGA CTG GGT GTG GAG CAT CTG GTT GCA TTG GGA CAC CAG
CAA ATT GCA CTG CTT GCG GGC CCA CTC AGT TCT GTC TCA GCA AGG CTG
AGA CTG GCC GGC TGG CAT AAA TAT CTC ACT AGG AAT CAA ATT CAG CCA ATA
GCT GAA AGA GAA GGG GAC TGG AGT GCC ATG TCT GGG TTT CAA CAA ACC
ATG CAA ATG CTG AAT GAG GGC ATT GTT CCC ACT GCA ATG CTG GTT GCC AAT
GAT CAG ATG GCA CTG GGT GCA ATG AGA GCC ATT ACT GAG TCT GGG CTG
AGA GTT GGT GCA GAT ATC TCG GTA GTG GGA TAC GAC GAT ACC GAA GAC
AGC TCA TGT TAT ATC CCG CCG TTA ACC ACC ATC AAA CAG GAT TTT CGC CTG

51

CTG GGG CAA ACC AGC GTG GAC CGC TTG CTG CAA CTC TCT CAG GGC CAG
GCG GTG AAG GGC AAT CAG CTG TTG CCA GTC TCA CTG GTG AAG AGA AAA
ACC ACC CTG GCA CCC AAT ACA CAA ACT GCC TCT CCC CGG GCA TTG GCT
GAT TCA CTC ATG CAG CTG GCA CGA CAG GTT TCC CGA CTG GAA AGC GGG
CAG -3'
The operator was placed within the CMV\IE\Promoter region of the minimal CMV
promoter 13 base pairs downstream of the TATA box. The following is the sequence of
the CMV\IE\Promoter region including the Lsym operator in bold:
5'- CGC CCC GTT GAC GCA AAT GGG CGG TAG GCG TGT ACG GTG GGA GGT CTA
TAT AAG CAG AGC TCG AAT TGT GAG CGC TCA CAA TTG AGC TCG TTT AGT GAA
CCG TCA GAT C -3'
The plasmid map of pIRES Lsym YFP IRES EuLacmCh is given in Figure 2.4. The pSW
plasmid expresses EuLac followed by the 2A sequence followed by either the GFP or
Luciferase gene Figure 2.5. The entire cassette is flanked by ITR repeat regions for
inclusion into AAV-viral capsids.
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Figure 2.4. Plasmid map of the pIRES plasmid with the minimal CMVI promoter under
control of the Lsym operator. The plasmid co-expresses YFP and the lac repressor
fused to mCherry.
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Figure 2.5. pSW-GFP plasmid map. The CMV promoter in this plasmid has one Lsym
site in the same location as described above for the pIRES series plasmid.
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Chapter 3:
Linking Mutation to Thermodynamics
(Adapted from Daber, Sochor and Lewis (2011) Thermodynamic Analysis of Mutant lac
Repressors. Journal of Molecular Biology. 409, 76-87.)
3.1

Introduction
The study of the lac repressor, like many proteins, includes a large body of work

wherein the repressor itself is mutated and its altered function analyzed. For the lac
repressor, this history is complicated by the ever changing experimental techniques and
knowledge of the repressor itself. So while a huge body of lac repressor mutations and
their phenotypes is present in the literature, there is no direct link between how mutating
specific parts of the lac repressor could potentially change the thermodynamic
equilibrium and binding parameters specified by the MWC model of allostery. It is a
much more stringent test of the MWC model if it can successfully explain not only the
behavior of the wild type repressor, but also mutations to specific regions which should
directly alter one or more of the thermodynamic parameters while leaving the others
unchanged.
As discussed previously, the tetrameric lac repressor is doubly allosteric. First,
the tetramer allosterically binds two DNA operators which has the effect of increasing the
affinity of the repressor for operator DNA. Second, each dimer allosterically lowers its
operator DNA affinity upon inducer binding. These two allosteric mechanisms work in
concert to efficiently regulate the lac operon in E. coli. The vast majority of studies on
the lac repressor take place with a full length tetrameric protein where the effect of both
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mechanisms are present. It would be much more ideal to study the two processes in
isolation in order to understand their individual effects.
It is relatively straightforward to isolate the allostery of DNA binding by the
tetramer. One simply needs to study the properties of the repressor and operator DNA
binding in the absence of any effector molecules. The natural lac operon includes three
operators: O1 which is located within the promoter, O2 which is 401 base pairs
downstream of O1, and O3 which is 92 base pairs upstream of O1. The operators are
all pseudo-palindromic and have similar, yet distinct sequences and different affinities for
the lac repressor. The last operator that is typically studied is a fully symmetric operator
that was created by copying the left half of the O1 operator and removing the central G
base, which we call Lsym (Sadler, Sasmor, & Betzt, 1983). The sequences of the four
operators is given in Table 3.1.
Name

L6-4

L3-1

P0

R1-3

R4-6

O1

5' -

AA TT

GTG

AGC

G

GAT

AAC

AA TT

-3'

O2

5' -

AA AT

GTG

AGC

G

AGT

AAC

AA CC

-3'

O3

5' - GG CA

GTG

AGC

G

CAA

CGC

AA TT

-3'

5' -

GTG

AGC

GCT

CAC

AA TT

-3'

Lsym

AA TT

Table 3.1. The sequences of the three natural operators of the lac operon and the left
symmetric operator.
What is immediately obvious is that positions 1-6 of the left side (L1-6) of all of
the operators is identical. Affinity is essentially then a function of base pairing with the
right side and the spacing (or lack thereof) created by the central guanine base at
position 0 (P0).
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An elegant study quantitatively established exactly how the lac repressor
cooperatively binds its various operators (Oehler et al., 1994). They used a quantitative
β-galactosidase assay to quantify repression by either dimeric or tetrameric lac
repressor on promoters with various combinations of DNA operators. They first
established that dimeric lac repressor and tetrameric lac repressor will repress a single
operator in the O1 location (regardless of which operator) with the same efficiency.
There is no inherent benefit to binding the first operator through tetramerization. They
also established that O1 represses ~4 times more than O2 and ~200 times more than
O3. Next they added a second downstream operator and showed an ~10 fold increase
in repression for tetramer. There was no improvement for dimeric lac repressor, as
expected. There is a similar benefit in placing additional operators upstream in the O3
position for the tetrameric lac repressor. The spacing between the two operators was
later shown to be critical with a specific phase of approximately 11 base pairs between
repression maximums (Müller et al., 1996). This phasing is understood to be related to
the structure of DNA. DNA has the famous double helix structure with a minor and major
groove. The helix-turn-helix of the lac repressor binds within the major groove of DNA
making specific contacts with bases 4, 5 and 6 of the operator. Since the DNA twists
with every additional base and the lac repressor dimers are linked through the coiled-coil
tetramerization domain, specific spacing is required between the two operators such that
the major groove for positions 4, 5 and 6 (for both the left and right halves) is facing the
helix-turn-helix of each dimer of the lac repressor tetramer. Taking an MWC view of
tetrameric lac repressor binding two operators requires considering multiple structures of
not only the repressor, but also the DNA. Conceptually however, there are two
combinations of conformations that matter. In one, only one dimer binds one operator
with a mild affinity. In the second conformation, the tetramer and the DNA are twisted
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such that an extremely stable pairing exists and both dimers bind both operators with
very high affinity. The two sets of conformations are in equilibrium and adding a second
operator within the DNA molecule at the correct spacing will alter the effective
conformational equilibrium towards the higher DNA affinity state. The net effect is an
approximately 10 or higher fold increase in repression.
While the allosteric binding of two DNA operators is useful for bacteria to more
completely shut off the lac operon, it is confounding if we want to study the allosteric
relationship between effector and DNA binding. If we want to isolate this effect, we must
work only with the dimeric lac repressor and a single DNA operator. The next goal is to
isolate perturbations to DNA binding from perturbations from effector binding. This is
achieved by targeting residues in the lac repressor that contribute to either specific DNA
binding or effector binding. A quantitative assay must be employed that measures DNA
binding as a function of effector concentration (or vice versa). Finally, a comprehensive
MWC allosteric model and solution to the model must be defined. Using all of these
tools it should be possible to globally compare wild type lac repressor to mutants and
measure how those mutations alter the thermodynamic parameters of the MWC model
of allostery.
3.2

The MWC Model of the Dimeric Lac Genetic Switch

First we will establish an MWC model of the dimeric lac repressor binding to effectors
and operator DNA (Figure 3.1).
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Figure 3.1. MWC model of dimeric lac repressor (R and R*) binding to a single DNA
operator (O) and one or two effector molecules (E). The conformational equilibrium
between the two conformations of the lac repressor (R and R*) is denoted by KRR*. The
remaining parameters are the equilibrium affinity constants of the two states for operator
(KRO and KR*O) and effector (KRE and KR*E).
The dimeric lac repressor exists in two primary conformations in this model, R
and R*. The R conformation is designated as the higher DNA affinity conformation.
Each lac repressor dimer can bind one operator DNA (O) and two effector molecules (E).
The model assumes that the dimeric structures of the lac repressor are symmetric.
Therefore for each given conformation the two effector binding sites are the same and
have the same affinity of for effector. We assume that this symmetry is not broken upon
binding of the first effector molecule, hence the binding of the second molecule to the
second site has the same affinity as the first.
Experimentally, we would like to measure the output from a promoter regulated
by the lac genetic switch. It is assumed that transcription by RNA polymerase from the
promoter is linearly related to the occupancy of the DNA operator within the promoter by
the lac repressor,
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transcription ∝

[O]
[O]tot

(42)

In order to model experimental data, we need to compute the occupancy of the
DNA operator in terms of the thermodynamic constants (KRR*, KRE, KR*E, KRO, and KR*O)
and the total concentration of repressor, effector and operator ([R]tot, [E]tot, and [O]tot).
We begin by defining the constants,

[R *]
[ R]

(43)

[RE]
[R][E]

(44)

KRR *=

KRE =

[R*E]
[R ][E]

(45)

KRO =

[RO]
[R][O]

(46)

KR*O =

[R*O]
[R* ][O]

(47)

K[R*E]=

We also need to define the total concentrations of operator in terms of the
individual bound and conformational states,

[O ]tot =[ O ]+[RO]+2 [REO]+[RE 2 O]+
[R*O ]+2[R*EO]+[R*E 2 O]

(48)
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The factors of 2 in from of the [REO] and [R*EO] states are due to the
degeneracy of effector binding to the dimer. The effector could be bound to either the
left monomer or right monomer which look identical, hence they are degenerate. To
account for both species we need to multiply by two.
We can state the various bound species from Equation (48) in terms of the
thermodynamic constants and the unbound concentrations of repressor, operator and
effector ([R], [O], and [E], respectively),

[RO]=KRO [R][O]

(49)

[REO]=KRE KRO [R][E][O]

(50)

[RE 2 O]=K2RE K RO [ R][ E]2 [O]

(51)

[R*O ]=K RR* KR*O [R][O]

(52)

[R*EO]=KRR* KR*E KR*O [R][E][O]

(53)

2

2

[R*E 2 O]=KRR* KR*E KR*O [R][E] [O ]

(54)

We then note the following equality for simplification,

(1+[ E]K RE )2=1+ 2[E]KRE +[E] 2 K2RE

(55)

Plugging in Equations (49) - (54) and using the equality in Equation (55) into
Equation (48),
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O tot=[O]+[O][R]KRO (1+[E]K RE )2 +[O][R]KRR* K R*O (1+[E]K R*E )2

(56)

We then rearrange put Equation (56) in the form which is proportional to
transcription as in Equation (42),

[O]
1
=
2
[ O]tot 1+[R](KRO (1+[E]K RE ) +KRR* KR*O (1+[E]KR*E )2 )

(57)

We now have the occupancy of the operator in terms of the thermodynamic
parameters and the free species of repressor and effector. Unfortunately, we do not
know the free species concentrations, only the total concentrations.
The experiment we would like to model however allows for some simplifications
of Equation (57). We measured GFP production from a reporter plasmid which has a
single operator within the promoter region. This plasmid has a very low copy number
and hence the number of DNA operators in the cell is approximately 20. Meanwhile, the
repressor is constitutively expressed from a second plasmid with also with a low copy
number (~10-20) (Daber et al., 2009). This promoter, the natural promoter of the lacI
gene in E. coli, has been estimated to make approximately 40 lac repressor dimers per
promoter (Oehler et al., 1994), hence we have approximately 400-800 dimers per cell.
Since a fraction of the operator itself is free, and the affinity of repressor for operator is
high, we can assume that free operator concentration is approximately 0 with respect to
the total repressor concentration,

[R ]tot ≫[O]≈0

(58)
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We then can approximate the total repressor concentration in terms of free
species and thermodynamic binding constants,

[R] tot=[R]+ 2[RE ]+[RE2 ]+[R*]+ 2[R*E]+[R*E 2 ]+
[RO]+ 2[REO]+[RE2 O]+[R*O]+ 2[R*EO]+[R*E2 O ]

(59)

Using the assumption of Equation (58), we can say that all of the operator bound
species of the repressor only marginally contribute to the total, which leads to the
approximation that,

[R ]tot ≈[R]+2 [RE]+[RE2 ]+[R*]+2[R*E]+[R*E2 ]

(60)

[R ]tot≈[R]((1+[E]K RE )2 +K RR*(1+[E]KR*E )2 )

(61)

Solving for the free repressor concentration,

[R ]≈

[R]tot
(1+[E]KRE ) +KRR* (1+[E]K R*E) 2

(62)

2

We then can substitute Equation (62) into Equation (57)to arrive at,

[O]
=
[ O]tot

1+

1
[ R]tot (KRO (1+[ E]K RE )2 +KRR* KR*O (1+[E]KR*E )2 )
2

2

(63)

(1+[E]K RE ) +KRR* (1+[E]KR*E )

We then define the two following constants,
2

f=

(1+[E]KRE )

(1+[E]K RE )2 +KRR* (1+[E]KR*E )2

(64)
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s=

( 1+[E]KR*E )2
(1+[E]K RE )2 +KRR* (1+[E]KR*E )2

(65)

r=[R]tot KRO

(66)

r*=[R]tot K RR* K R*O

(67)

[O]
1
=
[O]tot 1+rf +r*s

(68)

The final assumption required is regarding the free effector concentration, [E].
We assume that free effector concentration does not significantly differ from the total
effector concentration. The error in this assumption will decrease as total effector
concentrations comes to greatly exceed total repressor and total operator
concentrations, which occurs in our experimental system at full induction. We then
approximate Equations (64) and (65),

f≈

s≈

(1+[E]tot K RE )2
(1+[E]tot KRE )2 + KRR* (1+[E]tot KR*E )2

(1+[E] tot K R*E)

(69)

2

(1+[E]tot KRE )2 + KRR* (1+[E]tot KR*E )2

(70)

Using these assumptions we have finally stated the occupation of the operator
solely in terms of total repressor and effector concentrations and the thermodynamic
constants. We will use Equations (68), (69), and (70) to understand our experimental
data in this chapter in the frame of the MWC model of allostery.
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The phenotypic properties of the lac genetic switch can also be understood in
terms of this model. We define three phenotypic properties: leakiness is the expression
without effector (basal expression), dynamic range is the difference between maximal
induction or co-repression and the leakiness, and [E]50 is the concentration of effector
needed for half maximal induction or co-repression.
To model leakiness, we set [E]tot = 0 and find,

f =s=

Leakiness(L)=

1
1+KRR*

[O]
([E]tot =0)=
[O]tot

(71)

1
r +r*
1+
1+K RR*

(72)

Similarly we can find dynamic range by measuring the operator occupancy at
saturating effector concentration ([E]tot → ∞) and subtracting leakiness. At very large
effector concentrations, the terms multiplied by [E]tot are much larger than 1, hence,
2

f ([E]tot →∞)≈ f≈

([E]tot KRE )

([E]tot K RE )2 +KRR* ([E] tot K R*E)2
2
KRE
f ([E]tot →∞)= 2
2
KRE +K RR* KR*E

s([E] tot →∞)=

K2R*E
K 2RE +KRR* K2R*E

=
(73)

(74)
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[O]
([E]tot →∞)=
[O] tot

1+

1
r K +r* K2R*E
2
RE

K2RE +K RR* K 2R*E

[O]
([E]tot →∞)−L =
[O] tot
1
1
D=
2
2
r +r*
r K +r* K R*E
1+
1+ 2 RE
1+KRR*
K +K K 2

(75)

Dynamic Range (D)=

RE

RR*

(76)

R*E

Finally, the [E]50 is calculated by solving for the effector concentration at half
maximal induction which is equal to the leakiness plus half of the dynamic range. We
therefore need to solve the following equation for [E]tot,

L+D/2=

1
1+rf +r*s

(77)

A solution for [E]50 exists if we assume that the R* conformation has effectively
very low affinity for DNA (relative to r) and we set r* = 0. In that case we have,

L+D/2=
1+

1
2
r (1+[E]50 KRE )
(1+[E] 50 KRE )2 +K RR* (1+[ E]50 K R*E)2

(78)

We then define the following constant and use it to re-arrange Equation (78),

1
1
ϕ = D −1
L+
2

(79)
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1
ϕ=

r ( 1+[E]50 KRE )2
(1+[E]50 K RE )2 +KRR* (1+[E]50 KR*E )2

(80)

We then multiply the denominators on both sides of the Equation and find,

[E]250 (K2RE ( ϕr −1)−KRR* K 2RE )+
[E]50 (2K RE (ϕ r−1)−2KRR* KR*E )+ϕ r−KRR*−1=0

(81)

If we then define the following constants we can easily solve for [E]50,

A=K 2RE ( ϕr −1)−KRR* K 2RE

(82)

B=2KRE (ϕ r−1)−2KRR* K R*E

(83)

C=ϕ r−K RR*−1

(84)

[E]50=

−B±√(B2−4AC)
2A

(85)

Equation (85) of course only holds when r* = 0 and [E]50 must be real and greater
than zero. Now that we have a solution to the MWC model, we can generate mutants of
the lac repressor and test them using the solution.
3.3

Mutations to the DNA Recognition Domain
The DNA recognition domain of the lac repressor has been shown to be positions

1, 2 and 6 of the DNA recognition helix which corresponds to positions tyrosine 17 (Y17),
glutamine 18 (Q18), and arginine 21 (R21). The recognition helix is aligned within the
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major groove of DNA and makes specific contacts with positions 4, 5, and 6 of the lac
DNA operators.
The recognition domain of the lac repressor has been an important target for
mutagenesis in order to explore how proteins use helix-turn-helix motifs to specifically
bind DNA. First it was shown that specificity could be changed by combining Y17, Q18,
and R22 mutations with mutations to the operator at positions 4, 5 and 6 (Sartorius et al.,
1989). Next, a mutant library was created where all three positions were mutated to all
20 amino acids creating approximately 8000 mutant repressors. This library was
screened against the O1 and Lsym operators with the goal of finding tighter binding
mutants (Daber & Lewis, 2009). They found 33 different mutants that repressed
transcription through O1, however only with mutations to positions 17 and 18; any
mutation to position 22 failed to repress. Interestingly, only one mutant, Q18M, was
found to bind O1 tighter than wild type repressor. Finally, they found a relationship
between the repression of these mutants and dynamic range; tighter binding could lead
to less leakiness of expression but it also decreased the maximal inducibility. This led to
the hypothesis that DNA specificity mutants primarily change the lac repressor-DNA
operator affinity (KRO).
We sought to test this hypothesis in vivo by globally modeling the transcriptional
regulation phenotype of dimeric lac repressor with and without mutations to the DNA
specificity residues.
Three point mutations were selected for analysis: Y17I which is leakier in
regulating O1 than wild type, Q18A which is also leakier, and Q18M which is less leaky
in regulating O1. All three point mutations were separately cloned using inverse PCR
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mutagenesis into the pLacI plasmid which constitutively expresses dimeric lac repressor
(11 C-terminal residues are truncated) from the natural constitutive promoter of the lacI
gene from E. coli.
The wild type repressor and three point mutants were tested using the
prokaryotic GFP regulation assay (Figure 3.2).

Figure 3.2. Regulation of GFP by headpiece mutants of the lac repressor and O1.
Positions 17 and 18 both reside within the recognition helix of the N-terminal headpiece
of the lac repressor and are known to be important for specificity in DNA binding. Point
mutations Y17I and Q18A both are leakier (higher expression without IPTG) than wild
type lac repressor whereas Q18M is less leaky. The dynamic range is decreased in all
mutants with respect to wild type lac repressor.
Figure 3.2 shows that all three point mutants can still regulate GFP expression
using the O1 operator. Y17I is the leakiest mutant (~50% leakiness) and it essentially
induces to constitutive expression of the promoter at [IPTG] ≥ 0.1 mM. Q18A is
marginally less leaky than Y17I (~25% leakiness) and also reaches constitutive levels of
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expression upon induction with [IPTG] ≥ 0.1 mM. Q18M is approximately half as leaky
(~2% leakiness) than wild type (~4% leakiness) and its maximal induction is severely
limited.
It is of note that the dynamic range of the genetic switch appears to be limited by
the upper and lower bounds. We can model this behavior using our MWC model of the
lac genetic switch. Figure 3.3 shows simulated lac genetic switch data where only the
affinity for the R state of DNA is changed (r = [R]totKRO is altered). Figure 3.3.B clearly
demonstrates the limiting nature of the upper and lower bounds on dynamic range; a
median value of r produces a minimally leaky switch that maximally induces. This is
precisely the relationship we see in the experimental data of Figure 3.2 where the only
mutation is to the specificity region of the N-terminal DNA binding domain. We
hypothesize therefore that point mutations to this regions specifically change the affinity
of repressor for DNA (KRO and KR*O). It of course is possible that the point mutations
change the total concentration of repressor ([R]tot), however given the current experiment
we have no means of measuring the repressor concentration. This is a limitation of this
study and it will be addressed later in this chapter.
We globally modeled the three headpiece mutants of the lac repressor dimer
along with the wild type by assuming the only difference could be in the KRO
thermodynamic parameter. We therefore performed regression between simulated
curves and experimental curves looking for thermodynamic parameters that fit the data.
For the four data sets there are 11 fit parameters (rWT, rY17I, rQ18A, rQ18M, r*WT, r*Y17I, r*Q18A,
r*Q18M, KRE, KR*E, KRR*) however it was previously found that for wild type dimeric lac
repressor KR*O is effectively zero (Daber et al., 2009) so we will set all of the r*
parameters to zero and fit the remaining 7 parameters.
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Figure 3.3. Simulated lac genetic switch data as a function of changing r. The
following thermodynamic parameters were used: r* = 0, KRE = 4 mM-1, KR*E = 60 mM-1,
KRR* = 2. (A) Simulated induction curves with an effector shows that lower r (lower Rtot
and/or KRO) makes a leakier switch that more fully induces, whereas higher r leads to
tighter and tighter switches that cannot fully turn on. (B) The dynamic range shows that
a happy medium exists when altering r where the switch is minimally leaky and
maximally inducible.
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There is another complication to the modeling that also needed to be addressed
before thermodynamic parameters could be measured. Figure 3.4 shows the effect of
altering KRR* on the induction of the genetic switch.

Figure 3.4. Simulated lac genetic switch data as a function of changing r. The
following thermodynamic parameters were used: r=50, r* = 0, KRE = 4 mM-1, KR*E = 60
mM-1. Changes to KRR* mirror changes to r because it effectively makes more or less of
the high affinity conformation, R, of the protein. Since the r parameter also contains the
repressor concentration, these two parameters become linked.
Changes to KRR* on the induction curve of the lac genetic switch look very, very
similar to changes to KRO. From the model alone, it is unclear whether the headpiece
mutants are altering DNA affinity or the conformational equilibrium. From a structural
perspective, the location of the point mutations in the recognition domain of the DNA
binding domain strongly indicates the former, however it would be better if we could
eliminate the possibility that KRR* is changing. Analyzing the limits of the MWC
equilibrium actually provides a mechanism to isolate KRR* from r, and hence investigate
which may be changing for this data. We start by re-defining Equation (75),
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y 2=

[O]
([E]tot →∞)=
[O] tot

1+

1
r K +r* K2R*E
2
RE

K2RE + KRR* K 2R*E

(86)

Looking at the formula for leakiness, Equation (72), we can isolate r in both
equations pretty easily (assuming r* = 0),
2
r KRE
1
−1= 2
y2
KRE +KRR* K 2R*E

1
r
−1=
L
1+K RR*

(87)

(88)

The ratio of Equations (87) and (88) then eliminates the r parameter and gives us
an experimental measure that isolates KRR*,

1
−1
2
2
y2
K +K K
z=
= 2RE RR* 2RE
1
−1 K RE +K RR* KR*E
L

(89)

Figure 3.3.A and Figure 3.4 show the same resultant phenotype from changing r
and KRR* separately, however Figure 3.5 shows a large difference in the z parameter.
Obviously, there is no effect when altering r, as z is independent of r. There is however a
significant decrease in z when you increase KRR*.
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Figure 3.5. Calculation for the z parameter as a function of either r or Krr*.
Thermodynamic parameter values for the blue bars (where r changes) were: r* = 0, KRE
= 4 mM-1, KR*E = 60 mM-1, KRR* = 2. Since z is independent of r, there is no change. The
thermodynamic parameter values for the red bars (where KRR* changes) were: r=50, r* =
0, KRE = 4 mM-1, KR*E = 60 mM-1. As KRR* increases (more repressor in the R*
conformation) the z parameter decreases.
Figure 3.6 shows the z values for wild type and the three headpiece mutants.
Y17I and Q18A are approximately unchanged from wild type, while Q18M has a much
higher value. The z parameter calculation is especially sensitive to small changes in
small numbers due to the inversion, hence small changes in the leakiness measurement
will have large effects on the experimental calculation of z. The question is then: is the
difference between wild type and Q18M z due to experimental error in measuring small
signals or does Q18M alter the KRR* parameter. We can address this question by fitting
the Q18M data set while changing either r or KRR*, calculating z and seeing if the
magnitude of the z change is comparable with experiment.
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Figure 3.6. Calculated z values from wild type and the three headpiece mutants of
the lac represor. Y17I and Q18A have approximately the same z value as WT,
indicating the altered phenotype is a result of changing the r parameter. Q18M has a
higher value which could be due to changes in KRR*.
The final complication in fitting arises from the non-uniqueness of solution due to
the compensatory nature of r and KRR*. We will bootstrap our value of r based upon the
findings of Daber, Sharp, and Lewis who determined that r = 150 +- 50 for a heterodimeric form of the lac repressor (Daber et al., 2009). Their finding was based upon
fitting z parameters for their experimental data.
We then globally fit the four experimental curves given rWT = 150 fitting for three
parameters common to all four experiments (KRR*, KRE, and KR*E) and with one
independent parameter for each of the headpiece curves (r Y17I, rQ18A, and rQ18M). Table 3.2
shows the fit parameters. We then refit the Q18M looking for altered KRR* given: r=150,
KRE = 60 mM-1, KR*E = 500 mM-1. This fit is given in Table 3.3.
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log10 [E]50

Construct

r

KRR*

KRE (mM-1)

KR*E (mM-1)

Leakiness

Dynamic
Range

Wild Type

150 ± 50

5.8 ± 0.07

60 ± 0.2

500 ± 5

0.044

0.7

-1.94

Y17I

8.6 ± 0.07

5.8 ± 0.07

60 ± 0.2

500 ± 5

0.44

0.5

-2.66

Q18A

18.0 ± 0.2

5.8 ± 0.07

60 ± 0.2

500 ± 5

0.28

0.7

-2.49

Q18M

1404 ± 1

5.8 ± 0.07

60 ± 0.2

500 ± 5

0.005

0.2

-1.56

(mM)

Table 3.2. Fit values where only the r parameter was altered between the 4 different
experimental curves.
log10 [E]50

Construct

r

KRR*

KRE (mM-1)

KR*E (mM-1)

Leakiness

Dynamic
Range

Wild Type

150 ± 50

5.8 ± 0.07

60 ± 0.2

500 ± 5

0.044

0.7

-1.94

Q18M

150 ± 50

0.65 ± 0.1

60 ± 0.2

500 ± 5

0.005

0.2

-1.56

(mM)

Table 3.3. Fit values where Q18M were re-fit looking for changes in KRR* instead of
changes in r.
We then calculated z and compared to experimentally calculated z to determine if
Q18M primarily changes r or KRR*. Table 3.4 shows the results and the difference
between theoretical and experimental z values.
Construct

z Predicted

z Experimental

|Δz|/z

Wild Type

0.017 ± 0.0003

0.014 ± 0.003

0.15

Y17I

0.017 ± 0.0003

0.016 ± 0.004

0.02

Q18A

0.017 ± 0.0003

0.013 ± 0.002

0.25

0.017 ± 0.0003

0.058 ± 0.008

2.45

0.040 ± 0.007

0.058 ± 0.008

0.47

Q18M
(Table 3.2)
Q18M
(Table 3.3)

Table 3.4. Predicted z values versus experimental values of z. The last column
shows the difference relative experimental z where lower values are better.
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The normalized difference values in Table 3.4 show that Y17I and Q18A
phenotypes are well explained by only changing the r parameter whereas the Q18M
mutant is best explained by altering the KRR* parameter.
It would be expected that the Y17I and Q18A mutations primarily alter KRO due to
their location within the DNA recognition helix of the lac repressor, however these
mutations could also alter the total concentration of the repressor, [R]tot. It is unclear how
Q18M could alter the conformational equilibrium parameter but we also do not have a
good structural picture of the N-terminal domain of the lac repressor in the effector
bound conformation. Crystal structures do not show density (likely indicating mobility of
this region) for the N-terminal domain when IPTG is bound in the effector binding pocket.
Q18M makes the conformational equilibrium go from greater than 1 (favoring the low
operator DNA affinity conformation R*) to less than 1 (favoring the R conformation). This
mutation takes a large polar residue (glutamine) and changes it to a still large, more
apolar residue (methionine). Perhaps the solvation of residue 18 between the R and R*
states plays a significant role in the very close energetic balance between these two
states, significant enough to alter the conformational equilibrium. Central to this idea,
however, is that the methionine can still make good specific contacts within the major
groove of DNA.
Figure 3.7 shows the experimental data with the best fit MWC curves for wild
type lac repressor and the three head piece mutants.
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Figure 3.7. Best fit values for wild type, dimeric lac repressor and three point
mutations to the DNA recognition domain. The MWC model is very accurate at reproducing the experimental curves.
3.4

Mutations to the Effector Binding Pocket
The effector binding pocket of the lac repressor includes a large number of

residues that both make specific contacts with the repressor and which are important for
making secondary, stabilizing contacts. The residues arginine 197 (R197), asparagine
246 (N246), and aspartic acid 274 (D274) form hydrogen bonds to the O2 and O3
hydroxyls of sugar effector molecules. As these are essential for effector binding, they
are poor candidates for mutation if we are trying to change the thermodynamic binding
parameters without completely destroying binding. Much like our approach in the DNA
binding domain, the residues that are responsible for specificity in effector binding were
instead targeted. Effectors are known that are inducers, co-repressors and neutral and
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the difference between the molecules is on the substituent groups on the first and sixth
carbons of the sugar ring (Barkley, Riggs, Jobe, & Bourgeois, 1975). These substituent
groups make contacts with residues 79, 148, 161, 291, 293 and 296. These residues
were targeted by making 6 libraries where each site was individually mutated to all 20
amino acids (120 mutants screened) and their in vivo GFP regulatory phenotype was
recorded (Daber et al., 2011).
Here we analyze a subset of these mutations that have phenotypes which are of
particular interest. Again, we would like to globally fit the GFP regulation of these
mutants with the goal of linking effector pocket point mutations to changes in the effector
binding parameters (KRE and KR*E). It is also possible that point mutations in the effector
binding pocket could alter the conformational equilibrium (KRR*) (Figure 3.4). The two
effector binding parameters can change in two significant ways: first, the magnitudes
could change (stronger or weaker binding) and second, the relative magnitudes between
the two affinities could change. Here we define the relative magnitude as,

X=

KR*E
KRE

(90)

We can then use the MWC model to predict how these two changes alter the
regulatory phenotype. Changes in the magnitudes of the binding affinities cause either a
left or right shift in the curve, which is reflected as a change to the half maximal effector
concentration, [E]50 (Figure 3.8). Lower magnitudes of KRE and KR*E increase [E]50 (more
effector is needed to bind) whereas higher affinities decrease [E]50 (less effector is
needed). Alternatively, changing the ratio between the two effector binding affinities
changes the dynamic range of the switch (Figure 3.9). Larger X makes a more inducible
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switch because more repressor goes to the R* conformation upon addition of effector.
The effector binding affinities, predictably, do not change the leakiness. Any changes in
leakiness must be due to either changes in r (likely due to changes in [R]tot) or KRR*.

Figure 3.8. Effect of changing the magnitudes of the effector affinity on MWC gene
regulation. Leakiness and dynamic range are unchanged. There is however a
significant effect on the midpoint of maximal induction, [E]50. Higher affinity to effector
decreases the [E]50, and vice versa.
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Figure 3.9. Effect of changing the relative magnitudes of the effector affinities (X)
on MWC gene regulation. Leakiness is unchanged. There is however a significant
increase in dynamic range as X increases due to effector more efficiently moving lac
repressor to the R* conformation. [E]50 is marginally affected by changing the ratio X.
We then want to select effector pocket mutants that change the gene regulatory
phenotype in various ways with the goal of globally linking these phenotypic changes to
the underlying thermodynamic parameters. Our hypothesis is that we can model every
effector pocket mutant phenotype only through changes to KRE, KR*E, and KRR*.
Table 3.5 shows the selected point mutants along with an effector that gives rise
to a particular phenotype. This list includes many interesting phenotypes: tighter and
weaker IPTG binding, more ideal on-off genetic switches, and even inverted switches
which go from on to off with a dynamic range comparable to wild type lac repressor.
Three mutations to phenylalanine 161 (F161) were found to have a more ideal
on-off behavior (Figure 3.10). All three mutants are less leaky than wild type and induce
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to a higher level with IPTG. We hypothesize that this region alters both the
conformational equilibrium and the effector binding.
Mutation

Effector

Phenotype

Wild Type

IPTG

Canonical inducing

Wild Type

ONPG

Canonical co-repressing

L148D

ONPG

Inverted genetic switch

L148W

ONPG

Inverted genetic switch

F161N

IPTG

Better on-off switch

F161S

ONPG

Weakly inducing with canonical co-repressor

F161T

IPTG

Better on-off switch

F161W

IPTG

Better on-off switch

Q291I

IPTG

Decreased leakiness

Q291K

IPTG

Weaker IPTG binding

Q291M

IPTG

Stronger IPTG binding

Q291R

IPTG

Non-responsive to IPTG

L296W

IPTG

Less leaky but weaker IPTG binding

L296W

ONPG

Weakly inducing with canonical co-repressor

Table 3.5. Point mutations to the effector binding pocket of the lac repressor and their
phenotypic response with specific effectors.
Four point mutations to glutamine 291 (Q291) primarily change maximal
expression (higher for Q291M and much, much lower for Q291R) or the mid-point of
induction (lower effector needed for Q291M and higher effector needed for both Q291I
and Q291K) (Figure 3.11). We hypothesize that this region primarily alters the effector
binding affinities in both magnitude and in relative affinity between the two
conformational states of the lac repressor.
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Figure 3.10. IPTG induction profiles of lac repressor dimer and point mutants in
the effector binding domain. Mutations to F161 appear to create more ideal
repressors. L296W is still inducible with IPTG but at a much, much lower affinity than
wild type.
Two point mutations to leucine 148 (L148) have the the notable phenotype of
being inverted switches with the effector ONPG (Figure 3.12). They exhibit much leakier
expression and co-repress very effectively. We hypothesize that these mutations alter
the conformational equilibrium while ONPG binding remains similar to wild type lac
repressor which normally co-represses with ONPG. Alternately, two point mutations,
F161S and L296W, are seen to induce with ONPG. Of particular interest is L296W
which also induces with IPTG (Figure 3.10). Somehow, wild type is co-repressable with
ONPG and inducible with IPTG, whereas L296W is inducible with both. We hypothesize
that these two point mutations alter the relative effector binding affinities of the two
conformational states of the lac repressor.
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Figure 3.11. IPTG induction profiles of lac repressor dimer and point mutants in
the effector binding domain. Mutations to Q291 alter the affinity of the lac repressor
for effector, both higher and lower and between the two conformations.

Figure 3.12. ONPG induction and co-repression profiles of lac repressor dimer and
point mutants in the effector binding domain. Mutations to L148 appear to create
inverted repressors. F161S and L296W on the other hand change ONPG from a corepressor to an inducer.
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We globally fit the effector pocket mutants along with wild type dimeric lac
repressor induction and co-repression curves. We assumed that total repressor
concentration is the same for every mutant and that operator DNA affinity is unchanged,
hence we used rWT = 150 for every pocket mutant. The same thermodynamic
parameters from the headpiece fitting were used for wild type with IPTG. Table 3.6 gives
the final fit parameters.

Construct

Effector

r

KRR*

KRE (mM-1)

KR*E (mM-1)

Leakiness

Dynamic
Range

Log10 [E]50
(mM)

Wild Type

IPTG

150 ± 50

5.8 ± 0.07

60 ± 0.2

500 ± 5

0.044

0.7

-1.94

Wild Type

ONPG

150 ± 50

5.8 ± 0.07

13 ± 1.5

1.3 ± 0.9

0.044

0.7

-1.94

L148D

ONPG

150 ± 50

525 ± 7

2.4 ± 0.2

0.46 ±
0.05

0.78

-0.7

-0.012

L148W

ONPG

150 ± 50

325 ± 6

18 ± 0.7

3.2 ± 0.2

0.69

-0.6

-1.13

F161N

IPTG

150 ± 50

0.98 ±
0.34

23 ± 0.8

670 ± 127

0.013

0.8

-1.64

F161S

ONPG

150 ± 50

26.5 ±
0.01

0.25 ± 0.1

0.54 ±
0.02

0.16

0.3

0.57

F161T

IPTG

150 ± 50

2.7 ± 1.4

82 ± 6.5

1415 ±
293

0.024

0.8

-2.21

F161W

IPTG

150 ± 50

0.47 ±
0.23

18 ± 9

615 ±307

0.01

0.8

-1.42

Q291I

IPTG

150 ± 50

0.07 ±
0.02

26 ± 2.8

1889 ±294

0.007

0.7

-1.46

Q291K

IPTG

150 ± 50

5.9 ± 0.04

11 ± 0.3

86 ± 5

0.044

0.7

-1.18

Q291M

IPTG

150 ± 50

8.9 ± 0.6

44 ± 3.1

515 ± 51

0.062

0.8

-2.07

Q291R

IPTG

150 ± 50

1.33 ±
0.03

251 ± 19

296 ± 25

0.015

0.0

-2.36

L296W

IPTG

150 ± 50

0.04 ±
0.01

3.8 ± 0.1

409 ± 38

0.007

0.73

-0.66

L296W

ONPG

150 ± 50

0.04 ±
0.01

0.007

0.36

0.65

0.4 ± 0.01 17.5 ± 1.7

Table 3.6. Globally fit thermodynamic parameters from fitting wild type dimeric lac
repressor and effector pocket mutants to the MWC model of allostery.
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Effector pocket point mutants alter leakiness through changes in conformational
equilibrium
The assumption that effector pocket mutations do not alter DNA binding affinity
means the conformational equilibrium must change if leakiness differs from wild type.
This set of mutants shows a wide variety of altered leakiness. L148D and L148W are
much, much leakier with ~85% and ~75% basal expression, respectively. This requires
nearly 100 fold and 55 fold increases in KRR* to push more of the repressor in the low
operator DNA affinity conformation, R*. Conversely Q291I and L296W are extremely
non-leaky with ~1% and ~0.5% basal expression, respectively. These mutants push the
conformational equilibrium to ~80 and ~150 fold less than wild type. Equation (8) links
conformational equilibrium and energy changes which we can re-state for the lac
repressor conformational equilibrium,

KRR*=exp (

−Δ G
)
kB T

(91)

Experiments were carried out at 37C, so we can measure the energy difference
between the two states,

k B T=1.987e

−3

kcal
kcal
310 K=0.616
molK
mol

Δ G=−k B T ln(K RR*)

(92)

(93)

Table 3.7 gives energy differences for all of the effector pocket mutants and also
double difference measurements from wild type where,
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Δ Δ G=ΔG mut −Δ G WT

(94)

Construct

Krr*

ΔG

ΔΔG

WT

5.8 ± 0.07

-1.08 ± 0.01

L148D

525 ± 7

-3.86 ± 0.01

-2.78 ± 0.01

L148W

325 ± 6

-3.56 ± 0.01

-2.48 ± 0.01

F161N

0.98 ± 0.34

-0.01 ± 0.21

1.1 ± 19

F161S

26.5 ± 0.01

-2.02 ± 0.002

-0.94 ± 0.0001

F161T

2.7 ± 1.4

-0.61 ± 0.32

0.47 ± 0.25

F161W

0.47 ± 0.23

0.47 ± 0.30

1.55 ± 1

Q291I

0.07 ± 0.02

1.64 ± 0.18

2.72 ± 0.29

Q291K

5.9 ± 0.04

-1.09 ± 0.01

-0.01 ± 4x10-5

Q291M

8.9 ± 0.6

-1.35 ± 0.04

-0.26 ± 0.01

Q291R

1.33 ± 0.03

-0.18 ± 0.01

0.91 ± 0.07

L296W

0.04 ± 0.01

1.98 ± 0.15

3.07 ± 0.24

Table 3.7. Calculated differences in energy between the two structural conformations
(ΔG) in kcal/mol based upon the conformational equilibrium parameter, KRR*. Double
energy differences are also given which is the difference from the wild type (WT) value
(ΔΔG) in kcal/mol.
Wild type lac repressor has an energy difference between its two conformational
space of only about 1 kcal/mol, which is small. It has however been noted that for
simple two state folding proteins the entire folding energy is only on the order of 1-10
kcal/mol due to enthalpic and entropic concerns (Muñoz & Eaton, 1999). The energy
difference between R and R* of 1 kcal/mol is therefore very significant. This difference is
made more prominent in the aforementioned point mutations: L148D and L148W which
stabilize the R* conformation by 2-3 kcal/mol relative to R and Q291I and L296W which
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stabilize the R conformation by 2-3 kcal/mol relative to R*. Three of these mutations are
apolar to polar residues and the third is polar to apolar so none is conservative and each
could potentially play a significant role in the stability of each conformation. Interestingly,
the only mutation that does not appear to alter the conformational equilibrium is Q291K
which are both polar and of similar size but lysine is positively charged. This may be a
close to neutral mutation with respect to conformation but Q291K has a drastically lower
affinity for IPTG.
In general, the energy scale of 0-3 kcal/mol due to point mutation is not
unreasonable given a range of 1-10 kcal/mol folding energy. It is plausibile that these
mutations are indeed altering the conformational equilibrium.
Effector pocket point mutants alter [E]50 through a subtle interplay between effector
affinity and conformational equilibrium
Several of the mutants we tested have altered affinity for their effectors. This
altered affinity takes two forms: changes in amount of effector needed to induce or corepress ([E]50) and changes in maximal expression which alters the dynamic range.
First, we look at mutants that have altered [E]50. Only two mutants had higher
[E]50 for IPTG than wild type repressor: F161T and Q291M. Interestingly, these two
mutants show the flexibility of the allosteric approach in altering phenotype. Normally to
improve binding a more perfect pocket must be developed. F161T has essentially the
same IPTG affinity for the R state as wild type (82 ± 6.5 mM-1 and 60 ± 0.2 mM-1,
respectively) but has a 3-fold higher affinity in the R* state (1415 ± 293 mM-1 and 500 ± 5
mM-1, respectively). F161T does indeed form a better pocket for only one of the lac
repressor conformations. This however is not the only way to improve [E]50 in an
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allosteric system. Q291M has approximately the same IPTG affinity in the R* state as
wild type (515 ± 51 mM-1 and 500 ± 5 mM-1, respectively) but actually impairs binding of
the R conformation to IPTG by nearly a third (44 ± 6.5 mM-1 and 60 ± 0.2 mM-1,
respectively). Nature does not always need to make a more perfect pocket, it could
simply break the right part while leaving the rest in tact. Central to both mutations
however is conformational equilibrium greater than 1 which means the lac repressor
mutants still favor the R* state. Both mutants have increased the inducibility factor X
(Equation (90)) and the protein prefers the low operator DNA affinity state. The net
effect is less IPTG is needed to do the same job: induce the genetic switch.
Most of the mutants had lowered [E]50. The mutation F161W is a good counterexample to Q291M. Much like Q291M, the R affinity for IPTG is reduced versus wild
type (18 ± 9 mM-1 and 60 ± 0.2 mM-1, respectively) while maintaining R* affinity relative
to wild type (615 ± 307 mM-1 and 500 ± 5 mM-1, respectively). On the surface, F161W is
an even better example with an even higher inducibility factor X, however the [E]50 is
much lower than both Q291M and wild type. This is the result of the point mutation
switching the conformational equilibrium towards the R state (0.47 ± 0.23). Repressor is
too favorable to the R state and despite the better X it still takes more IPTG to induce.
F161N follows the same route as F161W; higher X cannot compensate for a lower
conformational equilibrium so [E]50 is lower. Q291I provides the same counter-example
for F161T. It drastically improves R* binding of IPTG nearly four-fold but it comes at the
cost of a conformational equilibrium vastly in favor of the R conformation (0.07 ± 0.02).
Q291K maintains a positive conformational equilibrium, however the affinity for
effector in the R* state is decreased over 5-fold. L296W simply is worse across the
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board; both IPTG affinities are lower and conformational equilibrium greatly favors the R
state. Both mutants have a lower [E]50 than wild type.
The final mutant of interest is Q291R. This mutant very weakly induces and does
so because the inducibility factor X is nearly 1. Q291R strengthens the ability to bind
ITPG in the R conformation while weakening binding to R* until they are approximately
the same. The repressor binds effector but it fails to push the effective equilibrium
between the two conformations; they both just bind the same amount of IPTG and DNA
occupancy is unaffected.
Effector pocket point mutants alter the dynamic range by changing the relative effector
affinities (X) and leakiness
Dynamic range is of course tied intimately to leakiness which has been
established to be a function of conformational equilibrium. We will instead focus on how
effector pocket mutants can maximize dynamic range by maximizing the relative effector
affinity, X.
Q291R of course is the best example of a flattened dynamic range. X has been
brought nearly to unity resulting in the collapse of the dynamic range of the switch.
Alternately, several mutants excel at separating the two conformations affinities
for effector. L296W has the highest X for IPTG with a greater than 100-fold preference
for the R* state. Despite the greatly decreased leakiness of this mutant it can induce the
nearly wild type levels. The cost of course is paid in [E]50 as discussed previously.
Q291I follows nearly an identical path but doesn't have quite as poor an [E]50.
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F161N, F161T, F161W and Q291M all have dynamic ranges that exceed wild
type lac repressor and do so by having larger X. Only F161T achieves the necessary
balance of effector binding and conformational equilibrium to be less leaky, have a larger
dynamic range and do so with less IPTG (lower [E]50) than wild type. F161T is a simply
a more ideal on-off genetic switch than wild type dimeric lac repressor.
In the case of co-repression, a decreased X is desirable. L148D and L148W
both bind ONPG weaker than wild type lac repressor however they maintain
approximately the same co-repressing factor X. Given the large increase in the
conformational equilibrium of both L148D and L148W such that the repressor vastly
favors the R* state, the very low ratio X suddenly becomes much more relevant.
Leakiness is now very large (~80% and ~70%) and so the dynamic range for corepression with ONPG goes from practically non-existant for wild type to negative 6070% for the two mutants.
3.5

Relative Lac Repressor Concentrations in Prokaryotes
One key assumption was made throughout this chapter. Namely, that repressor

concentration does not change with point mutation. It proved non-trivial to reproducibly
measure the very small amount of lac repressor produced by the cells and a repressor
tagging strategy was developed to enhance the signal. The fluorescent protein mCherry
was fused to the C-terminus of the lac repressor to allow for direct measurement of the
lac repressor in living cells.
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Figure 3.13. Verifying that Lac-mCherry functions in vivo. The assay conditions
have changed (EPB229 cells in MOPS minimal media) and a C-terminal tag was added,
however the induction profile with IPTG is relatively unchanged. In particular, LacmCherry is slightly less leaky and does not induce quite as high as previously. It is close
enough however to compare between mutants to see if overall levels of repressor have
changed upon point mutation.
The lac repressor-mCherry fusion protein (hereafter called Lac-mCherry) was
cloned into the pLacI plasmid with an 11-base pair linker to make a construct that has
been previously shown to be functional (Lau et al., 2004). This plasmid was first used in
the previous assay with DH5α cells double transformed with reporter and repressor
plasmids grown in LB media. Unfortunately, no mCherry signal could be measured as
the media contributed considerable autofluorescence in that excitation/emission range.
We found MOPS minimal media did not have autofluorescence in the mCherry region.
DH5α cells however did not grow in MOPS minimal media supplemented with glucose
presumably due to significant amount of alterations to the bacteria, many of which impair
infectivity and growth. We did find that a strain, EPB229, developed from MG1655 cells
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with the natural lac operon deleted, was capable of growing in the MOPS minimal media
with glucose. We therefore altered the assay to EPB229 cells, double transformed with
Lac-mCherry repressor and a reporter plasmid, grown in MOPS minimal media with
glucose.
We first verified that the IPTG induction of wild type lac repressor was the same
as Lac-mCherry. Figure 3.13 shows Lac-mCherry does function correctly in E. coli but it
has altered leakiness and maximal expression compared to wild type dimeric lac
repressor in the original assay. The addition of the weakly dimerizing mCherry could
potentially change the conformational equilibrium and even the overall level of repressor
in the cell. The fact is however that Lac-mCherry is functional and can be used to
measure differences in expression upon point mutation.
We next made point mutations to Lac-mCherry and measured both GFP
regulation and mCherry signal in vivo. We saw no significant deviations from expected
GFP regulatory phenotype due to the addition of the mCherry tag. Figure 3.14 shows
the relative signal from mCherry normalized to wild type Lac-mCherry. All of the tested
mutants have expression slightly higher than wild type repressor, however all the
changes are less than two-fold. As the phenotypic changes were much more significant
than this, we can safely say that our initial assumption was correct: [R]tot is relatively
unchanged by point mutation. The fitting and conclusions regarding the r parameter are
then valid.

93

Figure 3.14. Relative expression of Lac-mCherry and point mutants. All of the
mutants tested had expressions that varied less than two-fold from wild type repressor.
This verifies the initial assumption that [R]tot is unchanged upon point mutation.
3.5

Discussion
We sought to link point mutations in structurally interesting regions of the lac

repressor to specific changes in thermodynamic parameters. We were able to definitely
link headpiece mutants to repressor-operator affinity and effector pocket mutants to
repressor-effector affinities, however both stories are complicated by changes to the
conformational equilibrium between the R and R* state.
We found mutations to the specificity domain of the DNA binding region can have
phenotypes explained by changes to the r parameter of our MWC model solution.
Furthermore, we found that the in vivo concentration of lac repressor does not change
enough upon point mutation, hence changes to r must be reflected in changes to the
affinity of repressor for operator DNA (KRO). One point mutation, Q18M, is potentially
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better explained by altering the conformational equilibrium, KRR*. We also cannot rule out
this mutation changing both KRR* and KRO with the net effect of a less leaky repressor.
Any experimental measurement of Q18M – operator DNA affinity will be an effective
affinity that is a combination of the entire MWC equilibrium and hence it may still not be
possible to discern changes between KRO and KRR*. Our approach where we use
normalized expression at saturating effector to separate the two thermodynamic
parameters may be the only way to accurately separate these two parameters. It would
not be unreasonable however that the conformational equilibrium is capable of being
altered by this point mutation as the balance between the two states appears to be
incredibly malleable as evidenced by the effector pocket mutant data.
Mutants in the effector pocket were incredibly effective in creating phenotypically
interesting genetic switches through single point mutations. Nearly every point mutant
changed the leakiness of the switch. Repressor-operator affinity should be unchanged
and the overall concentration of the lac repressor does not greatly change, hence the r
parameter is the same same for effector pocket mutants. Leakiness changes must then
be reflected in changes of the conformational equilibrium, KRR*. The conformational
equilibrium was able to change in both directions (in favor of either the R or R*
conformation) by up to 3 kcal/mol of energy upon single point mutations which provides
an astounding ability to increase leakiness up to 70% or lowers it nearly 7-fold.
Furthermore, effector pocket point mutations were able to both increase and decrease
the magnitudes of the repressor-effector affinities for both conformations. More
importantly, the affinity changes did not always mirror each other, as in both don't
increase together or decrease together. This means the ratio of the two affinities, X, can
increase or decrease allowing for bold changes in the dynamic range of the switch;
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higher dynamic range than wild type and even flipped dynamic range creating induction
from co-repression. Of note was the precise interplay between the three thermodynamic
parameters KRE, KR*E, and KRR*. Only one mutant, F161T, had all three parameters move
in the correct directions to make a switch with improvements in all three phenotypic
parameters necessary for making a more ideal on-off genetic switch.
We showed a link between structural regions of the lac repressor and the
thermodynamic binding parameters associated with these regions. Furthermore, we
showed that the conformational equilibrium of the dimeric lac repressor is balanced on a
razors edge and is easily tipped one way or the other through point mutation. The
interplay between binding affinity and conformational equilibrium leads to a wide array of
genetic switches that are potentially relevant given the right gene that needs regulation.
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Chapter 4:
Linking In Vivo to In Vitro
4.1

Introduction
In Chapter 3 we sought to link the in vivo functioning of the lac genetic switch to

the thermodynamic parameters of the MWC model by specifically perturbing the switch
in key structural locations and looking for corresponding changes in the model
parameters. This approach worked very well, linking DNA affinity to the DNA binding
domain and effector affinity to the effector pocket and finally showing that the
conformational equilibrium is malleable.
A study by Poelwijk, et al. looked for unique phenotypes through random
mutagenesis of the lac repressor (Poelwijk, de Vos, & Tans, 2011). Mutants were
identified which exhibited an inverted repression behavior; a phenotype also found by in
Chapter 3 by mutating the effector binding domain. Interestingly, Poelwijk’s mutations
were in regions physically distinct from either the DNA or effector binding domains. One
potential explanation is that the mutations destabilize the folded form of the repressor,
altering the conformational landscape. Mutagenesis of the repressor can result in more
than just predictable changes of thermodynamic binding constants.
Central to all of these studies is the use of in vivo data to understand the
behavior of genetic switches. It has been pointed out that a lack of corroborating in vitro
evidence prevents the identification of other processes which may significantly play into
the equilibrium, such as non-specific DNA binding or effector uptake (Tungtur, Skinner,
Zhan, Swint-Kruse, & Beckett, 2011). They attempted to measure the thermodynamic
binding of a LacI/GalR hybrid repressor both in vitro and in vivo. Notably, a DNA pull
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down assay was used to quantify the in vivo concentration of their hybrid repressor.
Unfortunately, they were unable to rectify a greater than 25-fold difference between their
two data sets. This indicates that they are missing a significant contributor to the genetic
switch by only analyzing in vivo data.
Here we sought to overcome the limitations of past studies three ways: 1.)
measure the in vivo concentration of the lac repressor, 2.) measure the in vitro
transcription of purified lac genetic switch, and 3.) use an assumption free solution to the
MWC equilibrium to model both in vitro and in vivo data.
We were able to measure lac repressor concentration in vivo and use in vitro
transcription to assess the purified lac genetic switch. Furthermore, we found excellent
agreement between in vitro and in vivo data when molecular crowding was taken into
consideration. We do however find that the repressor-DNA affinity is much lower than
has previously been measured. Additional concerns, such as effector uptake and nonspecific DNA binding do not appear to play significant roles.
4.2

Measuring the In Vivo Concentration of the Lac Repressor
We sought a method where we could simultaneously measure repressor

concentration and transcriptional regulation and thus chose to fluorescently tag the
repressor. The fluorescent protein mCherry was chosen due to minimal autofluorescence from MOPS minimal media and minimal spectral overlap with our reporter
gene YFP. Furthermore, a dimeric Lac-mCherry fusion construct is known to be
functional in vivo (Lau et al., 2004). The goal is to measure raw mCherry fluorescence
and OD600 in growing E. coli cells and convert those measurements to an intracellular
concentration of lac repressor (Figure 4.1).
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Figure 4.1. Measuring intracellular Lac-mCherry concentration. Raw mCherry
fluorescence and OD600 are measured on a plate reader. Calibration curves for both
were established given our experimental setup (cell line, plasmids, media, amount of
sample loaded, plates and plate reader). Raw fluorescent signal is converted to
concentration of Lac-mCherry per well. Raw OD600 signal is converted to the fraction of
well volume that is intracellular. Dividing Lac-mCherry well concentration by intracellular
volume fraction effectively concentrates the Lac-mCherry to be intracellular. These two
measurements, combined with the appropriate calibrations, allow a quick and accurate
measurement of intracellular Lac-mCherry concentration.
A linear relationship was established for OD600 and cell count. We estimate the
volume of E. coli growing in glucose supplemented minimal media to be 1x10-15 L
(Tungtur et al., 2011). We then measured OD600, calculated the number of cells and
multiplied by volume of the cell to calculate the fraction of the well that is intracellular. A
linear relationship was also established for purified Lac-mCherry fluorescence and
concentration of Lac-mCherry.
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We assume all of the Lac-mCherry is intracellular; therefore we divided the LacmCherry concentration by the fraction of volume that is intracellular. Using this method,
we can quickly and accurately measure in vivo Lac-mCherry concentrations.
Intracellular Lac-mCherry concentration in EPB229 cells

Figure 4.2. In vivo Lac-mCherry and YFP regulation show no growth dependence.
(A) Lac-mCherry was calculated for growing E. coli cells and found to have minimal
OD600 dependence. As expected for a constitutively expressed gene, there is no change
in Lac-mCherry concentration with increasing IPTG concentration. (B) Normalized YFP
simultaneously measured and again no OD600 dependence was found throughout the
exponential growth phase. In stark contrast the Lac-mCherry, a distinct induction profile
is measured for YFP.
EPB229 cells expressing Lac-mCherry and the reporter plasmid were grown in
varying concentrations of the inducer IPTG. Intracellular concentration of Lac-mCherry
was calculated from mCherry fluorescence and OD600 and found to be 664 ± 90 nM at
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mid-log growth phase (OD600 = 0.6) (Figure 4.2.A). As expected for a constitutively
expressed gene, minimal variation was seen with IPTG and cell growth (Figure 4.2.B).
We then converted to molecules per cell,

6.6 e−7 M∗1 e−15

L
molecules
molecules
∗6.022 e23
=397
cell
mole
cell

(95)

We have previously estimated the copy number of our plasmid to be ~10-20
plasmids/cell (Daber et al., 2009). This corresponds to approximately 20-40 LacmCherry dimers per plasmid which agrees well with previous estimates of ~40 Lac
repressor dimers per plasmid for our promoter (Oehler et al., 1994).
4.3

Measuring the In Vivo Regulation of YFP
In addition to mCherry fluorescence and OD600 measurements, YFP

fluorescence was measured in cells as a function of IPTG. Unregulated expression was
established by measuring OD600 and YFP in cells co-transformed with O1 YFP reporter
and a plasmid which does not contain any repressor (pABD34). These positive control
cells were grown in tandem with cells containing both reporter and repressor and grown
in a variety of IPTG concentrations.
Positive controls showed no IPTG dependence as expected, so data from every
sample was combined to determine an overall positive control polynomial fit. YFP
fluorescence is seen to increase as cells grow as would be expected due to the
increased number of cells per µL. We remove this bias and normalize regulated YFP
expression by dividing by the positive control fit curve.
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Normalized YFP expression was then measured as a function of OD600 and
IPTG (Figure 4.4, blue squares). Almost no OD600 dependence can be noted in the
induction profile (Figure 4.2.B). The YFP signal is repressed without IPTG and is
approximately 1-5% of unregulated expression. Upon induction with saturating IPTG we
see a robust YFP increase to approximately 60% of the unregulated expression.
4.4

Measuring the In Vitro Regulation of mRNA
While the in vivo experiment measures translation product (fluorescing YFP) we

know the lac repressor actually regulates mRNA production. Previously, our lab has
determined a linear relationship between mRNA and fluorescence protein signal allowing
us to use fluorescence as a proxy for mRNA regulation in vivo. The situation in vitro is
reversed; it is much easier to measure mRNA production.
We used the Maxiscript T7 in vitro transcription kit (Ambion) which produces
mRNA from linearized DNA with a T7 promoter. We then measured incorporation of
radioactive labeled CTP into mRNA. The T7 promoter was modified to add an O1
operator DNA site and we were able to modulate Lac-mCherry and IPTG concentrations.
A positive control of constitutive mRNA production is established by not adding any LacmCherry.
We first established that radioactively labeled mRNA was linearly observable by
constitutively producing mRNA and loading various dilutions onto polyacrylamide gels
and established that mRNA concentration was linearly related to the concentration of
mRNA loaded on the gel. Positive controls were included for every experiment and were
used for normalization.
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The additional benefit of in vitro transcription is the flexibility in dosing not only
IPTG, but also Lac-mCherry. We exploited this flexibility by first titrating in Lac-mCherry
without IPTG present and with saturating IPTG (1mM) (Figure 4.3.A). As expected,
increasing concentration of Lac-mCherry decreases mRNA production. Furthermore,
addition of IPTG returns mRNA signal to near constitutive levels.

Figure 4.3. In vitro transcription controlled by the lac repressor is accurately fit by
the MWC model. (A) Lac-mCherry was added at varying concentrations with 11nM O1
DNA and mRNA was quantitated (blue squares). The repression was relieved upon
addition of 1mM IPTG (orange diamonds). The data was globally fit by the MWC model
and an accurate solution was found for the Lac-mCherry titration (solid blue line).
Unfortunately, the model predicts higher induction than was measured experimentally
(solid orange line). (B) IPTG was added at varying concentrations with 333nM LacmCherry and 11nM O1 DNA and again mRNA was quantitated (blue squares). A robust
induction profile was measured showing induction up to approximately 90% of
constitutive expression. The global fit also accurately fits the IPTG titration data (solid
blue line).
We then titrated IPTG at a fixed Lac-mCherry concentration (Figure 4.3.B). The
induction of mRNA is seen to very closely resemble that of the in vivo data, but it is
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noticeably leakier. Maximal repression was about 5% and maximal induction was
approximately 90%.
4.5

Modeling Using MWC Thermodynamic Equilibrium
Finally, we sought to simultaneously model the in vivo and in vitro data using the

Monod, Wyman, and Changeux (MWC) model of thermodynamic equilibrium.
Previously, we have relied upon approximate solutions of the lac genetic switch
equilibrium to model in vivo induction profiles. This solution assumes that the total
repressor concentration greatly exceeds operator concentration (Rtot >> Otot). This
condition does not hold for our in vitro experiment where we titrated in Lac-mCherry nor
would it necessarily be true in all in vivo systems. Therefore, we sought a solution to the
equilibrium that held for every potential input.
We modeled transcription using the Monod, Wyman and Changeux (MWC)
thermodynamic equilibrium. Normalized expression is then modeled as free operator
concentration, [O], divided by total operator concentration, [O]tot.
We then want to take known quantities and measured normalized regulation ([O]/
[O]tot) and measure the equilibrium thermodynamic parameters of our model. We know
the total concentrations of repressor ([R]tot), operator DNA ([O]tot), and effector ([E]tot).
We also will act as if we know all of the thermodynamic constants. We want to make no
assumptions so that both in vivo and in vitro data can be directly compared.
In Section 3.2 we started the problem by defining all of the thermodynamic
parameters in Equations (43) - (47) and formulas for total operator in Equation (48) and
total repressor in Equation (59). We have also already defined some of the bound
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species in Equations (49) - (54). We therefore need to define the missing formula for
total effector concentration,

[E]tot =[E]+2[RE]+ 2[RE 2 ]+2 [R*E ]+ 2[R*E2 ]
+2 [ROE]+2[ROE2 ]+ 2[R*OE]+ 2[R*OE2 ]

(96)

We therefore begin by writing the equation for total repressor solely in terms of
free species and thermodynamic constants,
2

2

[R]tot =[R]+ 2[R][E]K RE +[R][E] KRE
+[R]KRR* +2[R][E]KRR* KR*E +[R][E]2 KRR* K2R*E
+[R][O]KRO +2[R][O][E]KRO KRE +[R][O][E]2 KRO K 2RE
+[R][O]KRR* KR*O +2[R][O][E]K RR* K R*O K RE +[R][O][E]2 KRR* KR*O K2RE

(97)

We then make the following definitions,

α1 =1+KRR*

(98)

β1=2K RE + 2KRR* K R*E

(99)

2
γ1 =KRE
+ KRR* K 2R*E

γ2 =2K RO KRE

2

(100)

(101)

δ1 =KRO K RE

(102)

β2=K RR* KR*O

(103)
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γ3 =2K RR* KR*O K R*E

2
δ2 =KRR* KR*O KR*E

(104)

(105)

Substituting into Equation (97),

[R]=

[R]tot
2
2
α 1 +[E]β1 +[E] γ1 +[O](K RO +[E] γ2 +[ E] δ1 +β2 +[E] γ3 +[E] δ2 )
2

(106)

The equation has been organized such that polynomials in [E] are apparent. As
long as we only add and multiply polynomials, they can trivially be treated as symbolic
functions for further simplification. We define the following polynomials,

B1 =α 1 +[E]β1 +[ E]2 γ1

(107)

B2=K RO +β2 +[E](γ 2 + γ 3 )+[E]2 (δ 1 +δ2 )

(108)

Now substituting back into Equation (109),

[R]=

[R]tot
B1 +[O ]B2

(109)

We next want to follow the same path for [E] and [O]. Inspection of Equations
(48), (59), and (106) show that we have already done the most complicated case. We
can then quickly arrive at,

[O ]=

[O] tot
1+[R]B2

(110)
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The effector equation is similar, but it has a few extra coefficients of two within its
equations. We define two more polynomials,

A1 =β1 +[E] 2 γ1

(111)

A2 =γ 2 + γ3 +2[E](δ1 + δ2 )

(112)

Substituting into Equation (106),

[E]tot=[E]+[R][E] A 1 +[R][E][O] A3

(113)

We can then eliminate [O] by substituting Equation (110) into Equations (107)
and (113). Since we can only multiply and add polynomials, we multiply the denominator
of Equation (110) on both sides.
Substituting into Equation (107),

[R]tot +[R]B2 [R] tot=[R]B1 +[R]2 B1 B2 +[R]B2 [O] tot

(114)

We then define the following polynomials,

ϕ1 =B1 B2

(115)

ϕ2 =B1 +B2 ([O]tot−[R] tot)

(116)

Substituting into Equation (114),
2

[R] ϕ1 +[R] ϕ 2=[R]tot

(117)
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The substitution of Equation (110) into Equation (113) requires the following
definitions,

ψ1 =[E] A1 B2

(118)

ψ2 =[E](B2 + A 1 + A2 [O]tot )−B2 [E]tot

(119)

We then arrive at,

[R]2 ψ1 +[R]ψ2 =[E]tot−[E]

(120)

In principal we can get this down to a single equation, but in order to do so the
final polynomial becomes of a much higher order which prevents accurate computational
solutions.
The strategy is then to guess at the free effector concentration to calculate
Equations (115)-(116) and (120)-(121). Equations (117) and (120) can then be solved for
[R] by looking for the roots to the equation. When the correct free effector concentration
is found the roots of Equation (117) and Equation (120) will converge. By minimizing the
difference between the roots a solution can be reached. All other concentrations are then
trivial to calculate once [R] and [E] are known. Custom Matlab (Mathworks) software was
written to numerically solve the MWC equilibria (Matlab File Exchange ID #40602).
The accuracy of the solution is easily checked by using the bound and free
species concentrations to calculate the total species concentrations and thermodynamic
parameters. Calculated values should agree with input values.
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Using the assumption-free solution to measure thermodynamic parameters
Experimentally we know the total concentrations ([R]tot, [E]tot, [O]tot) and
normalized transcription/expression ([O]/[O]tot). We want to measure the
thermodynamic constants (KRR*, KRE, KR*E, KRO, KR*O). This leaves 5 independent
constants in the MWC model to fit to the experimental data. The large number of
independent constants results in a myriad of non-unique solutions to the equations. This
complication was limited by the following algorithm.
First, since it is widely reported to be effectively zero, KR*O was set to be very,
very small (1x10-10 nM-1). This leaves four independent parameters.
Next, it had been observed from previous studies that the ratio of KR*E to KRE is
well defined when the concentration of repressor greatly exceeds that of operator. Under
this assumption, a simpler solution of the MWC equilibrium exists as explored in Section
3.2. We isolated a subset of the in vitro data where this condition was true and used a
non-linear least squares fitting algorithm to measure the ratio X = KR*E/KRE as a function
of conformational equilibrium. The ratio was seen to asymptote at approximately 13.75.
This value is then used to reduce the number of independent constants to 3 (KRR*, KRE,
and KRO).
We then simultaneously fit the in vitro data to obtain the best fit thermodynamic
parameters using a non-linear least squares algorithm in Matlab (Table 4.1). The model
accurately fits both the IPTG (Figure 4.3A) and the lac repressor doping (Figure 4.3B) in
vitro transcription experiments. The fit values agree well with values obtained in the
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literature with the exception of repressor-DNA affinity. The repressor-DNA affinity was
measured to be 0.4 ± 0.2 nM-1. This is significantly weaker than the 100-3333 nM-1 that
has been measure previously (Sharp, 2011). It does agree well with an estimated value
of 1 nM-1 for lac repressor-DNA affinity that prevails under conditions within the E. coli
cell (Muller-Hill, 1996). The thermodynamic equilibrium value (6.3 ± 3.3) does not
significantly differ from that measured previously by our group. The repressor-IPTG
affinity (7.6x10-4 ± 2.5x10-4 nM-1 for the higher affinity conformation) was found to be
slightly higher than previously published values (2.3x10-4 nM-1) but it is generally within
agreement. The ratio of affinities for the two conformations (13.7) was in good
agreement with previously measured values.
Using the in vitro thermodynamic parameters to predict in vivo genetic regulation
The raison d’être for in vitro measurements is to inform what is occurring in vivo.
One of the central difficulties in using in vitro measurements is the lack of a well enough
defined in vivo system to directly compare it with. Furthermore, a model is required
which can accurately function in both circumstances and provide useful predictions. We
then seek to fully define our in vivo experiment to model it with the in vitro determined
thermodynamic parameters.
We estimate the copy number of our operator reporter plasmid to be ~ 20 copies
per cell (Daber et al., 2009). This then gives us,

[O ]tot =

20molecules
1
nM
∗ −15 ∗1 e9
=33 nM
M
23 molecules
1
e
L
6.02 e
mole

(121)
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The strain of E. coli used has the lac genetic switch deleted from the genome;
therefore lac permease is also deleted. It is then assumed that IPTG enters the cell
through passive diffusion and has the same concentration as the media.

KRR* =
[R*]/[R]
KRO
(nM-1)
KRE
-1

(nM )
KR*E
-1

(nM )

This
study

Daber,
Sharp,
and
Lewis†

Chapter 3

6.3 ± 3.4

2 ± 0.5

5.8 ± 0.07

0.42 ±
0.21
5.6x10-5 ±
1.8x10-5

6x10-5 ±
2x10-7

7.6x10-4 ±
2.5x10-4

5x10-4 ±
5x10-6

Sharp, Set Sharp, Set Sharp,
1‡
2‡
Set 3 ‡

3330

100

1510

2.3x10-4

2.3x10-4

2.3x10-4

MüllerHill §

1

KR*O
(nM-1)

1.0x10-10

Rtot
(nM)
664 ± 90
[with 40% [1660 +
crowding]
225]
r=
KRO * Rtot
[with 40%
crowding]

278
[697]

X=
KR*E / KRE

13.7 ±
0.13

150 ± 50 150 ± 50
15 ± 3
8.28

Table 4.1. Fit values from the MWC models compared with literature values. All fit
parameters agree with the exception of repressor-operator DNA affinity (KRO). †(Daber
et al., 2009) ‡(Sharp, 2011) §(Müller-Hill, 1996).
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Figure 4.4. In vivo regulation by the lac repressor is accurately predicted with
molecular crowding. (A) YFP under control of the lac repressor was measured in E.
coli cells at varying concentrations of IPTG (blue squares). We used the measured
intracellular concentration of the lac repressor (660nM) and the fit values from in vitro
transcription to predict the in vivo induction curve with the MWC model (solid blue line).
The model agrees at low IPTG concentrations but shows a significant over-prediction at
full induction. Our repressor-DNA affinity was much lower than previously published
values, so we also modeled three curated data sets from Sharp [10] (dashed orange,
dotted purple, and solid green lines). All three predict greatly over-repressed YFP
expression and do not fit the in vivo data. (B) Molecular crowding is known to play a
significant role in cells. We modeled this by estimating the available volume in
percentage for our repressor and calculated an effective repressor concentration. We
modeled several percentages and 40% available volume (solid purple line) accurately
reproduces the in vivo regulation from the in vitro transcription derived thermodynamic
constants. This corresponds to an effective repressor concentration of 1.6μM.
Figure 4.4.A shows the simulated in vivo data along with experimentally
determined values. Clearly, the model predicts accurate leakiness but higher induction
than is observed. There is a known molecular crowding effect in living cells due to the
density of molecules. Figure 4.4.B shows the effect of including molecular crowding on
the predicted in vivo induction curve. The model shows excellent agreement with
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experiment at a molecular crowding of 40% which estimates effective in vivo repressor
concentration to be 1.6 μM. Furthermore, this value agrees well with estimates of 20%40% available space in vivo (Kubitschek & Friske, 1986).
Since there is a notable deviation in repressor-DNA affinity with previous
measurements, the same analysis was carried out for the three curated data sets from
Sharp (Sharp, 2011). Using the values from the literature, we find that they do not in any
case come close to replicating our in vivo data (Figure 4.4.A). The DNA affinities are
much too high for the measured DNA and repressor concentrations. At these affinities
the switch is essentially completely off and cannot be induced with any concentration of
IPTG. Crowding only enhances the deviation from experiment as it further increases the
concentration of repressor.
Simulating native in vivo lac genetic switch phenotype
The thermodynamic constants from our in vitro data better represents our in vivo
model system. The question then is: which set of thermodynamic parameters could
effectively regulate the native lac genetic switch?
Essentially we have rebuilt the lac operon with the lacZ, lacY and lacA
polycistronic message replaced by the reporter gene YFP and the dimeric lac repressor
constitutively expressed by its native promoter. We have a higher copy number of both
the reporter and repressor plasmids (~20 copies per cell) which increases both the
operator and repressor concentrations above that normally found in the cell. A secondary
deviation is the removal of the tetramerization domain and multiple operator DNA sites
(O2 and O3 additionally exist on the genome) which simplifies our analysis. The
cooperativity of the native tetrameric lac repressor is known to decrease leakiness

113

approximately 10-fold, so we might expect a dimeric lac repressor with one operator
(O1) to have some leakiness in its repression (Oehler et al., 1994).
As previously mentioned, in vivo lac repressor dimer concentration was
measured to be ~40 dimers per cell, which gives,

[R ]tot=

40 molecules
1
nM
∗ −15 ∗1 e9
=66nM
M
23 molecules
1e
L
6.02 e
mole

(122)

And we know there is one operator per cell,

[O]tot =

1 molecules
1
nM
∗ −15 ∗1 e9
=1.7 nM
molecules 1 e L
M
6.02 e23
mole

(123)

Using these values, along with the experimentally determined binding constants
derived from this study and those curated by Sharp, we can simulate dimeric lac
repressor induction curves at native conditions. Figure 4.5.A shows that the values
determined in this study predict a leaky repressor that is maximally inducible. The much
higher DNA affinities of the curated data sets all produce over-repressed curves that do
not show good induction.
The over-repression is even more prominent as cell crowding is considered.
Using the value of 40%, which gives Rtot = 66 nM / 0.4 = 165 nM, we find that the overrepression of the high affinity DNA sets all produce curves that weakly induce or do not
induce at all (Figure 4.5.B). The predicted curve using our thermodynamic parameters
again provides reasonable induction (~10% leakiness up to ~95% maximal induction).
While this level of leakiness would be intolerably high for efficient regulation of the lac
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operon, the restoration of the tetramerization domain would significantly decrease the
leakiness while minimally impairing inducibility.

Figure 4.5. Simulating a simplified lac operon from in vitro derived thermodynamic
constants. The correct repressor-DNA affinities must be able to provide robust
switching under conditions naturally experienced by E. coli. With this in mind, we
modeled a dimeric lac repressor regulating a gene with a single operator sequence. (A)
The natural lac promoter makes ~66nM of lac repressor dimer and one operator is at ~
1.7nM in the cell. We modeled these conditions for the thermodynamic parameters from
this study and for the three curated data sets of Sharp. The predicted curve from this
study shows a reasonable repression and induction profile (solid blue line). Only Set 2
from Sharp is weakly inducible (dotted purple line). (B) Including molecular crowding
(40% available volume) enhances the situation. The curated data sets do not make
useful switches. Alternately, the predicted induction curve from in vitro transcription
derived constants shows a leaky switch that induces very well (solid blue line). (C) We
next sought to model the minimal possible repressor to find a condition where the
curated data sets produce reasonable induction curves. 1 molecule of dimer per cell
(~1.7nM) does show good induction profiles for set 2 (dotted purple line) and set 3 (solid
green line). Set 1 still shows a switch that can marginally be induced and would likely not
be useful (dashed orange line). (D) Molecular crowding effects again enhance the
repressor concentration and only set 2 could reasonably regulate a gene (dotted purple
line). The values from this study (solid blue line) predict a very leaky switch. Although the
second curated set could effectively regulate the gene at this concentration, in reality a
single dimer and single operator DNA binding would be dominated by stochastic events
creating an inherently unstable switch.
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If we consider the lowest possible concentration of lac repressor (1 molecule/cell;
Rtot = 1.7 nM; with 40% crowding Rtot = 4.25 nM) we find that second curated data set
does produce reasonable induction curves, even if 40% crowding is taken into
consideration (Figure 4.5.C and Figure 4.5.D). Unfortunately, in this regime the binding
would be highly stochastic and hence noisy, which would not produce stable repression.
Furthermore, this level of repressor expression does not agree with published values.
While it is technically possible for these affinities to be accurate, it is highly improbable.
The first and third data sets would require less than 1 molecule of dimeric lac repressor
per cell to be functionally useful according to our model.
Given the wide range of repressor-operator DNA affinities (100nM – 3333nM) it
can be reasonably concluded that these values must contain significant artifacts from the
experimental techniques. Techniques such as gel shift assays, where molecular “caging”
effects are known to be significant, and nitrocellulose filter binding assays, where the
binding is removed from the solution phase, were used to create the curated data sets.
Our measurement of repressor-DNA binding affinity did require an indirect
measurement, namely transcription; but it did occur in the solution phase. We attribute
the difference in values to differences in experimental setup.
4.6

Discussion
We have reproduced the transcriptional regulation of the lac repressor dimer in

vitro and shown that it accurately reproduces the in vivo repression of YFP under control
of the lac repressor. Accurate modeling of the in vivo data required an estimate of 40%
cellular crowding in the cell, which agrees with previous estimates. Non-specific DNA
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binding and IPTG uptake did not appear to have any significant effect. Crowding could
be tested in vitro through crowding agents such as BSA or PEG. Alternative
explanations are potentially possible such as fluctuations in the size of the E. coli. What
is essentially important is that the concentration of lac repressor in the cell greatly affects
the maximal induction given our thermodynamic parameters. The curve is extremely
sensitive in that region to changes in repressor concentration. So only an approximately
two-fold increase in repressor concentration is sufficient to replicate the in vivo data.
Whether the lac repressor concentration is increased by molecular crowding or by
decreased E. coli volume would have to be tested by further experiments.
The measured thermodynamic binding parameters match well for IPTG binding
and conformational equilibrium, except there is significantly lower repressor/operator
DNA affinity measured (by approximately 3-4 orders of magnitude). This discrepancy
was modeled and it was demonstrated that the affinity measured in this study is capable
of reproducing not only the in vivo data from this study, but also can predict reasonable
induction curves at concentrations of repressor and DNA that are naturally seen by E.
coli. We therefore conclude that lac repressor DNA affinity is significantly weaker than
previous in vitro measures and more in line with the estimates for repressor-DNA affinity
at in vivo conditions where we do find good agreement with previously published values.
Finally, this study highlights the difficulty in using in vitro data generated from
experimental techniques that are divorced from conditions closer to that of the cell.
Experimental artifacts may greatly overshadow actual values, which should come as no
surprise in the case of lac repressor binding to operator DNA where the published
binding constant has changed 33-fold as experimental techniques have changed. The
difficulty in in vitro measurements is well known in the field as is evidenced by the large

117

consideration given to differences in buffer conditions (Ha, Capp, Hohenwalter,
Baskerville, & Record, 1992), DNA length (Khoury, Lee, Lillis, & Lu, 1990), and even
hydrostatic pressure (Royer, Chakerian, & Matthews, 1990). Techniques such as gel
filtration or nitrocellulose filter binding assays are excellent at differentiating binding
strength between point mutants; they are limited in comparison with in vivo results.
Using experimental setups which more closely mimic the in vivo system can significantly
improve the ability of the predictive capabilities of in vitro experiments. They do come
with the caveat that the data interpretation is not as straightforward as simple binding
experiments.
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Chapter 5:
An Autogenously Regulated Lac Repressor for AAV-mediated Eukaryotic Gene
Therapy
5.1

Introduction
Bacterial gene regulation is interesting due to its simplicity. The lac genetic

switch consists of a single protein that binds to a known short operator DNA sequence
all regulated by a small sugar molecule. Eukaryotic gene regulatory systems are not so
simple (Roeder, 2003). Could we use the much simpler bacterial systems to regulate
specific genes of interest in eukaryotes?
The first attempt to translate any bacterial gene regulation to eukaryotes was the
lexA protein. LexA was shown to block transcription when its operator was placed within
a promoter (Brent & Ptashne, 1984). The lac repressor was then tested in a mouse L
cell line for the ability to regulate a transgene (Hu & Davidson, 1987). Prior to this paper
it was unknown if the protein could fold, dimerize, tetramerize, migrate to the nucleus, or
even bind DNA which might be in a chromatin bound state. Hu and Davidson found that
not only does the lac repressor block transcription, it can do so with an operator located
in three different regions within the promoter: between the start codon and the
transcription start site, between the transcription start site and the TATA box, and
upstream of the TATA box. Not only does the lac repressor bind, it is capable of stopping
transcription from a wide variety of locations. Furthermore, they showed that repression
was relieved upon addition of IPTG. They did, however, note that only 10% of the
repressor was localized to the nucleus. Addition of a nuclear localization signal localized
all of the repressor to the nucleus but with the odd caveat that operator DNA binding was
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reduced 6-fold (Hu & Davidson, 1991). The lac genetic switch was shown to transiently
and stably regulate a Simian Virus promoter, SV40, in cell culture (Brown et al., 1987;
Figge, Wright, Collins, Roberts, & Livingston, 1988). A quantitative assay was developed
that showed stable HEK293 cell lines expressing constitutive lac repressor and
regulated lacZ were capable of 5-fold induction with IPTG from an Epstein-Barr virus
derived promoter (Biard, James, Cordier, & Sarasin, 1992; Liu, Feliciano, & Stambrook,
1989). The lac repressor was shown to work in tandem with the Tet repressor to create
a regulatory cascade capable of responding to IPTG, tetracycline, or both (Aubrecht,
Manivasakam, & Schiestl, 1996). Plant cells were also shown to be capable of
regulating gene expression using the lac genetic switch (Ulmasov, Capone, & Folk,
1997).
Up till this point, the lac genetic switch was shown to be functional in both
transient and stable eukaryotic cell lines with the operator in varying positions in various
promoters. The next logical step was to test the lac repressor in a transgenic mouse
model (Scrable & Stambrook, 1997). This first required re-encoding the lacI gene to use
more optimal mammalian codons (synlacI) (Zhang, Zubay, & Goldman, 1991). Scrable
and Stambrook found that the E. coli lacI gene was transcriptionally silenced whereas
the mammalian optimized synlacI gene was ubiquitously transcribed. The full lac
genetic switch was then shown to functional in the mouse (Cronin et al., 2001). Mice
were developed with the tyrosinase gene under control of the lac operator and it was
shown that coat color of the mice could reversibly be changed upon feeding of IPTG.
Interestingly, they found that the synlacI gene previously described did not form
measurable protein product nor was it functionally capable of regulating gene
expression. The found a cryptic splice site within the synlacI gene that, when reverted to
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the lacI sequence, creates functional lac repressor in cells. This mouse model was later
used to investigate the timing of tyrosinase expression in embryogenesis to study
occulocutaneous albinism (Cronin, Ryan, Talley, & Scrable, 2003). The lac genetic
switch functionality was also shown to persist through embryonic stem cell differentiation
(Caron et al., 2005) and it was shown to be functional in living plants (Moore, Gälweiler,
Grosskopf, Schell, & Palme, 1998).
Clearly the lac repressor is capable of functioning in gene regulation in
eukaryotes. It is not, however, optimized for that purpose. Furthermore, the use of the
lac genetic switch on the animal level has required making transgenic animals where the
genome has directly been modified. These approaches are not useful in human gene
therapy for both practical and safety reasons. One leading method of gene therapy
delivery is the use of Adeno-Associated Virus (AAV). AAV virus can be targeted to
specific tissues and the delivered genes exist on an episomally separate from the
genome (Penaud-Budloo et al., 2008), and the delivered genes can be stably expressed
over long periods of time. One serious drawback is that the size of the viral capsid
creates an upper limit on the length of the gene that can be delivered to the cell; only so
much DNA can be packed within the AAV viral capsid.
With this in mind, we sought to develop a lac genetic switch that would provide
robust gene regulation in AAV-mediated gene therapy. This required making a genetic
switch that is as small as possible and optimizing the minimal switch for gene regulation
in Eukaryotes.
5.2

Development of an Autogenously Regulated Lac Repressor
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The lac repressor is constitutively expressed in E. coli from its own promoter.
Therefore, the lac genetic switch is usually applied by inserting a promoter driving lac
repressor and a second promoter driving the gene of interest under control of a lac
operator DNA sequence. Constitutively expressed repressor is the exception, not the
rule, in the LacI/GalR family (Swint-Kruse & Matthews, 2009). Many repressors are
autogenously regulated; they control their own expression.
The question then is: what will happen if we make an autogenously regulated lac
repressor? It is first instructive to consider the behavior of a properly tuned constitutively
expressed lac repressor on the lac genetic switch. Looking back on the modeling of
Chapter 3, we saw that the effect of changing repressor concentration was the same as
changing the repressor-operator DNA affinity, KRO. Figure 3.3.A shows that higher
repressor concentration (higher r) will make a less leaky switch that is not as inducible.
Lower concentration of repressor will make a leakier switch that easily maxes out
induction. Figure 3.3.B shows that an ideal lac repressor concentration exists where the
dynamic range is maximal and this spot coincides with a non-leaky switch. The wild type
lac repressor promoter has evolved to constitutively express the lac repressor at just this
correct range. If we want to utilize the constitutively expressed lac repressor genetic
switch in a different organism we would need to optimize the promoter and/or the
repressor-operator DNA affinity to get the maximal dynamic range. In making stable cell
lines, one alternative approach is to incorporate a random number of repressor
promoters and reporter promoters into the genome and then select for optimal dynamic
range. This is just not possible for gene therapy; you cannot select for good cells in a
patient.
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An autogenously regulated switch on the other hand auto-tunes the repressor
concentration at equilibrium. As repressor is made it begins to shut off the promoter. At
equilibrium, the promoter will make just enough repressor to maintain its off state. This
means however that the autogenously regulated is inherently leaky; it must let enough
transcription occur to keep the repressor concentration high enough to shut off the
switch. A constitutively expressed switch has no necessary leakiness. There are
benefits to autoregulation however; the effector response is linearized (Nevozhay,
Adams, Murphy, Josic, & Balázsi, 2009), the response to effector is faster (Rosenfeld,
Elowitz, & Alon, 2002), and the genetic switches are more stable (Becskei & Serrano,
2000). All of these benefits, combined with a smaller overall transgene, led us to develop
an autogenously regulated lac genetic switch with the goal of minimizing the inherent
leakiness of the switch.
An autogenously regulated lac genetic switch in E. coli
We first made an autogenously regulated lac genetic switch by placing the lacI
gene fused to mCherry after the natural lac promoter. A reporter gene, YFP, was
included after an 18 base pair spacer (Figure 5.1). Prokaryotes are capable of
expressing a poly-cistronic message where multiple genes are expressed off of a single
promoter (which is how the lacZ, lacY, and lacA genes are naturally expressed),
therefore we expected this single plasmid to make both a lac repressor-mCherry fusion
protein and the YFP reporter gene.
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Figure 5.1. Plasmid organization for prokaryotic autogenously regulated lac
genetic switch. The native lacZ/Y/A promoter under control of the O1 natural lac
operator controls two genes: lac repressor fused to mCherry and YFP. Lac-mCherry
binds to O1 leading to autoregulation and the YFP acts as a cytoplasmic readout of the
switch.
The autogenously regulated prokaryotic switch was tested in EPB229 cells
growing in minimal media supplemented with glucose. Both mCherry and YFP were
measured in living cells in the same manner as the in vivo experiments of Chapter 4.
Figure 5.2 shows that the autogenously regulated lac genetic switch successfully turns
off YFP expression and induces to a lower value than the constitutive lac genetic switch.
Essentially, the autoregulation diminishes the overall dynamic range of the prokaryotic
switch, which is expected because the promoter that drives the lac repressor in E. coli is
well tuned to have a maximal dynamic range switch. Figure 5.3 shows that the
autoregulation also regulates the lac repressor. The induction is much less than what is
seen for YFP. One thing to note is that the calculated lac repressor concentration from
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the autogenously regulated switch is actually much higher than was measured from the
constitutive plasmid in Chapter 4.

Figure 5.2. Autogenously regulated lac genetic switch versus constitutively
regulated. The autogenously regulated (Self Regulated) switch has a similar leakiness
to the constitutively regulated (WT LacI) but it cannot induce to as high of levels.
The reporter operator is much stronger than the natural lacI promoter that makes
constitutive lac repressor. The autogenously regulated stronger promoter actually
makes more repressor than the constitutive weak promoter. That is why leakiness is not
greater in the autogenously regulated as expected. On the flip side, there is so much
repressor that the switch cannot turn fully on. Clearly the strength of the promoter that is
being autogenously regulated plays a significant role in the functional output of the
genetic switch.
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Figure 5.3. Autoregulation of the lac repressor as measured by mCherry signal.
Lac repressor levels are seen to rise upon IPTG induction as would be expected for a
autogenously regulated repressor. The measured levels of repressor are higher than
measured from the constitutive plasmid.
It is unlikely that placing an autogenously regulated switch on most promoter will
result in a gene regulation profile that fits the needs of gene therapy. We would like to
use the known mutants of the lac repressor to be able to improve upon the genetic
switch. The question is: do lac repressor mutants still give rise to the same phenotypes
in an autogenously regulated switch? We tested both the DNA binding domain mutants
(Figure 5.4) and effector pocket mutants (Figure 5.5) from Chapter 4 on the
autogenously regulated lac genetic switch in prokaryotes. The two DNA binding domain
mutants clearly follow the same phenotypic changes seen in the constitutive switch
therefore we can change leakiness and dynamic range by mutating the DNA binding
domain. The effector pocket mutants also exhibited changes in leakiness, dynamic
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range, and [E]50 as previously found. Therefore we can mutate the effector pocket to try
to optimize any of the three phenotypic properties.

Figure 5.4. DNA binding domain mutants in the prokaryotic autogenously
regulated switch. Q18A is still leakier and Q18M is still less leaky than wild type, just
as observed in the constitutive switch. The tradeoff between leakiness and dynamic
range is still present.
The demonstration of the autogenously regulated lac genetic switch in E. coli
essentially established that, as expected, the lac repressor is functional autogenously
regulated and that the phenotype is malleable through point mutation of either the DNA
binding domain or the effector binding pocket. Furthermore, the strength of the promoter
significantly effects the levels of protein that are made.
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Figure 5.5. Effector pocket mutants in the prokaryotic autogenously regulated
switch. Four point mutants in the effector binding pocket are seen to alter the leakiness,
dynamic range and [E]50 of the autogenously regulated switch. Clearly this region of the
repressor is still an ideal target for mutagenesis to alter the phenotype of the of the
switch.
5.3

The Autogenously Regulated Genetic Switch in HEK293T Cells
We next sought to test the autogenously regulated lac repressor in transiently

transfected HEK293T cells to test its ability to regulate a reporter gene. We first
developed a plasmid that has the minimal CMVI promoter with the Lsym lac operator
between the TATA box and the transcription start site (Figure 5.6). Eukaryotes do not
translate poly-cistronic mRNA messages so an alternative strategy is needed to express
the two genes. We first used an Internal Ribosomal Entry Sequence (IRES) that allows
the ribosome to translate a second gene within the mRNA and therefore make an
autogenously regulated switch. We used YFP as the reporter gene and the lac
repressor sequence was the codon optimized sequence corrected for a splice site, which
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we term EuLac, which was then fused the mCherry (Cronin et al., 2001).
EuLac::mCherry fusion has the canonical nuclear localization sequence (NLS) on the Cterminus to localize the repressor to the nucleus.

Figure 5.6. The pIRES-EuLacmCh-YFP plasmid. This plasmid expresses an
autogenously regulated dimeric lac repressor mCherry fusion construct which can bind
one Lsym operator site and has YFP as a readout.
This autogenously regulated IRES plasmid was transiently transfected into
HEK293T cells and media was supplemented either with or without 2.5 mM IPTG.
Figure 5.7 shows that both the YFP and the lac repressor are induced upon addition of
IPTG. YFP is dispersed throughout the cell while the mCherry signal is localized to the
nucleus (labeled blue by Hoechst nuclear stain). The autogenously regulated IRES
switch clearly is functional in transient transfections of HEK293T cells. This construct is
not however ideal for applications in AAV-mediated gene therapy. The mCherry tag is
unnecessary now that we know the NLS correctly localizes lac repressor to the nucleus.
Second, the IRES is more than 300 base pairs. A smaller sequence is known to be able
to express two genes in eukaryotes from a single promoter in the 2A sequence. The 2A
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sequence encodes for a protein that causes a slippage as it is being translated through
the ribosome. The result is that, with a certain frequency, two proteins are made rather
than one large fusion protein. One benefit of the 2A sequence is that the two proteins
are made in equimolar amounts which is not necessarily true for IRES sequences.

Figure 5.7. Autogenously regulated IRES lac genetic switch in HEK293T cells. YFP
and lac repressor (mCherry) both are induced upon addition of IPTG. YFP is dispersed
throughout the cell whereas the mCherry signal is localized to the nucleus (labeled by
Hoechst stain).
We next developed a minimal length cassette with the goal of using it in an AAV
viral delivery vector. This cassette again uses the same minimal CMV I promoter with a
Lsym operator DNA sequence. The gene order has been switched so the EuLac gene is
first, followed by the 2A sequence, followed by GFP as the readout (Figure 5.8).
Extraneous DNA was trimmed and unique restriction enzyme cleavage sites were
designed around every gene in the cassette for easier downstream cloning. The same
plasmid was made with luciferase as the readout gene.
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Figure 5.8. The pSW-GFP plasmid. This plasmid expresses an autogenously
regulated dimeric lac repressor construct which can bind one Lsym operator site and has
GFP as a readout. This cassette easily fits into the AAV viral capsid. The same plasmid
expressing luciferase rather than GFP is called pSW-Luc.
We first need to verify the efficiency of the 2A sequence to split the two proteins.
HEK293T cells were transiently transfected with either: 1. the original autogenous IRES
plasmid, 2. the new autogenous 2A plasmid, or 3. a constitutively expressed GFP under
control of the chicken β-actin (CBA) promoter. Cells were grown in varying
concentrations of IPTG and whole cell lysate was harvested for western. We performed
a western with α-GFP antibodies (Figure 5.9). The original plasmid only has a single
band for YFP (which is also detected with α-GFP) which induces ~ 2-fold with IPTG.
The autogenous 2A plasmid has three primary bands: the highest band corresponds to
Lac::2A::GFP fusion protein, the middle band is truncated 2A fused to GFP, and the third
band is likely a degradation product. Comparing the highest band to the middle band we
estimate ~90% breakage of the fusion protein to separated lac repressor and GFP. We
also see induction of GFP with increasing IPTG, again approximately 2-fold (Figure
5.10).
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Figure 5.9. α-GFP western of HEK293T cells. Construct 1 is the autogenously
regulated IRES plasmid from Figure 5.6. Construct 2 is the autogenously regulated 2A
plasmid from Figure 5.8. CBA is the CBA promoter constitutively expressing GFP. We
see induction with IPTG for both construct 1 and construct 2, both with maximal
induction of approximately 2-fold. For the 2A cassette there is clearly a higher, unbroken
fusion protein. We see approximately 90% splitting of the fusion protein into the two
desired proteins, lac repressor and YFP.
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Figure 5.10. Quantification of autogenously regulated 2A cassette from western.
We see clear induction at only 6.26 μM IPTG and a maximal 2-fold induction.
5.4

The Autogenously Regulated Genetic Switch in Different Cell Types
A secondary question is whether the switch functions correctly in different cell

types. Ideally the switch would function well in every cell type as gene therapy has
many potential targets: liver, muscle, eye, brain, etc. We therefore set out testing the
switch to measure its functionality in two additional cell culture lines: COS-7 (CV-1
(simian) in Origin and carrying the SV40 genetic material) which are fibroblast-like and
derived from monkey kidney tissue, and ARPE-19 (Retinal Pigment Epithelial) which are
human derived RPE cells.
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We transiently transfected the autogenously regulated 2A plasmid from Figure 5.8 into
COS-7 cells. Figure 5.11 shows the quantified induction curve which again shows a 2fold induction with IPTG.

Figure 5.11. Induction profile of autogenously regulated 2A cassette in COS-7
cells.
We next wanted to quantitatively test the 2A autogenously regulated cassette in
ARPE-19 cells. We made a large lac truncation from residues 18-290 to create a
positive control cassette where the readout gene is unregulated. We then transiently
transfected HEK293T cells with the autogenously regulated 2A cassette and separately
transiently transfected HEK293T cells with the positive control plasmid. Figure 5.12
shows the normalized expression of the 2A autogenously regulated cassette. The
switch is not very efficient in its current form; it only represses approximately half the
constitutive expression and induces to 80%. Clearly, we have a lot of room to improve
the switch.
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Figure 5.12. Normalized regulation of the autogenously regulated 2A cassette in
ARPE-19 cells. The cassette poorly represses, reducing expression only down to ~
45%. This switch approximately has two-fold induction. This switch would not be useful
in AAV-mediate gene therapy.
The switch functions in three different cell lines and has approximately the same
induction ratio (~2-fold) in all three cell lines. There appears to be no cell specific bias,
however if the switch is to be used in a new setting it would strongly be recommended to
test its functionality in cell culture first.
5.5

Using Tetrameric Lac Repressor to Improve the Autogenously Regulated
Genetic Switch
The lac repressor construct we used has the 11 C-terminal residues of the lac

repressor truncated to create a dimeric repressor. While we have used a dimeric
repressor for clarity of understanding and studying allostery in Chapters 3 and 4, here
we just want a more effective switch. With that goal in mind we sought to restore the
tetramerization domain and multiple operator DNA sequences to restore the allosteric of
lac repressor to two DNA operators.
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First, we cloned a second Lsym operator DNA sequence 92 base pairs
downstream of the first Lsym site (Figure 5.13). We did not necessarily expect this
downstream site to be able to directly regulate transcription. We transiently transfected
dimeric lac repressor with one Lsym operator (pSW-Luc) and dimeric lac repressor with
two Lsym opeartors (pSW-Luc Lsym x2) into ARPE-19 cells and assayed for luciferase
with and without IPTG (Figure 5.14). The addition of a second operator decreased both
leakiness and maximal expression.

Figure 5.13. The pSW-Luc Lsym x2 plasmid. This plasmid expresses an
autogenously regulated dimeric lac repressor construct which can bind two Lsym
operator sites and has luciferase as a readout.

Figure 5.14. Effect of adding of a second Lsym operator with dimeric lac
repressor. The pSW-Luc construct expresses dimeric lac repressor and has a single
Lsym operator DNA. The pSW-Luc Lsym x2 construct has a second Lsym operator DNA
site 92 base pairs downstream. The addition of this second operator decreases
leakiness (green arrow) but also decreases maximal expression (red arrow).
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Next, the 11 C-terminal residues were re-inserted into the EuLac gene to make
what we will call EuLacTet to make the pSW2-Luc/GFP plasmids (Figure 5.15). This
gene still has the 11 amino acid linker and NLS sequence following the full lac repressor
itself, not to mention the partial 2A protein appended to the C-terminus. We first wanted
to see if the EuLacTet protein could form tetramers after 2A breakage. We cloned the
EuLacTet with a 6x Histidine tag (His-tag) into our standard pBAD expression vector and
followed the standard lac repressor purification protocol. We also purified the original
construct without the 11 C-terminal insertion which should be dimeric. These putative
dimeric and tetrameric proteins were run on a native electrophoresis gel where
oligomeric state will be preserved and stained for protein. The native gel confirmed that
the tetrameric protein ran at twice the molecular weight of the dimeric protein (Figure
5.16).

Figure 5.15. The pSW2-Luc plasmid. This plasmid expresses an autogenously
regulated tetrameric lac repressor construct which can bind two Lsym operator sites and
has luciferase as a readout. Two DNA operators are known to allosterically bind
tetrameric lac repressor to increase the operator binding affinity and decrease
repression. One model of this behavior is through DNA loops (pictured) wherein the
spacing between the two operator DNA sites is critical.
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Figure 5.16. Native gel electrophoresis to discern oligomerization state. The
EuLac construct which lacks 11 C-terminal residues known to form a coiled-coil domain
has two primary bands near ~84 kDa and ~42 kDa which correspond to dimeric and
monomeric species, respectively. The EuLacTet construct, which has the 11 C-terminal
residues restored, forms a single tight band near the predicted ~174 kDa which
corresponds with a tetrameric species. The highest band in both wells is a
contamination from the purification. Both constructs are oligomerizing as designed.
We transiently transfected tetrameric lac repressor with two Lsym operators
(pSW2-Luc) into ARPE-19 cells and assayed for luciferase with and without IPTG
(Figure 5.17). The addition of the tetramerization domain decreased leakiness and
increased maximal expression over the dimeric construct. Overall however, the potential
cooperative effect of tetrameric lac repressor binding to two operators was less than has
typically been seen in E. coli. This construct has an approximately 3-3.5-fold induction
with IPTG and the leakiness is decreased to ~25% of constitutive expression. These are
both significant gains from the starting pSW-Luc construct, however it does not appear
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that it is necessarily due to the allosteric advantages of binding two operators with
tetrameric lac repressor.

Figure 5.17. Effect of adding of a second Lsym operator with tetrameric lac
repressor. The pSW2-Luc construct expresses tetrameric lac repressor and has two
Lsym operator DNA sequences. The decreased leakiness is maintained (lower right
green arrow) and the maximal expression is marginally improved (upper right green
arrow). Overall a significant improvement from the starting pSW-Luc construct has been
obtained.
To measure if the tetramerization is playing a significant role we sought to repeat
a classic experiment from E. coli. It is known that the spacing between the two operator
DNA sites critically effects the ability of lac repressor to regulate gene expression
resulting in a periodicity of optimal spacing (Müller et al., 1996). Optimal spacing was
found at 70.5, 81.5 and 92.5 base pairs with significant drop offs in repression by altering
the spacing even 1 or 2 base pairs. With this in mind we inserted or removed one or two
base pairs between the two operator sites and also changed to spacing entirely to 70
base pairs. We tested these constructs in transient transfections of ARPE-19 cells with
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and without IPTG (Figure 5.18). There was no significant difference in measured
induction ratios between these constructs. Either the cooperative effect is minimal in cell
culture or further construct optimization is needed.

Figure 5.18. Alternate Lsym operator DNA base pair spacings. It has been observed
in E. coli that optimal repression by tetrameric lac repressor occurs when the two
operator sequences are properly spaced. We found no significant change in induction
ratio with alternative spacings.
We did reduce leakiness and increase dynamic range by using tetrameric lac
repressor and two operator DNA sites. It is unclear however if the system is working as
has been previously reported in bacteria.
5.6

Using Lac Repressor Mutations to Improve the Autogenously Regulated
Genetic Switch
We have ample evidence that point mutations of the lac repressor can decrease

leakiness, increase dynamic range, and change the affinity for effector molecules such
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as IPTG. We selected two mutants from Chapter 3 that should improve our eukaryotic
autogenously regulated switch: Q18M which decreases leakiness and dynamic range
and F161W which decreases leakiness and improves dynamic range.

Figure 5.19. Point mutations of dimeric lac repressor with one Lsym operator
(pSW-Luc). Q18M decreases leakiness from wild type (WT) lac repressor but it also
decreases the maximal induction. This is the classic tradeoff between leakiness and
dynamic range that was studied in Chapters 3 and 4. F161W decreases leakiness
below that even of Q18M and maintains the same maximal induction. The combination
mutant was less leaky than WT but leakier than either point mutation alone, and it had
the worst dynamic range.
We tested Q18M and F161W and the combination mutant Q18M F161W in the
pSW plasmid in ARPE-19 cells with and without IPTG. We found that both the Q18M
mutation and the F161W mutation functioned as has been previously found in E. coli in
the non-autogenous genetic switch (Figure 5.19). Q18M exhibited the classic tradeoff
between decreased leakiness and decreased dynamic range that was found in Chapter
3 when only the repressor-operator DNA affinity, KRO, is increased. F161W had both
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decreased leakiness and increased dynamic range, just as was found in bacteria, due to
its simultaneous changes to repressor-effector affinities and conformational equilibrium.
We were unsure if the mutations would have additive effects; the Q18M F161W double
point mutant shows that the two mutations do not work in concert. We hypothesized in
Chapter 3 that Q18M does not primarily alter KRO but instead the conformational
equilibrium KRR*, which is also altered by F161W. If that is the case it is unsurprising that
the two mutants do not work together.

Figure 5.20. Microscopy of point mutants of pSW2-GFP. GFP microscopy shows
that there is a clear induction of GFP with increasing IPTG concentration. The intensity
of the Q18M point mutant is significantly less both at no IPTG (basal leakiness) and
maximally induced with 2.5 mM IPTG. This is more consistent with what we saw with
the dimeric cassette pSW-Luc. F161W looks very similar to wild type repressor. Of note
is the unexpected increased GFP signal in the nucleus (DAPI stained, blue).
We next tested the two single mutants with the tetrameric cassette. The
luciferase assay does not have a control for number of cells and therefore is not ideal for
absolute comparison between different plasmids. It does function very well for
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establishing intra-plasmid behavior (i.e. measuring IPTG induction ratios). With that in
mind, we decided to measure the Q18M and F161W mutants in the tetrameric cassette
regulating GFP (pSW2-GFP). We transiently transfected ARPE-19 cells and grew the
cells in varying concentrations of IPTG. Cells were fixed and GFP was measured by
fluorescent microscopy (Figure 5.20). Q18M was seen to be less leaky than both wild
type and F161W and similarly has a decreased maximal expression. F161W did not
appear to have the improved leakiness and dynamic range that was measured for the
dimeric cassette.
Point mutations to the lac repressor appear to be potentially useful in improving
the phenotypic qualities of the autogenous genetic switch, however their application is
not straightforward due to the more complicated nature of the switch. Both Q18M and
F161W functioned similarly in the dimeric autogenous switch with a single Lsym
operator, but only Q18M worked as designed in the tetrameric autogenous switch with
two Lsym operators. This approach can certainly be used to further improve the switch
but point mutations will have to be verified to be functional in the each autogenous
switch design.
5.7

Comparing with Tet-On Technology
The gold standard for prokaryotic derived eukaryotic gene regulation is the tet

repressor derived tet-On and tet-Off systems. To see if our levels of leakiness and
dynamic range are comparable with these systems we first set out to make a single
plasmid tet-On system. We did this by isolating the tet-On activator and its promoter
from the pTet-On plasmid and inserting it into the pTRE-GFP plasmid. This plasmid will
constitutively express Tet-On activator and control the expression of GFP through the Tet
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Regulatory Element (TRE) via the effector doxycycline; we called this plasmid pTRE-OnGFP.
ARPE-19 cells were transiently transfected with pTRE-On-GFP side by side with
the pSW2-GFP and mutants (Figure 5.21). The pTRE-On plasmid clearly induces GFP
upon addition of doxycycline. The inherent leakiness and dynamic range of the pTRE-On
plasmid is very similar to the wild type tetrameric pSW2 plasmid. It seems to induce to a
slightly higher level. The Q18M tetramer is less leaky than the pTRE-On which is
encouraging if minimal leakiness is required.

Figure 5.21. Microscopy of point mutants of pSW2-GFP and pTRE-On-GFP. Our
autogenously regulated switch performs very similarly to the tet-On technology. Q18M is
actually less leaky than tet-On despite the limits of autogenous regulation. The dynamic
range of the tet-On switch however appear to be superior. Note the lac of nuclear
localization of GFP in the TRE-On system.
One thing that was revealed by the microscopy was an unexpected localization
of GFP to the nucleus. This was much more prevalent at the highest IPTG
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concentrations of the pSW2 plasmids (and hence highest GFP concentrations). This
could be due to un-broken Lac repressor::2A::GFP fusion proteins being localized to the
nucleus through the NLS signal on the repressor. This certainly will have a confounding
effect on the analysis. It is unknown if for some reason the 2A is breaking less efficiently
in this experiment (although no IPTG dependence was noted in the western). It is also
unknown if the repressor::2A::GFP protein is dimeric or tetrameric which could be
impeding the ability of tetrameric lac repressor to allosterically bind the two Lsym
operators. Finally, the half-life of the fusion protein in the nucleus versus the half life of
GFP in the cytoplasm will certainly have some effect on the quantification of these
experiments.
The TRE-On plasmids do not have this concentration of GFP in the nucleus.
There is no 2A site or NLS associated with the GFP on the TRE-On plasmid in anyway.
This strongly hints that the high nuclear GFP signal in the lac repressor expreriments is
due to the 2A and/or NLS signals.
5.8

Testing the Autogenously Regulated Genetic Switch in Mice
The end goal of this work is to develop a lac repressor based genetic switch that

is usable in AAV-mediate gene therapy. To move towards that goal we wanted to test
our autogenously regulated cassette in a mouse model.
We inserted the cassette from the pSW2 plasmid which has two Lsym operators
and tetrameric lac (Figure 5.15) into a plasmid which will make serotype 8-AAV virus.
Virus was made at a virus core facility and confirmed to function in HEK293T cells.
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Figure 5.22. Autogenously lac genetic switch controlling luciferase in mice. Mice
were live images for luciferase signal after being either on normal water (blue boxes) or
after being gavaged with 1M IPTG (red boxes). There is significant mouse to mouse
variation, however we always see potent induction after IPTG gavage. Luciferase is
seen to drop within 2 days of water feeding and re-induce. The autogenous lac genetic
switch is a reversible regulator of a transgene in mice.
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We performed tail-vein injections of 12 nude mice with SW2-Luc (same cassette
as pSW2-Luc (Figure 5.15)) virus (Multiplicity of Infection (MOI): 1e11) to target the liver.
The 12 mice were split into two cohorts of 6 to differentiate between time dependent
changes in luciferase signal and IPTG dependent changes in luciferase signal. Noninjected mice were also included as a control and showed no measurable luciferase
signal.
Four mice died in the study, either due to complications with gavage or unknown
circumstances. Of the remaining mice, two from each cohort appeared to have
luciferase correctly targeted to their livers in the imaging. Many mice had significant
luciferase signal in muscle tissue in the tail and surrounding region and were excluded
from further analysis. Mice were fed sequential diets of either water or gavaged (force
feeding) 1M IPTG. We previously confirmed that gavage of 1M ITPG provides
concentrations of IPTG in excess of 100 μM in brain, retina, vitreous, muscle, liver,
kidney, serum and urine. Mice were given intraperitoneal (IP) injections of luciferin and
scanned on a live animal imaging scanner throughout the experiment (Figure 5.22).
All four animals have low but measurable levels of luciferase one month after the
tail-vein injection. There is noticeable animal to animal variation with mouse #281 being
particularly leaky. The mice were not age and gender matched and they were all given
the same amount of viral vector regardless of weight which could account for some of
the variation.
The first cohort (Mice #288 and #281) were initially kept on a normal water diet
throughout the first week (Figure 5.23). There is a ~2-fold increase in luciferase signal
throughout this time. The second cohort (Mice #295 and #269) were gavaged two times
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a day for three days; there is a potent increase (>20-fold increase) in luciferase signal in
these two mice (Figure 5.24).
The first cohort was then gavaged with IPTG and saw a ~4-fold increase in
luciferase. Meanwhile the second cohort was put back on regular water and saw a ~3fold decrease in signal after 2 days and ~8-fold decrease after 6 days. Both cohorts
were then re-gavaged with IPTG to re-induce and there was a wide range of luciferase
signal increase from ~3-fold to ~30-fold. This re-induction confirms that the mice still
have AAV infected cells capable of regulating luciferase signal through the lac
autogenous genetic switch.

Figure 5.23. Quantification of luciferase counts for cohort 1 mice. The overall
signal level between the two mice is quite different but the same trend exists: luciferase
signal increases upon IPTG gavage and is low on a water diet.
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Figure 5.24. Quantification of luciferase counts for cohort 2 mice. Again the
expected trend is observed: luciferase signal increases upon IPTG gavage and is low on
a water diet.
Since both cohorts were induced with IPTG and repressed upon removal of IPTG
during water feeding, we averaged across cohorts (Figure 5.25). The mouse to mouse
variability of luciferase counts is very large which could be due to several factors: we did
not age and sex match the mice and we injected the same amount of viral vector
regardless of mouse weight.
We then used the averages to measure first induction ratio, repression ratio with
removal of IPTG (water feeding), and second induction ratio (Figure 5.26). Again there
is a very large variability but the trend is striking; there is an ~8-fold first induction, ~14fold repression, and ~8-fold second induction.

149

Figure 5.25. Average luciferase counts for mice throughout the experiment. The
luciferase signal significantly increases with the first gavage (p < 0.05) compared with
the initial water readings and significantly decreases upon returning to water (p < 0.05).
The luciferase signal increases a second time upon return to IPTG gavage, however the
change is not significant due to the large variation between mice.

Figure 5.26. Luciferase ratios upon switching from water to IPTG (Induction) or
IPTG to water (Repression). A ratio of 1 would be no change upon switching to or from
IPTG. Both the first and second induction had large luciferase signal increases with ~8fold increases. The repression was stronger with a ~14-fold decrease in signal upon
removal of IPTG.
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The repression ratio is notably larger than the first induction ratio. Since the lac
repressor is autogenously regulated in this switch, we are inducing not only luciferase
but also lac repressor; more lac repressor will be present in the nucleus after induction.
Upon removal of IPTG from the diet this excess repressor can and will bind the two
operator DNA sites and repress transcription. Since the lac repressor concentration will
exceed the equilibrium concentration before induction it is not surprising that the switch
would go even more “off”.
5.9

Discussion
The goal of this chapter was to develop a lac genetic switch that was functional in

AAV-mediated gene therapy. We showed that an autogenously regulated lac repressor,
which is small enough to pack into an AAV viral capsid along with a transgene, is
functional in both prokaryotes and eukaryotes. Furthermore, the eukaryotic switch can
function with either the IRES or 2A sequence to mediate the expression of both the lac
repressor and the transgene from a single promoter. We showed that the eukaryotic
autogenous switch is functional in HEK293T, COS-7, and ARPE-19 cell culture as well
as live mice. The switch appears to be broadly applicable to different cell types.
The first generation of autogenous switches were not particularly efficient gene
regulators; only repressing about half of the constitutive level and having a 2-fold
induction ratio. We showed that the lac repressor point mutations from Chapters 3 and 4
also change the gene regulatory phenotype in the autogenously regulated lac genetic
switch in prokaryotes. We then showed that these same point mutations can be used to
decrease the leakiness of the switch or to increase the dynamic range. Finally, we found
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that multiple DNA operator sites and a tetrameric lac repressor could both decrease the
leakiness of the switch and increase the dynamic range.
The autogenous switch was shown to function from transductions of AAV virusencoding transgenes in cell culture and in living mice. The living mice were stably
expressing the AAV-encoded luciferase nearly 1 month post infection and were capable
of reversibly regulating the expression of luciferase in their liver.
A curious finding is that the induction ratios measured in mice actually surpass
those from cell culture. The nature of our transient transfection experiments could
partially be to blame. The time window in which the cells are dense enough for
experiment and not too dense to have contact inhibition effects is small. The cells may
not have had enough to time reach an equilibrium before we were required to measure
their transgene signal. Regardless, it is very encouraging that the switch appears to
function better in living organisms which of course is much more relevant to our end goal
of developing a regulator for AAV-mediated gene therapy.
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Chapter 6
Conclusions
The lac repressor hasn't changed, but its measured properties have (Sharp,
2011). This is due to the wide variety of techniques, buffers, constructs, etc. that have
been applied over the years in order to best measure the property of interest given the
best technique of the day. This thesis sought to bring together this often discordant
information to link protein structure to genetics to in vivo phenotype to in vitro
measurements all through the use of the MWC model of allostery.
We have found that point mutations of certain amino acids can specifically alter
repressor binding affinities to effectors and that these changes agree with the structural
location of those amino acids. Two residues in the specificity region of the DNA binding
domain (Y17 and Q18) make specific contacts with positions 5 and 6 of the DNA
operator sequences. Point mutations to these two residues (Y17I and Q18A) result in
gene regulatory phenotypes that are well explained by reductions to the repressoroperator DNA affinity, KRO. All other thermodynamic parameters are unaffected; mutants
bind effector with the same affinity and have the same conformational equilibrium. One
residue in the specificity region of the effector binding domain (Q291) makes specific
contacts with the substituent group of thiogalactosides. A point mutation to this residue
(Q291K) results in a gene regulatory phenotype that is well explained by reductions to
the repressor-effector affinities, KRE and KR*E. All other thermodynamic parameters are
unaffected; this mutant binds operator DNA with the same affinity and has the same
conformational equilibrium.
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These three point mutations are a wonderful confirmation of the MWC model of
allostery for the lac genetic switch. Many mathematical functions can recreate the curve
shape of proteins binding to ligands, however they are just that: functions. They have no
basis in biophysical reality other than they happen to look like reality. One could throw a
ball and see that the trajectory looks a lot like a parabola; the fact that the physics of
throwing the ball predict a parabolic trajectory give the mathematical function meaning.
Now we can throw a ball, fit it to a parabola, and use that fit to measure the initial
velocity of the throw. Analogously, we see the normalized expression from the lac
genetic switch as a function of effector, we fit it to the curve shape predicted by the MWC
model, and use that to fit the inherent thermodynamic parameters of the lac repressor.
The point mutations Y17I, Q18A, and Q291K show that we can use the structure of the
lac repressor to specifically perturb individual binding affinities. The MWC model of the
lac repressor splits the binding affinities into individual properties that could be
independently manipulated to create unique gene regulatory phenotypes; these three
point mutations exactly fall into that model. Structure agrees with genetics agrees with
in vivo phenotype given the MWC model of allostery.
Now of course we studied much more than these three point mutants. The lion
share of point mutations were seen to perturb the conformational equilibrium between
the two primary structural conformations of the lac repressor, R and R*. Furthermore,
we saw that the conformational equilibrium could be manipulated from a variety of
locations in the protein: Q18, L148, F161, Q291, and L296. Using the Boltzmann we
saw that the wild type lac repressor only has an energetic difference of about 1 kcal/mol
between the R and R* state (the R* state has lower energy and is favored). It is not
surprising therefore that even a single point mutation could alter the conformational
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equilibrium. We measured conformational equilibrium parameters of lac repressor point
mutations that changed the energy between the two states as much as 3 kcal/mol (in
favor of the R* state for L148D and L148W; in favor of the R state for Q291I and
L296W). The Boltzmann distribution is sensitive to the exponential of the energy;
therefore even relatively small energy differences have profound changes on the
populations of the two conformations. For these point mutations we see the
conformational equilibrium change nearly 100-fold which has profound effects on the
phenotype of the lac genetic switch.
The observation that the conformational equilibrium is changed upon point
mutation may be the strongest test of the MWC model of allostery. The entire basis of
the MWC model is that the net function of a population of proteins can be altered by
shifting the population to a different conformation with altered properties. Multiple
structural conformations with different properties is inherent in this model. Consider
instead a model of the lac repressor with only one conformation, R, which can bind
operator DNA with an affinity KRO and effector with an affinity KRE. We then mutate the
effector binding pocket (F161W for example) and see that the genetic switch is
drastically less leaky: how is this possible? The point mutation is nowhere near the DNA
binding domain so KRO should be unaffected. The lac repressor still induces upon ITPG,
better even than wild type (Figure 3.10), so the lac repressor itself must be folding
correctly and functioning. The only other explanation is that there is more repressor,
however we measured the total repressor concentration and found no change from wild
type in vivo (Figure 3.14). Additionally, more repressor would impede maximal
expression. A single conformation model simply cannot explain the F161W mutant given
the data on hand. The MWC model of the lac repressor perfectly explains the in vivo
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phenotype. The conformational equilibrium between the two states is tipped 1.5
kcal/mol in favor of the R state reducing the leakiness. Meanwhile the mutation is in the
effector binding pocket and increases the affinity for IPTG for the R* state relative to the
affinity for the R state; adding IPTG more greatly populates the R* state than wild type
leading to greater induction. The structural location of the F161W mutant combined with
the in vivo phenotype can only be explained by an MWC model with at least two
structural conformations.
Of note are four point mutations from the literature: A110T, A110K, L148F, and
S151P (Müller-Hartmann & Müller-Hill, 1996; Swint-kruse et al., 2003). None of these
mutations are within the DNA binding domain of the lac repressor yet all four were found
to alter the net repressor-DNA affinity; all four altered the leakiness of the switch. Unlike
the targeted residues from this study, A110 and S151 are not part of the effector binding
pocket; both are within the N-terminal region of the core domain. The structure clearly
indicates that neither residue contributes to DNA binding or effector binding directly, yet
point mutations to both regions alter both parameters simultaneously. Again, the
conformational equilibrium parameter comes to the rescue. Figure 3.4 shows that, given
thermodynamic binding values similar to wild type lac repressor, increasing the
conformational equilibrium (favoring the R* state) creates a leakier genetic switch which
responds to less effector; effective DNA affinity is lowered and effective IPTG affinity is
increased. This is exactly what is observed for A110T and L148F. Conversely, if the
conformational equilibrium is decreased (favoring the R state) then the genetic switch is
less leaky and needs more IPTG to induce; effective DNA affinity is increased and
effective IPTG affinity is decreased. This is exactly what is observed for A110K and
S151P. The structural location of these residues is perfectly consistent with the ability to
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alter the stability of the repressor conformations and hence change conformational
equilibrium upon point mutation. A conformational equilibrium between the two states
that is close to one is ideal as it is most easily changed by single point mutations. Wild
type lac repressor has a conformational equilibrium of approximately 6-fold in favor of
the R* state which corresponds to only a 1 kcal/mol energy difference between the two
states. The conformational equilibrium is easy to perturb in the lac repressor due to the
small energy difference between its two conformations.
The other effector pocket mutants showed that the interplay between the
conformational equilibrium, the magnitudes of the repressor-effector affinities, and the
ratio of the two repressor-effector affinities define the resultant phenotype. The DNA
binding domain mutants showed that conformational equilibrium and repressor-DNA
affinity could be altered but they had the same resultant phenotype. The effector binding
pocket turned out to be much more interesting in terms of potential phenotypes upon
point mutation. So why did point mutations to the DNA binding domain give such a one
dimensional response? It is because the output (transcription and translation of a gene)
is linked to the occupancy of the operator DNA by repressor. RNA polymerase does not
care if IPTG is bound to the repressor but it does care if the IPTG bound repressor
drastically lowers the occupancy of DNA. You can alter the phenotype of the lac genetic
switch through mutating the DNA binding domain but to get more ideal lac genetic
switches (lower leakiness, higher dynamic range, lower [E]50) you need to target the
allosteric effector site, namely the effector binding pocket.
Many novel lac repressor genetic switches have been identified with properties
that could potentially be impactful. One obvious future direction would be the use of
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tighter binding lac repressors in the regulation of toxic proteins being recombinantly
expressed.
Utilizing genetics of the lac repressor to link structure to in vivo phenotypes with
the MWC model was a powerful technique. The next obvious “missing link” in the lac
repressor literature was the connection between in vitro data derived from purified
compenents and in vivo gene regulation taking place in living bacteria. We can measure
binding affinities via fits of the in vivo data to the MWC model but if our measured
affinities do not agree with the isolated proteins, DNA and effectors we are claiming to
model we are potentially missing key components of the system. Furthermore, it is not a
foregone conclusion that in vivo results will agree with in vitro predictions. One group
found a 25-fold discrepancy for a hybrid repressor between in vivo and in vitro data
(Tungtur et al., 2011). For the lac repressor itself, one study found very good agreement
between published in vitro values and in vivo values (Sharp, 2011). There was however
a major limitation to the data of the lac repressor study; the concentration of the lac
repressor itself was not taken into account. We did measure the lac repressor
concentration to be around 650 nM in vivo which agrees with previously reported values
for our promoter and the estimated copy number. We would expect wild E. coli with a
single lacI promoter expressing lac repressor to have ~10-20 fold less repressor (the
copy number of our plasmid) which corresponds to 30-65 nM lac repressor in vivo.
Using the values from Table 4.1 and the assumption free solution to the MWC model
from Chapter 4 we found that the thermodynamic binding values curated by Sharp could
not regulate gene expression because repressor-DNA affinities were too high (Figure
4.5). This is not an artifact of the more complicated model solution. If we simply take
the repressor-operator DNA affinity values and concentration of the repressor we can
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easily calculate the r parameter (r = KRO [R]tot): Chapter 4, r = 278; Sharp set 1, r = 2.2e6;
Sharp set 2, r = 6.6e4; Sharp set 3, r = 1e6. Figure 6.1 shows that the three curated
sets from the Sharp paper all are way over-repressed. We can, as before, model what is
occuring in natural E. coli by estimating [R]tot = 30 nM which reduces the r values 20-fold
and should lessen the drastic over-repression. Figure 6.2 shows that only Set 2 could
induce with IPTG given the thermodynamic parameters.

Figure 6.1. Simulated induction curves from various in vitro derived values at a
repressor concentration of 650 nM. Chapter 4 are the values measured from the in
vitro transcription experiment. Sets 1, 2 and 3 are derived from the published values in
(Sharp, 2011). The in vitro values from the literature are drastically over-repressed.
The in vitro measured values of Chapter 4 agree with previous in vitro
measurements for repressor effector binding and conformational equilibrium. The
repressor-operator DNA affinity was several orders of magnitude weaker than in vitro
results but agreed with a published value for affinity at conditions within the E. coli cell.
Regardless, only the in vitro values of Chapter 4 are capable of predicting lac genetic
switches that would function at the measured concentration of lac repressor in vivo.
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Figure 6.2. Simulated induction curves from various in vitro derived values at a
repressor concentration of 30 nM. Chapter 4 are the values measured from the in
vitro transcription experiment. Sets 1, 2 and 3 are derived from the published values in
(Sharp, 2011). Chapter 4 predicts a leaky repressor, however the values are derived
from dimeric lac repressor with a single operator DNA, which is known to be leakier than
the wild type operon. Set 2 predicts a very tight repressor that is capable of some
induction. Sets 1 and 3 are still drastically over-repressed.
Chapter 4 shows the inherent difficulty in rectifying in vivo and in vitro data. We
specifically set out with this goal and therefore were able to use the same lac repressor
construct and same DNA operator sequence in both our in vivo and in vitro experiments.
When attempting to compare values with literature values the setups rarely agree.
Furthermore, we used an in vitro technique that attempts to closely mimic the in vivo
assay. The in vitro transcription experiment takes place at the same temperature, in the
solution phase, in buffer conditions where RNA polymerase is active and hence
reminiscent of in vivo buffer, involves RNA polymerase to probe the operator DNA
occupancy (although our in vivo and in vitro experiments do not use the same promoters
or RNA polymerases), and uses long DNA strands. The comparison is not perfect but it
is closer than most techniques such as gel shift or nitrocellulose binding. Next, we had
an in vivo system where we could accurately estimate the total concentration of operator
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(due to a tightly controlled copy number of its plasmid) and effector (due to the removal
of thiogalactoside-permease from the E. coli limiting IPTG access to passive diffusion
through the cell membrane). Then we were able to measure the repressor concentration
throughout the experiment through the mCherry tag on the lac repressor and even able
to calibrate our experiment to get an absolute in vivo concentration that agreed with
previously published values. Finally, we had to develop a solution to the MWC model
that would work in all of our experimental conditions. This required coming up with an
assumption free solution so total operator, total effector and total repressor are directly
represented in the solution. This was important in the fitting of the in vitro transcription
data where we were able to titrate in lac repressor to more accurately measure
repressor-operator affinity. This experiment violated the assumption of our original
solution to the MWC model that [R]tot >> [O]tot but it was easily modeled with the
assumption free solution.
Despite our best efforts, Figure 4.4.A shows that the in vitro thermodynamic
parameters predict a leakier genetic switch than we measured in vivo. There is
approximately a 2-fold difference between our measured repressor-operator DNA affinity
and that which would be needed to decrease the leakiness of the switch to agree with in
vivo. This difference could potentially be rectified by including the well known
phenomenon of cell crowding. We modeled the increased effective concentration of the
lac repressor by dividing our measured concentration by effective cell volume. When the
effective cell volume is 40% of the total E. coli volume the in vitro data does an excellent
job predicting the in vivo phenotype. The value of 40% available volume agrees with
previously published values for E. coli (Kubitschek & Friske, 1986). In vivo phenotype
can be linked to in vitro binding parameters using in vitro experiments that attempt to
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mimic the in vivo setting. It is non-trivial to compare in vivo to in vitro data and it requires
knowing not just the binding constants of the various species but also the concentrations
of the species themselves. Trying to compare without knowing the concentration could
potentially lead to erroneous agreement.
While it is gratifying to link structure, genetics, in vivo data, and in vitro data
through a single MWC model, the entire enterprise is enriched by a real world
application. With that in mind we set out to apply what we know about the lac repressor
genetic switch to AAV-mediate gene therapy.
There was one primary limitation in AAV-mediated delivery of a lac genetic
switch: delivering two promoters and two genes to a cell through AAV capsids is not
possible due to genome size limitations. Only 5 kilobases of DNA can practically be
packaged within an AAV capsid (Wu, Yang, & Colosi, 2010). We therefore re-wired the
lac repressor to be autogenously regulated; the lac repressor controlled its own
expression. We demonstrated that an autogenously regulated lac genetic switch
functioned in both E. coli and three different eukaryotic cell types in cell culture
(HEK293T, Cos-7, and ARPE-19). We found that our first generation of eukaryotic
autogenous lac switches were not ideal; we measured 45% leakiness and only 2-fold
induction. Just about every method we thought of to improve the switch worked.
Addition of a second operator DNA site downstream of the promoter decreased
leakiness. Restoration of the tetramerization domain of the lac repressor marginally
increased dynamic range while maintaining the decreased leakiness. The Q18M
mutation in the DNA binding domain deceased leakiness at the expense of maximal
expression; Q18M functions has the same phenotype in E. coli. The F161W mutation
decreased leakiness and increased dynamic range in the dimeric lac repressor but may
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not function the same for the tetrameric lac repressor. Other groups have shown that
operator DNA can repress transcription in many locations relative to the promoter (Hu &
Davidson, 1987) and that the lac repressor functions with different promoters than the
minimal CMV promoter we studied (Brown et al., 1987; Caron et al., 2005; Liu et al.,
1989; Ulmasov et al., 1997). We are therefore extremely confident that many more
improvements are possible by systematic exploration of lac repressor mutation and
promoter/operator DNA combinations. Finally, different gene therapy applications may
be optimized by different leakiness and maximal expression values; some transgenes
need to be very, very off while others could tolerate leakiness if it meant higher
expression upon induction. Tailored autogenous lac repressor genetic switches for
specific gene therapy applications could be an incredibly important future direction of this
work.
It is currently not known if the tetrameric lac repressor is functioning as desired in
the eukaryotic autogenous switch. We have demonstrated that it is a tetramer however
the expected gain in dynamic range from cooperativity was not measured. Several
important experiments could shed light on the issue. First, if the 2A sequence is not
splitting the two genes efficiently enough and causing a dimeric lac repressor-2A-YFP
fusion protein to localize to the nucleus as the microscopy suggests, then the 2A needs
to be replaced with an IRES sequence which will make two separate genes. All of the
lac repressor will necessarily be tetrameric as there can be no C-terminal fusion from
this construct. This would easily be tested with microscopy and the cooperativity could
be tested with the assay varying the spacing between the first and second Lsym
operators. Secondly, the ability of the second operator site to repress is a confounding
factor. The second operator could be placed far upstream of the CMV promoter after the
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ITR region. This operator could be tested alone to confirm that it does not repress.
Once that has been established it could be tested in combination with the first Lsym site
to see if there is an improvement. This improvement would have to be attributed to
cooperativity of binding by the tetrameric lac repressor. Similarly, this construct could be
tested with the dimeric lac repressor to confirm that tetramerization is necessary.
Finally, we were able to test the behavior of our autogenous lac genetic switch on
the organism level. We showed that the tetrameric autogenous lac genetic switch was
capable of reversible regulation of luciferase in the livers of living mice. Surprisingly, the
induction ratios in mice surpassed those measured in cell culture resulting in
approximately 8-fold induction upon IPTG gavage and 14-fold repression after mice
were returned to normal water drinking. This study will need to be confirmed in an age
and sex matched mouse study and the functionality of the switch in additional tissues
such as the retina, where the field of gene therapy has enjoyed success, are important
future directions.
This thesis studied the lac repressor in purified in vitro experiments, in living E.
coli, in living eukaryotic cells, and finally in living mice. We have found good agreement
when comparing in vitro to in vivo E. coli. We have found good agreement between
structurally relevant mutations of the lac repressor and in vivo E. coli and even in cell
culture of eukaryotic cells. Finally, autogenous switches which were shown to function
in cell culture were also shown to function in the liver of a mouse. The functionality of
the switch on all of these scales are well explained by the Monod, Wyman, and
Changeux model of protein allostery.
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Appendices
A.1. An Assumption Free Model of the Autogenous Lac Genetic Switch
We can use the solution for the MWC model from Chapter 4 to model the
autogenous lac genetic switch. First, we define the concentration of the lac repressor for
a given unregulated promoter to be [R]tot. We measured [R]tot for our experimental
system in Chapter 4; for ~10-20 copies of the lacI promoter in EPB225 cells [R]tot ≈ 650
nM. It is important to remember that [R]tot will be a function of promoter strength and
copy number of the promoters in the cell. The equilibium value of repressor in the cell
for the autogenously regulated (AR) system is then defined as,

AR
[R]tot
=

[O]
[R]tot
[O]tot

(124)

Of course we know that the autogenously regulated repressor concentration is
bound by reality, such that,

0 mM≤[R] AR
tot ≤[R]tot

(125)

We then will start with Equation (109) which we will re-define here,
AR

[R]=

[R]tot
B1 +[O ]B2

(126)

We will then insert Equation (124) into Equation (126) and isolate the free
operator concentration [O],
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[O ]
[R] tot
O tot
[R]=
B1 +[O ]B2

[R]B1 +[R][O ]B2 =

[R]B1 =(

[R]tot
[O ]
[ O]tot

[R]tot
−[R]B2 )[O]
[O]tot

(127)

(128)

(129)

Now we can insert the formula for free operator from Chapter 4 (Equation (110))
into Equation (129),

[R]B1 =(

[R]tot
[O] tot
−[R]B2 )
[O]tot
1+[R]B2

(130)

Now we will re-arrange Equation (130) as we did in Chapter 4,

[R]B1 +[R]2 B1 B2=[R]tot−[R][O]tot B2

(131)

[R]2 B1 B2 +[R](B1 +[ O]tot B2 )=[R]tot

(132)

ϕ2AR=B1 +B2 O tot

(133)

[R]2 ϕ1 +[R]ϕ AR
2 =[R] tot

(134)

It is now abundantly clear that Equation (134) will take the place of Equation
(117). Just as before we have two Equations (134) and (120) which are polynomials of

166

[R] and [E]. Again, as before, we guess at values of [E], calculate [R] from each
equation, and minimize the difference.
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